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CHAPTER I 
 
INTRODUCTION 
 
Fluorescent Microscopy 
 
 The phenomenon of fluorescence was first observed by Sir John Frederick William 
Herschel in 1845.  Herschel noted that when a solution of quinine was illuminated with sunlight, 
it exhibited an ―extremely vivid and beautiful celestial blue colour.‖(9)  These early descriptions 
clearly demonstrated the recognition of an unusual phenomenon which, at the time, could not be 
explained scientifically.  Years later, the phenomenon he described, which would come to be 
known as fluorescence, would become a critical component in the development of a method of 
microscopy utilized to study interactions that occur on a scale too small to be seen with a light 
microscope.  Today, fluorescent microscopy is applied to a wide range of applications from 
protein-protein interactions to the effect of small molecules on biological systems.   
 
Fluorescent and Confocal Microscopes 
 It was an interest in the first discovered fluorophore, quinine, which led to the 
development of the first spectrofluorometer.  During World War II, there was an increased 
interest in the detection of antimalaria drugs such as quinine by the Department of War.  Early 
drug assays showed that the fluorescence property of the molecule would make an effective 
detection strategy and lead to a subsequent program at the National Institute of Health to develop 
the first spectrofluorometer.(9)  Today, fluorescent microscopes are a staple in the study of 
biological systems and have been developed for the use of multiple fluorophores, allowing the 
researchers to learn about a number of interactions simultaneously.  
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 Fluorescent microscopes resolve fluorescence as a function of spatial coordinates in 
either 2 or 3 dimensions for objects on the micro-scale.  The most commonly used fluorescence 
microscope is known as an epifluorescent microscope.  Epifluorescent microscopes are set up so 
that both excitation and observation is from above (epi-) the specimen.  An epifluorescent 
microscope has four main components which result in the specific detection of fluorescence.(10; 
11)  The first of these is the light source which is used for excitation of the specimen and 
typically is either a xenon arc lamp, mercury-vapor lamp or a wavelength specific laser.  The 
second and third components are an excitation filter and a dichoric mirror (or dichromatic beam 
splitter) which are both responsible for allowing only light of the wavelength necessary for 
excitation to reach the specimen.  The final component is the emission filter which is located 
between the the objective  
 
 
 
 
 
 
 
 
 
 
Figure 1.  Optical set up of an epifluorescent microscope. In an epifluorescent microscope, both 
illumination and detection come from above the specimen.  Further, the use of a dichoric mirror filters 
the illumination light so that the specimen is only hit with a particular wavelength of light which will 
lead to excitation.  Only the emitted fluorescent light and reflected excitation light is then directed to 
the objective, and is filtered further so that only the fluorescent light reaches the detector by the 
emission filter.(5) 
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and the detector.  The emission filter then seperates the reflected excited light from the emitted 
light so that only the fluorescence (emitted light) is detected.(10; 11)  With these components, a 
specimen which has been labeled with a specific fluorophore, is illuminated with a corresponding 
wavelength of light resulting in excitation of the specimen.  This causes fluorescence emission 
which is then separated from the reflected illumination light by the emission filter and the 
fluorescence is detected (Figure 1).(10)  In the case of the epifluorescent microscope, because 
most of the excitation light passes through the specimen unaltered, only reflected excitation light 
reaches the objective together with the emitted fluorescent light, giving an improved signal to 
noise ratio.(10)  Though a basic epifluorescent microscope is useful for a number of applications, 
it can not give the resolution necessary to focus on specific planes within a specimen.  In the case 
of biological applications, such as protein trafficking, simply being able to confirm fluorescence 
within a specimen is not enough, the ability to look at the exact location of the fluorescence is 
needed.  As a result, an improved fluorescent microscope, known as a confocal microscope, was 
developed.   
 The development of the confocal microscope revolutionized microscopy the way few 
things before it had.  Its power lies in the unique resolution it offers: 
―With the new microscope, one can slice incredibly clen, thin optical sections out of thick 
fluorescent specimens; view specimens in planes tilted to, and even running parallel to, the line of 
sight; penetrate deep into light-scattering tissues; gain impressive three-dimensional (3D) views at 
very high resolution; obtain differential interference or phase-contrast images in exact register 
with confocal fluorescence images; and improve the precision of microphotometry.‖(12) 
 
The concept of the first confocal microscope was devised by a post doc at Harvard University in 
1957 named Marvin Minsky.(12)  Today the basic idea of the confocal has been developed into a 
laser-scanning confocal microscope which is used in a broad range of biological applications.  
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While traditional epifluorescent microscopes give images with depths of 2-3 µm, the confocal 
microscope is able to yield images with depths less than 1 µm thick, simultaneously rejecting out 
of focus light.(4)  A typical confocal microscope is set up similar to an epifluorescent microscope 
with the addition of a pinhold apparatus known as the detector apparatus (Figure 2).(4; 12; 13)  
The ability of the confocal microscope to give images of such thin focal planes is the result of this 
detector apparatus located between the emission filter and the detector.  Only the light emitted 
from a narrow plane of the specimen, known as the focal point, will be traveling in a path which 
allows them to transverse the pinhole apparatus.  Any light originating from other planes will 
simply strike the walls of the pinhole apparatus.(4; 12; 13)  The pinhole apparatus is also 
responsible for  
 
 
 
 
 
 
 
 
 
 
determining the image thickness because there is a direct relationship between the size of the  
Figure 2. Optical Set up of a Confocal Microscope. The confocal microscope includes a pinhole 
apparatus which allows only light that originates on a particular plane (focal point) to be detected.  All 
other out of focus light is blocked by the pinhole apparatus.(5)  
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pinhole and the thickness of the focal point.  As the pinhole diameter increases, so does the 
thickness of the focal point; for larger pinholes, confocality is essentially lost.(4)  The use of a 
pinhole apparatus to discriminate fluorescent signal results in the detection of only one focal point 
at a time; therefore, in order to create a 2D image of an entire plane, it is necessary to scan the 
plane one focal point at a time.(4; 11; 13)  Two methods are typically employed to do this.  The 
first is the use of a Nipkow disc which is a rotating disc containing pinholes.  The second, which 
is used in laser-scanning confocal microscopy, is the use of a laser beam reflecting off vibrating 
mirrors.(4; 11; 13)  In this method, a cathode ray tube (CRT) is used to recreate the 2D image of 
the plane after the scan is complete.  By collecting scans of each focal plane, the images can in 
turn be used to create a 3D image of the entire specimen.   
 The advantages of the confocal microscope over traditional epifluorescent microscope are 
immediately evident when comparable images of the same specimen are compared (Figure 3).(4)   
 
 
 
 
 
Figure 3.  Comparision of the images from an epifluorescent microscope and a confocal microscope.  
In a normal epifluorescent microscope, emitted light from out of focus planes above or below is also 
detected in the image, leading to blurring (A).  The addition of the pinhole apparatus in the confocal 
microscope yields images that have more detail and are free of background fluorescence (B).(4)  
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The most notable advantages are reduced blurring of the image from light scattering, increased 
effective resolution and an improved signal to noise ratio.  Confocal microscopes also offer the 
ability to make xy scans over large areas of specimen and recreate 3D images of the 
specimen.(12)  Because confocal micrscopy offers such advances in fluorescent microscopy, it 
has been applied here to the study of a wide range of biological systems.  Here we discuss a 
number of applications wherein we have applied confocal microscopy to solving a scientific 
question.   
 
Applications of Confocal Microscopy to Biological Systems 
 
Monitoring β-hematin degradation in macrophage cells by confocal microscopy 
 An acute malaria infection is marked by a host inflammatory response, which produces 
chills and fevers, and anemia, arising from the destruction of an enormous percentage of red 
blood cells.(14)  However, this not the only pathology associated with the disease- there is also 
substantial but specific immune system dysfunction in parasite infected patients, brought on, in 
particular, by the phagocytosis of hemozoin.  Hemozoin (Hz) is a heme dimer based biomineral 
that is formed by the malaria parasite as a detoxification method to remove excess free heme that 
results from the parasites catabolism of host hemoglobin.(15-18)  Native Hz consists of two 
components – the biomineral Fe-heme core, and a lipid peroxidation product coating that arises 
from interactions with the red blood cell membrane when it ruptures.(19)  The 
immunomodulatory effects of the phagocytosis of native hemozoin span a range from the 
inability of phorbol esters or N-formyl-L-methionyl-L-leucyl-L-phenylalanine (FMLP) 
stimulation to produce oxidative burst, the inability of Hz-laden macrophage to kill ingested 
bacteria, fungi or tumor cells or even ingest opsonized, damaged erythrocytes.(19; 20)  The 
inhibitory effects of Hz phagocytosis on macrophage function is not global, however.   There is 
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evidence that Hz-laden cells are still viable and adherent, as well as able to maintain normal DNA 
and protein synthesis levels and only slightly abnormal ATP levels.(20)  This suggests that Hz 
associated dysfunction is a specific process and not just global poisoning of macrophage cells.  
Unfortuntely, the mechanism of this specific inhibition is not well understood.   Our project aim 
them was to individually assess the components of native Hz – the biomineral core and the lipid 
peroxidation products which coat it- to attempt to elucidate the source of this immunomodulatory 
activity.   
 When exploring this project, we found particular interest in the previous literature that 
showed that native hemozoin was not degraded within macrophage cells, even up to 72 hours 
after phagocytosis (Figure 4).(2) 
 
 
 
 
 
 
 
 
It was this trait of Hz-induced macrophage dysfunction that opened the door to the use of 
confocal microscopy to assess the effect of the biomineral core of Hz on the particular ability of 
macrophage to handle phagocytosed material.   To do this, the synthetic form of Hz known as β-
hematin (BH) was used.  BH is structurally identical to the Fe-heme core of Hz but has not been 
24 hr. 72 hr. 
1 hr. 12 hr. 
Figure 4.  Confocal microscopy of hemozoin.  Confocal microscopy shows the presence of hemozoin in 
phagolysosomes of macrophages for up to 72 hours after phagocytosis. (2) 
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exposed to the biological component of Hz.(7)  By using this synthetic version, we were able to 
focus entirely on the effect of the biomineral core alone, excluding potential contamination of 
biological products.  Confocal microscopy was used to discover whether the persistence of native 
Hz within macrophage cells was a result of the resistance of the biomineral core to the reactive 
oxygen and nitrogen species with which macrophage cells are equipped to handle phagocytosed 
material or if it was the result of a larger magnitude malfunction.   
 Corresponding biochemical experiments suggested preliminarily that BH is susceptible to 
being degraded by the reactive oxygen and nitrogen species found in functional macrophages, but 
these alone gave no insight into the behavior of BH inside macrophage cells. For this, we turned 
to confocal microscopy.  To determine whether BH was able to persist inside macrophage cells, 
its intrinsic fluorescent properties were used to directly image the biomineral after phagocytosis.  
By doing this, it was clear that in macrophage cells which had only been treated with BH, the 
ability to degrade the biomineral was not affected; rather, the biomineral was readily degraded 
(Figure 5).  This suggested preliminarily that the persistence of native Hz in macrophage cells 
was a product of different component acting upon the cells to cause the observed dysfunction.  To 
identify this component, we turned to the biological component of native Hz – the coating of lipid 
peroxidation products found associated with the biomineral core in native Hz.   
 When the lipid peroxidation products found associated with native Hz were analyzed, a 
variety of primary and secondary oxidation products were identified.  In particular, 4-
hydroxynonenal (HNE), a highly reactive electrophile, was identified.  Through a series of 
experiments (described in greater detail in Chapter 2), we were able to conclude that HNE 
inhibited macrophage ability to produce reactive oxygen and nitrogen species as a result of the 
inhibition of oxidative burst.  To investigate how this inhibition affects the macrophage ability to 
degrade BH, we once again turned to the power of imaging and confocal microscopy.  By 
repeating the BH phagocytosis experiment with the additional step of pretreating the cells with 
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HNE, it became clear through the image analysis that BH was not being degraded in HNE-treated 
cells (Figure 5).  This result, combined with the earlier biochemical experiments, allowed us to 
conclude that the lipid peroxidation products associated with native Hz were the culprit in the 
immunomodulation seen associated with the phagocytosis of native Hz.  In this project, confocal 
microscopy proved to be instrumental in allowing us to investigate the fate of the BH in a 
biologically relevant environment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A. 
B. 
C. 
D. 
Figure 5.  BH degradation in RAW macrophage cells.  Confocal of BH in RAW macrophage cells 
after 0 hours shows a strong fluorescent signal (A) compared to 72 hours where the fluorescent signal 
from the BH is nearly completely dimished (B).  When cells are pretreated with HNE prior to 
phagocytosis, samples look similar at 0 hours (C) but the fluorescent signal from BH persists after 72 
hours (D). 
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Investigating the functional consequences of HNE adduction to PKC 
 The intensely reactive nature of HNE has led to its implication in the pathology of a wide 
range of diseases including cancer, athlescelarosis, arthritis, and is considered a marker of 
oxidative stress. (21)  It has also been shown to inhibit oxidative burst, the mechanism by which 
macrophage cells produce reactive oxygen and nitrogen species.(20)  Proper oxidative burst is 
essential in the ability of the innate immune system to handle and destroy phagocytosed 
microbes.   As a result, its inhibition by HNE is of special interest.  Though the mechanism by 
which HNE is able to inhibit oxidative burst is not fully understood, preliminary research has 
shown that it HNE is able to form adducts on Protein Kinase C (PKC).(20) PKC isozymes make 
up a family of serine/threonine kinases which function in a number of cellular systems.  While the 
function of different PKCs can vary widely, the specific isoform PKCβII has been found to be 
necessary for the assembly of the NADPH complex, without which, a cell is unable to produce 
reactive oxygen species.(22)  Because of this, the interaction of HNE and PKCβII was 
explored.(23)   
 When PKCβII was treated with HNE, western blot analysis showed that HNE was able to 
form an adduct on the protein.  To gain information about the location and number of HNE 
adducts formed, MS/MS was used.(23)  This method allowed the peptide fragments of the protein 
to be analyzed and those which showed a shift corresponding to the addition of HNE to an amino 
acid within that peptide.  These positive peptides were then further analyzed by looking at the b 
and y ion fragments to determine the exact location of the HNE adduct.  Through this analysis, 
five sites where HNE had formed an adduct were identified.(23)   These five adducts were 
located on His 479, His597, Cys572 (or Lys573), Cys586 and His30.(23)  By knowing the 
location of the HNE adducts, interesting hypotheses about the effects of these adducts can be 
proposed.  However, they do not give any information about the functional consequences of the 
addition of these adducts.  To explore this, we once again turned to confocal microscopy.   
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 One of the major actions associated with proper PKC activation is it’s translocation from 
the cytosol of the cell, where it remains in its resting state, to being associated with the plasma 
membrane. (24) This translocation has been shown to be particularly crucial for the proper 
assembly of the NADPH complex.(25)  PKC translocation is the result of activation by a number 
of receptors, most importantly diacylglycerol (DAG) or its commonly utilized analog  phorbol-
12-myristate-13-acetate (PMA).(24)  As a result, we were interested in using confocal 
microscopy to study the effect of the HNE adducts on the ability of PMA to induce translocation 
of PKCβII.  For this study, PKCβII was labeled using anti-PKC antibodies in samples either before 
or after PMA activation and the extent of translocation as analyzed.  Further, both samples which 
had been pretreated with HNE and control samples which had not been exposed to HNE were 
analyzed. (23)  As shown in Figure 6, translocation of PKC was seen when macrophage cells 
were treated with PMA.  However, in samples which had been pretreated with HNE, the same 
fluorescent ring characteristic of the antigen being located near the membrane of the cell, was not 
seen.  Instead, the fluorescence continued to have a morphology akin to that seen in the 
unactivated samples.  This indicated that HNE treatment was inhibiting the ability of PKC to 
translocate from the cytosol to the membrane upon activation with PMA.   
 
  
Figure 6.  PMA-induced translocation of PKCβII.  A)  Untreated RAW cell samples were fixed with 
paraformadlehyde and labeled with Anti-PKC primary The samples should display a large distribution of 
PKC throughout the cytosol of the cell. B.) In cells which were activated with PMA it is evident that the 
PKC has now translocated and is concentrated at the plasma membrane of the cells.  C.) However, cells 
that were treated with 35 μM prior to PMA activation did not demonstrate the same translocation seen in 
PMA activation alone 
A. B. C. 
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Confocal microscopy allowed us to assess the functional effects of HNE adducts on PKC in a 
number of ways.  Not only were we able to explore the impact of HNE adducts on PKC 
translocation, but it could be applied to other functional aspects of proper PKC activation to draw 
conclusions about how these adducts affected the protein (see chapter 3 for more detail about 
other confocal experiments).   
 The use of confocal microscopy in these experiments served to highlight some of the 
challenges in using this technique to capture a process such as PKC translocation.  PKC 
translocation is a dynamic process which happens within a matter of minutes of PMA treatment.   
Because this experiment was being performed in fixed cells, it required a lot of optimization to 
capture the process; an error of minutes could cause it to be completely missed.  This 
demonstrated one of the challenges of using confocal microscopy to capture processes at the 
cellular rate.  This is not the only challenge of confocal microscopy, however.  
 
Lessons from Respiratory Syncytial Virus 
 A collaboration with the Wright Lab and the Crowe lab has aimed to both detect and 
study Respiratory Syncytial Virus (RSV).  RSV and other respiratory viruses combine to form the 
number one reason for medical presentation in the United States.  Worldwide, RSV itself causes 
6.5 million infections and 1 million deaths annually.  Despite the prevelance of this virus, it is still 
not well understood.  As a result, we set out to develop an intracellular RNA probe to study the 
progression of viral RNA in live cells.  To do this, we attempted to apply extracellular labeling 
techniques to our intracellular efforts.  Specifically, we attempted to utilize streptolysin O (SLO) 
enzyme to reversibly form pores in the cell membrane.  SLO is able to create a pore in the cell 
membrane  by attaching to chloresterol and polymerizing, forming a channel about 30 nm in 
diameter.   With the use of SLO, it was our goal to be able to internalize a quantum dot (QD) 
which would in tern be able to label the viral RNA of RSV.  However, this endeavor was met 
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with a fatal snag, QDs proved just too large to allow for entry into the cell.  From this it became 
clear that despite the power of microscopy, it is still limited by the tools available, especially the 
tools available to study RNA in live cell environments.   
 
The Challenge of Improving Microscopy 
 
Limitations of Microscopy 
 As the attempts to use QDs for a real-time intracellular probe demonstrated, there are 
limitations to the applications to which microscopy can effectively be applied.  In fact, there are 
three main limitations: resolution, multiplexing and the ability to capture dynamic cellular 
processes.  The limitations of microscopy are largely an artifact of the tools available to probe 
different subcellular biological systems.   Though the microscopes themselves may be sensitive to 
detect low levels of fluorescence and multiple colors almost simultaneously, the probes available 
to specifically label and detect these components are not of a high enough caliber to maximize the 
potential of the instrument. As we discovered with the RSV project, this is particularly true with 
the labeling and imaging of RNA.   
 
Development of a New Probe for RNA imaging 
 The challenges faced when trying to label RNA in live cells became quite 
apparent in the failed attempt to incorporate QDs into live cells for the labeling of RSV viral 
RNA.   At the present there are a number of common methods available for the labeling of RNA, 
each with their own advantages and limitations.  Reverse Transcriptase PCR (RT-PCR) is a 
highly specific and sensitive tool for detection of specific RNA sequences.(26-28)  RT-PCR has 
been used successfully in the detection of low levels of RNA making it a useful method when 
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sample is limited. Unfortunately, this method is labor intensive and contamination is a constant 
concern.  More importantly, RT-PCR cannot be used to study live cells because the RNA must be 
extracted rendering it for useless in studying the molecular mechanisms of RNA trafficking.  
Fluorescently-labeled oligonucleotide probes have also been widely employed to explore and 
quantify intracellular RNA.  Some of these methods include Förster resonance energy transfer 
(FRET) pairs, molecular beacons, and in situ hybridization(29-33).  These probes are designed to 
hybridize with a specific RNA sequence, providing in vivo spatial information about that 
particular strand of RNA.  However, probe internalization is a significant challenge with these 
techniques.  Various transfection methods have been developed to shuttle fluorescently labeled 
oligonucleotides into cells including cationic lipids and polymers, modified viruses, dendrimers, 
and liposomes.  Each of these methods has limitations and ultimately the necessity of chemical 
transfection reagents limits the utility of these probes. Further, these probes are also susceptible to 
rapid degradation by cellular nucleases leading to high backgrounds, false positives and poor 
target detection.  Although these obstacles can be circumvented by cell fixation, doing so renders 
them inapplicable for live cell imaging. Recently, the unique advantages of nanoparticles have 
been exploited to develop probes that overcome a number of limitations found with the 
aforementioned methods.(34; 35)   
AuNPs functionalized with oligonucleotides have been shown to efficiently enter live 
cells without the aid of harsh transfection/permeabilization agents and have limited cytotoxic 
effects.  The recent development of ―nano-flares‖ (NF) takes advantage of these qualities to yield 
a real-time probe capable of detecting specific RNA sequences with minimized background 
interference.(34)  A NF consists of an AuNP conjugated to a long probe sequence of DNA, which 
is compliment to the RNA of interest.  There is also a short hybridzed ―reporter‖ strand of 
fluorescently- tagged DNA.  In this state, the organic fluorophore is quenched as a result of its 
proximity to the AuNP. Upon hybridization of the probe strand with the target RNA compliment, 
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the reporter strand is released, spatially separating it from the AuNP and  resulting in a 
fluorescent signal that can be correlated to the presence of the RNA sequence of interest.(34)  
While NFs overcome many of the challenges faced by previous approaches, their design yields a 
signal that diffuses away from the hybridized RNA/NF construct.  Consequently, important 
spatial information is lost in live cell microscopy applications.   
After assessing the benefits and limitations of each of the present methods for RNA 
imaging, As a result, we set out to improve the technology available by developing a new probe 
that could be used for the live cell imaging of RNA that would allow not only for detection of 
RNA but for imaging of it in such a way to gave spatial information about the RNA trafficking.  
In the development of this probe, a list of critieria was developed that laid out the necessary 
characteristics in order to develop a probe that would meet the needs of our system. Specifically, 
our goal of this project was to apply chemical methods to the development of a novel nano-based 
probe for RNA imaging that meets all the demands of an ideal probe for LIVE CELL 
APPLICATIONS and overcomes the limitations of previous methods.  We also wanted to apply 
the use of this probe to the RSV viral system to detect and label viral RNA.  With this in mind, 
the list of optimal properties this probe had to possess are listed as follows: 
1. Easily Synthesized and Characterized 
2. Specific –in vitro 
3. Favorable in vivo properties 
a. Minimal cytotoxic effects 
b. Stabile  
c. Readily Internalized 
d. Specific –in vivo 
4. Multiplexing Capabilities 
5. Gives Spatial Information 
 
With this set of guidelines, we chose to apply the advantages of nanotechnology and in 
particular, AuNPs in designing the basis of our construct (for more details on these advantages, 
see chapter 4).  As a result, we have developed a new probe for studying RNA trafficking that 
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exploits the advantages of oligonucleotide functionalized AuNPs and overcomes the spatial 
limitations of previous designs.    Nanoblossom (NB) probes consist of an AuNP conjugated to a 
strand of hairpin DNA, which contains a fluorophore at the 3΄ end (Figure 7).   
 
 
 
 
 
A specific sequence of RNA, the compliment to the ―loop‖ region of the DNA hairpin, 
can be detected through hybridization with the NB.  Without compliment DNA or RNA, the 
hairpin sequence of the NB oligonucleotide remains folded, with the fluorophore quenched due to 
the proximity of the gold nanoparticle surface.  Upon binding the specific RNA target, the hairpin 
opens and the fluorophore extends a sufficient distance from the nanoparticle to overcome 
quenching.  More importantly, the fluorophore does not dissociate from the NB.  This allows not 
only the detection of the RNA of interest, but also the identification of its spatial location in real 
time.  Once this probe was designed and synthesized for a specific sequence, in our case a 
 
 
Au 
 
Au 
Figure 7. Nanoblossom Construct.  Nanoblossoms were synthesized by conjugating a 26 base hairpin DNA 
with a T-10 linker to a Au nanoparticle through a 5’ thiol. In the closed state, the fluorophore is quenched due 
to its proximity to the gold nanoparticle.  However, upon binding with the appropriate compliment, the hairpin 
opens and the fluorophore is then a sufficient distance from the nanoparticle to overcome the quenching.  This 
allows for the detection of compliment by monitoring fluorescence intensity.  Importantly because the 
fluorophore does not dissociate, the fluorescence intensity can be used to learn about the spatial orientation of 
the RNA.  
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sequence compliment to a region of genomic RSV RNA, it was characterized and implemented to 
our system.   We were able to show that it was synthesized in a straightforward Au-thiol 
conjugation, yielded specific fluorescent signal and had minimal adverse effects when used in an 
in vivo system.  More importantly, because of the nature of the construct, it allowed us to label 
RSV RNA in live cells and confidently gain spatial information about the location of that RNA.   
This was possible because the NBs can easily be combined with traditional labeling techniques to 
multiplex label a particular sample and as a result, achieve spatial resolution about the target 
sequence.  In this way, a new tool was developed that can be applied to any system of interest to 
allow for live cell imaging of a specific sequence of RNA to learn about how that sequence is 
trafficked within the cellular environment. 
 
Conclusion 
 
Fluorescent microscopy, and in particular, confocal microscopy is a powerful tool that 
allows the user to move beyond imaging specimen on the whole cell level and begin to probe the 
events happening on a subcellular level.  When applied to a biological question, fluorescent 
microscopy can provide information about cellular events that would be difficult to answer by 
another method.  Here we have shown two examples of just such problems.  The application of 
confocal microscopy to determine the fate of BH in macrophage cells in the absence and presence 
of lipid peroxidation products.  In doing this, we were able to determine that it was these 
oxidation products that caused the macrophage dysfunction associated with native Hz 
phagocytosis.  In another example of the power of fluorescent microscopy, the effects of HNE 
adduct formation on PKC function were assessed.  In doing so, it was possible to determine that 
the formation of HNE adducts inhibited the ability of PKC to translocate upon PMA activation.  
Not only that, but the HNE treatment inhibited the intracellular calcium flux normally seen with 
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PMA activation of PKC.  Each of these systems relied on microscopy to solve a specific 
biological question; however, it also began to highlight the challenges of using microscopy to 
capture dynamic biological processes. 
Despite its potential, fluorescent microscopy has its limitations.  The most challenging of 
these is the use of available probes for multiplexed imaging and capturing biological processes at 
the rate in which they occur.  In order to overcome these limitations, we developed a novel probe 
that would allow for easier live cell imaging of RNA and then applied it to the detection and 
imaging of RSV viral RNA.  NBs have proven to be easily sysnthesized and specifically label a 
particular sequence of RNA.  It can also be combined with traditional labeling techniques to give 
multicolor images that allow you to draw spatial information about the RNA as it is trafficked 
within a cell.  With the development of this new probe, we have made steps towards overcoming 
the limitations that are faced by this powerful tool. 
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CHAPTER II 
 
THE BASIS OF IMMUNOMODULATORY EFFECT OF MALARIA PIGMENT 
(HEMOZOIN) 
 
Statement of Effort 
 
 This project was the collaborative efforts of several people.  I personally was responsible 
for the contribution of experiments pertaining to the exploration of BH degradation.  These 
included in vitro degradation by ROS and RNS and the asscociated kinetics experiments.  It also 
included in vivo studies of BH degradation within macrophage cells both by confocal microscopy 
and flow cytometry.  While these experiments yielded interesting results, they could not have 
been conclusive without additional experiments contributed by Dr. Clare Kenny Carney and Dr. 
Alexandra Rutledge.    Dr. Clare Kenny Carney was kind enough to explore the inhibition of 
oxidative burst by both BH and various lipid peroxidation products.  Dr. Alexandra Rutledge 
helped provide a greater biologically relevant context by performing the ghost inhibition studies.  
By taking all of these experiments together, we were able to draw reasonable conclusions about 
the immunomodulatory effects of native Hz by studying its individual components.  Other minor 
contributions were made by Dr. Melissa Carter, Dr. Sarah Sewell Pierce, Reese Harry, Dr. Crystal 
Miller, Malgorzata Broncel, Ravinder Deol, Jacob Schaff.   
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 Introduction  
 
 
Malaria is the most lethal tropical parasitic disease facing the world today, responsible for 
1.5-2.7 million deaths and 300-500 million acute infections annually.(36)  Put into perspective, 
this year alone, malaria will kill the same number of people that AIDS has killed in the past 15 
years combined.(37) Not only does malaria cause a substantial loss of life, but also the economic 
toll of prevention and treatment in developing countries can be devastating.  The direct and 
indirect costs of malaria are estimated to slow the growth of developing countries by 1.3% per 
year as compared to countries without malaria.(36) According to the World Health Organization, 
malaria is considered one of the major public health challenges responsible for inhibiting the 
development of underdeveloped regions, on the same caliber as HIV/AIDS and tuberculosis.  The 
global impact of this disease has led to the need to better understand the pathology of the parasite, 
specifically how it modulates the host’s immune system.  
Though historically malaria was believed to have stemmed from fetid marshes, malarial 
infections are actually caused by parasites of the Plasmodium genus. Though there are four 
species of Plasmodium which can infect human hosts, Plasmodium falciparum is the most 
common and severe.(38) The vector responsible for transmission of the parasite is the female 
Anopheles mosquito which requires blood meals to produce eggs. As shown in Figure 8, sexual 
reproduction of the parasite takes place in the gut of the mosquito, and sporozoites, the parasitic 
form responsible for transmission, eventually travel to the salivary glands. During her next 
feeding, the female Anopheles injects the sporozoites into the human host.(38) Once in the 
vasculature, the sporozoites travel to the liver where they undergo a series of asexual  
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reproductions and develop into a feeding trophozoite that resides in the liver. After approximately 
a week, the trophozoites transform into merozoites and leave the hepatocytes.(38) The parasite 
then penetrates erythocytes in the blood. It is this intraerythrocytic cycle that is of interest to us.  
During the intraerythrocytic stage, the parasite again transforms into a feeding trophozoite, 
digesting up to 80% of the host hemoglobin inside an acidic (pH 4.8-5.0) lysosome called the 
Figure 8.  Lifecycle of Plasmodium falciparum.  Plasmodium falciparum goes through developmental 
stages in both the female Anopheles mosquito and a human host.  (151) 
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digestive food vacuole as a source of amino acids needed for growth and development.(15)  This 
enzymatically regulated catabolic process may result in the release of the free heme (ferric 
protoporphyrin IX, Fe(III)PPIX) at concentrations as high as 400 mM.(16)  This accumulation of 
heme results in the inhibition of digestive vacuole proteases, lipid peroxidation, generation of 
oxidative free radicals, and eventual lysis of the parasite.(39-42)  In order to circumvent this 
challenge, a detoxification pathway has evolved whereby free heme is aggregated in insoluable 
biomineral known as hemozoin.(43)  As the parasite continues to develop, eventually the 
erythrocyte cells rupture, releasing the parasite, hemozoin and cell debris into the vasculature.  
From here, the parasite can either enter another erythrocytic cell or be ingested by another female 
Anopheles mosquito during a blood meal, thus completing the life cycle.(3; 38) 
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Figure 9.  The structure and SEM of hemozoin.  A. The structure of the biomineral hemozoin (3) B. 
An SEM image of hemozoin isolated from P. falcipurum (top) and β-hematin (bottom).(8) 
A. B. 
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Hemozoin (Hz) is comprised of heme dimers that hydrogen bond to form long thin 
spicules. Though there was much debate over the structure of Hz, the final structure was 
determined using Rietveld refinement combined with X-ray diffraction.(3)  Shown in Figure 9, 
the planar heme dimers have reciprocal Fe-O bonds to one of the propionic side chains of 
protoprophyrin IX. Hydrogen bonding between the free propionic acid groups allows the diner to 
form an extended network, which results in biomineral formation.(3)  β-hematin is a synthetic 
form of hemozoin that is synthesized through a dehydrohalogenation reaction between hemin 
chloride and 2,6-lutidine developed by Bohle.(7)  However, structural identity between β-hematin 
and native hemozoin was proven by IR, ESR, and x-ray absorption spectroscopy.(17)   
Synchronized rupture of the red blood cells (RBCs) results in the release of the parasite 
and hemozoin along with other cellular debris, including the lipid membrane of the erythrocyte, 
into the vasculature.(38)  The innate immune system then responds to this cellular damage by 
phagocytosis of the hemozoin particulates, among other cellular debris.   Under normal 
conditions, a microbe phagocytosed by a macrophage would be degraded through a number of 
synergistic mechanisms.  The first mechanism by which macrophage cells destroy microbes is 
through the biogenesis of the phagosome containing the particulate to the mature 
phagolysosome.(44)  During phagocytosis, a unique organelle known as a phagosome is formed 
around the foreign material as it enters the cell.  Originally thought to function through a simple 
mechanism, this organelle has been shown to participate in a dynamic array of interactions 
ranging from membrane protein recycling to microtubular formation with other organelles for 
specific protein exchange.(45) The result of all these exchanges is the development of a 
biochemically distinct organelle known as a phagolysosome.  The internal environment of a 
mature phagolysosome is loaded with hydrolases and other lysosomal enzymes.  It also has a pH 
of five or below and is rich in reactive oxygen and nitrogen species produced by the macrophage 
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cell.  This mature phagolysosome houses the harsh environment responsible for degrading the 
majority of phagocytosed material.(46-48)   
 
 
 
 
 
 
 
 
 
The second mechanism by which macrophage cells can destroy phagocytosed microbes is 
through a process known as respiratory or oxidative burst.(49) Phagocytosis of a microbe 
activates the formation of a plasma membrane-associated complex known as NADPH-oxidase. 
Once activated, NADPH-oxidase transfers electrons from NADPH to molecular oxygen to form 
reactive oxygen intermediates such as superoxide anion (O2
-
).  The superoxide anion quickly 
reacts to form secondary reactive oxygen species such as hydrogen peroxide, hydroxyl radical 
and hypochlorous acid, all of which readily destroy phagocytosed microbes.(50)  NADPH-
oxidase is not the only free radical-generating system, however. Inducible nitric oxide synthase 
(iNOS) is an enzyme that produces nitric oxide by catalyzing the conversion of arginine to 
citrulline after lipopolysaccharide (LPS) activation.(49)  Nitric oxide can then react with 
Figure 10.  EM of native hemozoin.  After erythrocyte rupture, hemozoin is phagocytosed by macrophage 
cells. (1) 
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hydrogen peroxide or superoxide to form peroxynitrite, a powerful anti-microbial.(49)  These 
reactive oxygen and nitrogen species (ROS and RNS) create a potent environment capable of 
destroying phagocytosed microbes.  
Despite multiple mechanisms for destroying microbes, hemozoin presents a challenge to 
macrophage cells. After erythrocyte rupture, native hemozoin released into the vasulature is 
phagocytosed by macrophages (shown in Figure 10) but is not degraded.(2)  Moreover, native 
hemozoin has been shown to impair several other macrophages. Following phagocytosis of 
hemozoin, the macrophage’s capacity to generate oxidative burst is diminished and lipid 
peroxidation is induced.(19)  There is a lot of controversy in the literature over the exact 
biological activity of macrophage cells in response to the phagocytosis of hemozoin.  Various 
aspects of cell vitality have been reported to be diminished, including phorbol ester-induced 
oxidative burst, rephagocytosis, killing of ingested bacteria, fungi or tumor cells and response to 
interferon γ stimulation.(19; 51-54)  Additionally, there is an increased production of 
immunosuppressive molecules such as porstaglandine E2.(51)  In vivo, increased levels of the 
highly reactive 4-hydroxy-2-nonenal (HNE) and hydroxylated fatty acids have been correlated to 
hemozoin phagocytosis.(53-55)  Despite these deleterious effects, other cellular functions appear 
to go unaffected including ATP levels, cell adhesion and the lack of apoptosis.  Though some 
cellular processes remain unaffected, it is clear that the hemozoin-induced changes cause the 
macrophages to be irreversibly incapable of degrading phagocytosed native hemozoin.(2)  In fact, 
native hemozoin has been shown by confocal microscopy to remain present in phagolysosomes of 
macrophage cells for up to 72 hours (shown in Figure 11).(2)  
While there is a growing consensus in the literature that native hemozoin maintains 
immunosuppressive activity, there is considerable controvery over the reactivity of the synthetic 
form, β-hematin (BH).  Studies have generated a contradictory assortment of results.  Some 
resports find that synthetic hemozoin can induce a proinflammatory (increased TNF-α, IL-6, 
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MIP-1α, MIP-1β and chemotactic cytokinds) response in macrophage cells(56-58) while others 
highlight an anti-inflammatory (decreased TNF-α, IL-6, and chemotactice cytokines) 
response.{Schwarzer, 1999 #15;Taramelli, 1998 #107;Taramelli, 1995 #106;Taramelli, 1998 
#108}  Furthermore, there are varying reports about the ability of BH to inhibit oxidative burst 
and rephagocytosis.  Once again, some studies indicate that the synthetic form is able to inhibit 
the production of ROS and RNS(60), while others claim that it does not.(55)  Unfortunately, 
previous studies of the effect of hemozoin phagocytosis on macrophage function have utilized a 
variety of different methods of acquiring and purifying the hemozoin. Most of these methods are 
not thorough and either do not attempt to purge the hemozoin of biological debris or do not 
completely rid the hemozoin of cellular debris such as membrane lipids.  As a consequence, the 
resulting biological response can not be attributed to a specific source. 
 
 
 
 
 
 
 
 
The state of hemozoin must be carefully defined in order to elucidate which components 
may be interacting to disrupt the host immune response.  Native hemozoin refers to the material 
isolated from parasitized RBCs and washed gently to remove cellular debris but left with a coat of 
24 hr. 72 hr. 
1 hr. 12 hr. 
Figure 11.  Confocal microscopy of hemozoin.  Confocal microscopy shows the presence of hemozoin in 
phagolysosomes of macrophages for up to 72 hours after phagocytosis. (2) 
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lipids absorbed onto the hydrophobic plate of porphyrins.(19)  Purified hemozoin, however, has 
also been isolated from P. falciparum; however, lipid extractions have been performed in 
attempts to remove the gradient of oxidized lipid products from the biomineral by detergent or 
organic solvents.(62; 63)  Finally, synthetic hemozoin, BH, is material that has been synthetically 
prepared and purified.(7; 17)  Given the emerging importance of hemozoin in modulating a host 
immune response to malarial infection, and the literature controversy surrounding the specific 
role of the biomineral, a careful examination of the effects of the constitutive components of the 
malaria pigment—both the biomineral core and the lipid peroxidation coat— on macrophage 
response would significantly clarify the understanding of the process.   
 
Materials and Methods 
 
Materials  
 All chemicals were used as received unless otherwise noted. N-(1-
Napthyl)ethylenediamine (NED), sulfanilamide, piperazube-1,4-bis(2-ethanesulfonic acid) 
(PIPES), Sepharose 2B, lippopolysachharide (LPS), sodium hypochlorite, diethylamine/nitric 
oxide sodium complex (DeaNO), and hemin chloride were obtained from Sigma-Aldrich (St. 
Louis, MO, USA).  Phorbol-12-myrisate-13-acetate (PMA) and HNE were purchased from 
Calbiochem (San Diego, CA, USA).  2,6-Lutidene was obtained from Acros Chemicals. Cayman 
Chemicals (Ann Arbor, MI, USA) supplied the 15-S-hydroxyeicosatetraenoic acid (15-HETE).   
Fetal bovine serum was purchased from Atlanta Biologicals (Atlanta, GA, USA).  
Penicillin/streptomycin was obtained from Cellgros Mediatech (Herdon, VA, USA).  The murine 
macrophage cell line, RAW 264.7, originally obtained from the American Type Culture 
Collection (ATCC TIB-71) was a kind gift from the Virginia Shepherd laboratory (Vanderbilt 
University).  Lysotracker Red was obtained from Invitrogen.  Packed RBCs were donated from 
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the VUMC Blood Bank.  All other chemicals were purchased from Fisher Scientific (Hampton, 
VA, USA) unless otherwise specified.   
All powder diffraction X-ray studies were performed with a Scintag X1 ζ/ζ automated 
powder difractometer with a copper target, a Peltier-cooled solid state detector and a zero-
background silica (510) sample support.  The step size was 0.02, preset time 25 s. All samples 
were scanned from 4 to 35 ° 2ζ.  Fuorier transform IR (FTIR) spectroscopy was carried out in a 
KBr pellet using an ATI Mattson Genesis Series FTIR spectrophotometer and scanning electron 
microscopy was performed with a Hitachi S-4200 scanning electron microscope.  All UV-vis 
spectroscropy was carried out either with an Agilent 8453 diode-array spectrophotometer or with 
a Bio-Tek Synergy HT multidetection microplate reader.  The Bio-Tek Synergy HT 
multidetection microplate reader was also used for fluorescence measurements.  All work done in 
an inert atmosphere was accomplished in a two-port Vacuum Atmospheres 2000-M glove box.  
All chromatography was performed inside a 4 °C chromatography refrigerator.  Confocal images 
were obtained using a Zeiss LSM 510 Meta inverted confocal microscope equipped with LSM 
Image Browser software.  Quantative analysis of the fluorescence of these images was 
accomplished using Metamorph software.  Cell sorting for BH degradation flow cytometry 
experiments was done on a Miltenyi Automacs Magnetic Cell Sorter. 
 
BH preparation and characterization 
 BH was synthesized using a modification of the Bohle dehydrogalogenation method.(7)  
In an inert atmosphere, 0.3 g of hemin chloride was dissolve in minial amount of 2, 6-lutidine 
(usually approximately 4 mL) with stirring.  Upon completion of dissolution, 40 mL of 1:1 
mixture of anhydrous methanol and dimethyl sulfoxide (DMSO) was added and te flask was 
sealed and covered with foil to protect the mixture from ambient light.  After leaving the mixture 
undisturbed for 3 months, it was removed from the inert atmosphere and the black solid product 
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was collected via vaccum filtration onto a 0.45-µm filter.  Relying on the differential solubility of 
hemin chloride and BH, excess free heme and small aggregates were removed by exhaustive 
washings in methanol, DMSO, 0.1 M sodium biocarbonate, pH 9.0, and deionized water.  Once 
agan, the solid was isolated using vaccum filtration onto a 0.45-µm filter and was dried overnight 
at 150 °C.  The resulting BH was characterized using IR spectroscopy, scanning electron 
microscopy and X-ray diffraction, with the results matching previously reported spectra.(3; 17; 
64) 
 
Cell Culture  
The adherent murine macrophage cell line, RAW 264.7, was maintained in continous 
culture with RPMI 1640 medium (GIBCO/BRL), supplemented with 10% (v/v) heat-inactivated 
fetal bovine serum, and 100 μg/mL penicillin/strptomycin (complete medium) in an atmosphere 
of 5 % CO2, 5% humidity at 37 °C.  Cell viability was determined by Trypan Blue exclusion 
using a hemocytometer. 
 
Measurement of ROS and RNS production 
 Measurement of ROS was accomplished using luminal-dependent luminescence.  In 
these experiments, RAW 264.7 cells were plated overnight in complete medium at a density of 4 
x 10
6
 cells per well in a six-well plate.  The following day, the medium was removed, the cells 
gently washed with phosphate-buffered saline (PBS) and treated.  After 3 hrs of incubation at 5 % 
CO2, 5% humidity at 37 °C, the supernatant was removed, cells gently washed with PBS and 
NADPH oxidase was activated by the addition of 1.0 mL of 100 nM PMA in PBS.  After 4 min, 
950 µL of this supernatant was collected into a luminescence tube followed by the addition of 50 
µL of 1.0 mM luminal (in PBS).  Luminescence was immediately measured using a Monolight 
3,010 luminometer for 10 s.  Alternatively, ROS were monitored using dichlorofluorescein 
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diacetate (DCF-DA).  In these reactions, cells were plated overnight in complete medium at 
density of 5 x 10
5
 cells per well in a 24-well plate.  The next morning, the cells were washed, then 
treated with HNE or 15-HETE, 100 nM PMA in PBS and 8 µM (final) DCF-DA for 60 min at 37 
°C and 5 % CO2, 5% humidity.  The formation of the fluorescent dicholorfluorescien was 
monitored with the Bio-Tek Synergy HT multidetectionmicroplate reader using a 485/20 
excitation filter and a 528/20 emission filter.  It is important to recognize that this assay, unlike 
the luminal assay described earlier, does not involve preincubation of the cells with HNE or 15-
HETE.  All assays were performed in triplicate and the average value is reported with the 
standard deviation.   
 Triplicate measurement of RNS was accomplished using the Griess assay.  For these 
experiments, RAW 264.7 cells were plated overnight in complete medium at a density of 5 x 10
5
 
cells per well in a 24-well plate.  The next day, cells were treated and then stimulated by the 
addition of 10 µL of 50 µg/mL LPS (1 µg/mL final) followed by incubation in 5% CO2, 5% 
humidity at 37 °C.  After 24 hrs, 300 µL of the supernatant was removed from the cells and spun 
down at 13,200 rpm for 15 min.  A 100-µL aliquot of the supernatant was then transferred to a 
96-well plate and the production of NO was monitored using the Griess assay.  For this assay, 
100 µL of each sample was reacted with 50 µL of 1 % sulphanilimide in 5% phosphoric acid, 
followed by 50 µL of 0.1 % NED.  After 5 min, the absorbance of the resulting azo complex was 
measured at 540 nm using a Bio-Tek Synergy HT multidetection microplate reader.  To 
investigate the effect of BH on the production of ROS and RNS, 120 µg/mL (final concentration) 
BH suspended in complete medium was used in all cases unless otherwise specified.   
 
Reaction of HNE and 15-HETE on stimulated RAW 264.7 cells 
 The ability of HNE and 15-HETE to inhibit PMA- and LPS-stimulated oxidative burst 
was analyzed.   To examine the effects of HNE and 15-HETE on the activation of NADPH 
 31 
 
oxidase, 5 x 10
5
 cells per well were plated in 24-well plates.  The following day, the cells were 
treated in triplicate with HNE (0-100 µM) or 15-HETE (0-12 µM) and incubated in 5% CO2, 5% 
humidity at 37 °C.  After 60 min, the cells were examined for NADPH oxidase activity using 
DCF-DA, a dye that is converted to the fluorescent dichlorofluorescein in the presence of 
oxidizing species (described earlier).  To investigate LPS inhibition, 5 x 10
5
 cells per well were 
plated in 24-well plates overnight.  Subsequently, the cells were washed once with PBS, followed 
by treatment with HNE (0-20.5 µM) or 15-HETE (0-20 µM), followed by stimulation of iNOS 
with LPS (1 µg/mL final per well).  These samples were allowed to incubate for 24 hrs before 
analysis of the supernatant via the Greiss assay (described earlier).  
 
Ghost cell preparation 
 To obtain erythrycyte membranes (ghosts),(65; 66) 3.0 mL of packed RBCs was 
suspended in 12.0 mL of 5 mM NaH2PO4 supplemented with 150 mM NaCl, pH 8.0 and 
centrifuged at 1,000 g for 10 min.  The supernatant was removed and the pellet was resuspended 
in the same buffer system.  After repeating the wash cycle four times to removed packaging 
contaminants, the pellet was resuspended in 5 mM NaH2PO4, pH 8.0 at 10% hematocrit.  The 
suspension was rigiously shaken and placed in an ice bath for 15 min prior to loading 15.0 mL 
(6% of the bed volume) onto a Sepharose 2B column (2.5 cm x 50 cm) located in a 4 °C 
chromatography refrigerator and equilibrated in 15 mM Pipes buffer with 0.1 mM EDTA, pH 6.0.  
The sample was eluted with 20 mM N-(2-hydroxyethyl)piperazine-N’-ethanaesulfonic acid 
(HEPES) buffere supplemented with 146 mM sodium chloride (pH 7.4) at flow rate of 15 mL/hr 
and 700 µL fractions were collected.  Elution of ghosts was monitored by absorbance of aromatic 
residues in proteins at 280 nm and they were typically found to be eluted in the dead volume.  
Relavent fractions were pooled and ghosts were collected by centrifugation (10,700g, 15 min, 4 
°C).  The supernatant was removed and the white pellet was resuspended in 20 mM HEPES 
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buffer supplemented with 146 mM sodium chloride, pH 7.4.  In order to disrupt the membranes, 
samples were alternately vortexed with glass beads for 2 min followed by placement in an ice 
bath for 2 min for a total of five cycles.  It should be noted that collection of reactive RBC ghosts 
is nontrivial and extremely sensitive to minor changes.   
 Reactions between RBC ghosts and BH were prepared in test tubes with a total volume of 
2 mL.  RBC ghosts, normalized to an absorbance of 0.7 at 280 nm, were added first, followed by 
500 µL of 3 mg/mL BH (0.75 mg/mL final) and the samples were taken up to 2-mL volume with 
RPMI 1640 complete medium.  After stirring for 24 hr at RT, the reaction mixtures were 
centrifuged for 15 min at 5,500 rpm to pellet ghost membranes and BH, RAW 264.7 murine 
macrophage cells were then treated in triplicate with varying amounts of the supernatant (from 0 
to 100%).  Luminol-dependent luminescence (see earlier) was used to measure the effect of the 
supernatant of the ghost-BH reaction on the production of ROS and the Griess assay (see earlier) 
was used to monitor the effects on the production of RNS. 
 
Degradation of β-hematin by ROS 
To study the ability of ROS to degrade BH in vitro, reactions between BH and 
standardized 0-100 mM hydrogen peroxide (67)and 0-10 mM sodium hypochlorite (68) were 
prepared in triplicate.  Breifly, to a 1.5-mL microcentrifuge tube, 100 μL of a 2.0 mg/mL 
suspension of BH in 100 mM sodium acetate buffer pH 4.8 was added to 300 μL of sodium 
acetate buffer, follwed by the addition of 100 μL of the appropriate concentration of hydrogen 
peroxide or sodium hypochlorite.  Prior to incubation in a 37 °C water bath for 20 h, the solutions 
were capped, covered with Parafilm and vortexed.  After incubation, the samples were 
centrifuged at 13,200 rpm for 30 min to pellet the remaining BH.  The clear supernatant was 
removed and the pellet washed once with deionized water and recentrifuged.  Finally, the BH was 
dissociated into free heme by dissolving the pellet in 1.0mL of 1.0 M NaOH and the absorbance 
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of free heme was monitored at 400 nm using a Bio-Tek Synergy HT multidetection microplate 
reader to quantitate the remaining heme. 
 
Degradation of β-hematin by RNS 
To study the ability of RNS to degrade BH in vitro, reactions between BH and 0-100 mM 
DeaNO, a nitric oxide (NO) releasing agen, were prepared in triplicate.  Briefly, to a 1.5-mL 
microcentrifuge tube, 100 μL of a 2.0 mg/mL suspension of BH in 100 mM sodium phosphate 
buffer pH 7.4 was added to 390 μL of sodium phosphate buffer, followed by the addition of 10 
μL of the appropriate conentration of DeaNO.  Prior to incubation in a 37 °C water bath for 20 h, 
the solutions were capped, covered with Parafilm and vortexed.  After incubation, the samples 
were centrifuged at 13,200 rpm for 30 min to pellet the remaining BH.  The brown supernatant 
was removed and the pellet washed once with deionized water and recentrifuged.  Finally, the BH 
was dissociated into free heme by dissolving the pellet in 1.0 mL of 1.0 M NaOH and the 
absorbance of free heme was monitored at 400 nm using a Bio-Tek Synergy HY multidetection 
microplate reader.  At concentration of DeaNO of 25 mM or greater, it was necessary to add 10 
μL of 5.0 M NaOH and allow the tube to rotate overnight to obtain complete dissociation of the 
BH pellet.  Finally, the absorbance of free heme was monitored at 400 nm using a Bio-Tek 
Synergy HT multidetection microplate reader in order to quantitate the remaining BH.  
Additionally, IR spectroscopy was used to analyze the formation of an Fe-NO complex at the 50 
mM DeaNO concetration.  The amount of NO released by DeaNO in this experiment was verified 
by running a series of control reactions.  Here, the samples were prepared and treated exactly as 
those described earlier except the 100 μL of BH was replaced with 100 μL of sodium phosphate 
buffer.  To analyze the amount of NO produced, the Griess assay (69) was employed.  It should 
be noted that Fe(III)PPIX solutions may absorb onto plasticware and can exist in different 
aggregation states, resulting in minor changes in absorbance.  
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Kinetics of Degradation of β-hematin by ROS and RNS 
To study the rate of ROS and RNS degradation of BH in vitro, reactions between BH and 
standardized 0-100 mM hydrogen peroxide (67), 0-10 mM sodium hypochlorite (68), and 0-100 
mM DeaNO were prepared in triplicate.  Here the samples were prepared and treated exactly as 
those described earlier exacept the incubation time was varied from 0-24 h in three hour 
incriments yeilding nine time points for each kinetic experiment. 
 
Confocal microscopy  
The localization of BH inside acidic phagolysosome was demonstrated using lysotracker, 
a pH-sensitive dye.  Here, 5 x 10
4
 cells were plated overnight, followed by a gentle PBS wash.  
Next, the cells were treated with 100 μL of 0.12 mg/mL BH suspended in complete medium and 
allowed to phagocytose in an atmosphere of 5 % CO2, 5 % humidity at 37 °C.  After 90 min, the 
cells were washed two times with PBS, and were treated with 2 mL of 100 nM PMA diluted in 
complete medium.  After 10 min of 5% CO2, 5 % humidity at 37 °C, the PMA was removed, the 
sample washed with PBS and covered with 2 mL of fresh PBS.  Approximately 5 min prior to 
imaging, 4 μL of 20 μM lysotracker diluted in PBS was added to the dish.  Fluorescence imaging 
of BH was accomplished by excitation at 514 nm followed by collection using a band-pass filter 
from 533.2 to 542.9 nm.  Lysotracker fluorescence was obtained by excitation at 543 nm 
followed by the use of long-pass 585-nm filter for emission.  The images were stacked into a 
composite figure in order to determine colocalization.  Confocal microscopy was also utilized to 
determine the fate of BH that has been phagocytosed by RAW 264.7 macrophage cells.  Cells 
were plated at 5 x 10
4
 cells per dish onto Mat-Tek dishes.  The following day, the cells were 
gently washed with PBS, followed by treatment with 100 μL of 0.12 mg/mL BH suspended in 
completely medium.  After 90 min at 5 % CO2, 5 % humidity and 37 °C, the samples were gently 
washed twice with PBS to remove any unphagocytosed BH.  Fresh complete medium was added 
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to the top, followed by incubation for 0, 48, and 72 h in an atmosphere of 5 % CO2, 5 % humidity 
at 37 °C.  At each time point, the samples were gently washed once with PBS, convered with 2 
mL of fresh PBS and immediately imaged on the Zeiss LSM 510 Meta inverted confocal 
microscope.  Fluorescence imaging of BH was accomplished by excitation at 514 nm, followed 
by collection using a band-pass filter from 533.2 to 542.9 nm.  In order to quantiate the 
fluorescence emission from the samples, projections were made of the z-stacks from 300 to 400 
cells per samples and Metamorph software was used to quantiate the amount of fluorescence 
above the background threshold.  The effect of HNE treatment on BH degradation in RAW 264.7 
macrophage cells was studied by confocal microscopy in the manner described above.  However, 
directly after treatment with BH (as previously described), the samples were treated with 35  μM 
HNE and incubated in an atmosphere of  5 % CO2, 5 % humidity at 37 °C for 3-4 h.  The samples 
were then gently washed with PBS to remove any excess HNE. Fresh complete medium was 
added to the top, followed by incubation for 0, 24, and 48 h in an atmosphere of 5 % CO2, 5 % 
humidity at 37 °C.  Finally, samples were imaged as described above.   
 
Flow Cytometry 
To determine the ability to distinguish β-hematin-laden cells from control cells by flow 
cytometry, a preliminary experiment compared the emission of these two populations.  The 
samples were prepared by plating 1 x 10
6
 cells in a 10 cm dish and incubating for 24 hours in an 
atmosphere of 5 % CO2, 5 % humidity at 37 °C.  The half samples were then treated with 5 mL of 
0.12 mg/mL suspension of β-hematin in RMPI 1640 medium.  The samples were incubated in an 
atmosphere of 5 % CO2, 5 % humidity at 37 °C for 90 min. All samples were then washed three 
times wth PBS to remove any excess β-hematin, or RPMI 1640.  Five milliliters of 0.05% 
EDTA/trypsin solution was added to each plate and incubated in 5 % CO2, 5 % humidity at 37 °C 
for 1 hour.  After incubation, the samples were scraped and 15 mL of RPMI 1640 was added to 
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quench the trypsin.  The samples were then centrifuged at 1500 rpm for 5 min.  The pellet was 
resuspended in 200 μL of PBS and centrifuged again for 5 min at 1500 rpm.  The pellet was 
resuspended in the working solution of 250 μL 0.5% BSA in PBS.  All samples were then run on 
Custom Becton Dickinson five-laser LSRII analytical cytometer.  The samples were excited at 
630 nm and emission was detected at 680 nm.  Approximately 10,000 cells were analyzed from 
each sample.  To assess the degradation of BH in RAW 264.7 cells by flow cytometry, 1 x 10
6
 
cells were plated into T-25 flasks and allowed to grow to 80% confluency in an atmosphere of 5 
% CO2, 5 % humidity at 37 °C.  The samples were then treated with BH as described above.  
After BH treatment, the cells were disassociated from the T-25 culture flask by aspirating the 
media and adding 5 mL of Cell Stripper solution to the sample for 30 min.  The samples were 
then prepared for analysis and sorting by flow cytometry as described above.  All samples were 
then run on a Custom Becton Dickinson five-laser LSRII analytical cytometer, with excitation at 
630 nm and emission detection at 680 nm.  The remaining sample was then sorted based on 
positive fluorescent signal using a Miltenyi Autosort Magnetic Cell Sorter and re-plated into three 
new T25 culture flasks.  These sample was then incubated for either 24, 48 or 72 hours in an 
atmosphere of 5 % CO2, 5 % humidity at 37 °C.  Analysis was repeated at the appropriate time 
interval for each sample to determine the overall BH degradation original RAW 264.7 cell 
population.  The effect of HNE treatment on the degradation of BH in RAW 264.7 macrophage 
cells was explored in a similar fashion.  Samples were plated, treated and analyzed as described 
above.  However, directly following BH treatment, samples were treated with 35 µM HNE for 3-
4 hrs.  In all flow cytometry experiments, the viabily of the samples was determined by the 
addition of 1 ng/mL of propidium iodide (PI) buffer to each sample. The fluorescence for each 
sample determined the number of dead cells within the sample population.   
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Results and Discussion 
 
BH synthesis and characterization 
 The Bohle method of synthesis was used to synthesize BH for studies of the heme dimer 
core of BH (Scheme 1).(7)  This dehydrohalogentation method requires three months for BH 
formation, ultimately leading to BH that has the long rod morphology seen with native maralia 
hemozoin.(7)    Once synthesized, the BH is cleaned taking advantage of the differential 
solubility of the BH crystal and any aggregated heme monomers and dimers with repeated washes 
in water and sodium bicarbonate.  The high pH of the sodium bicarbonate successfully dissolves 
any heme monomers and dimers which would remain aggregated within the BH crystals without 
dissolving the BH itself, which is resistant to dissolution at pH 9 (Figure 12).(6)   
 
 
 
 
 
  
 
 
 
 
Figure 12.   Differential Solubility of BH.  Plot of β-hematin purification showing the decrease in non-
crystallized hemin chloride during differential solubility washes as monitored by Soret band absorption. 
Insert shows details at low absorbance.(6) 
Scheme 1. Bohle method of BH synthesis.  β-hematin is a synthetic form of hemozoin that is 
synthesized through a dehydrohalogenation reaction between hemin chloride and 2,6-lutidine developed 
by Bohle.(7) 
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Once cleaned, the BH was characterized to show that it was structurally identical to native 
hemozoin.  To do this, both IR and XRD were utilized.  The XRD of BH shows characteristic 
peaks at 7, 21 and 24 2ζ.  It is evident that the BH has been cleaned of any contimaint starting 
material by the lack of a peak at 23 2ζ which is representative of the presence of hemin chloride 
(Figure 13).   Additional analysis of the synthesized BH by IR revealed two characteristic 
hemozoin peaks: 1211 cm
-1
 and 1664 cm
-1 
(Figure 14).  The peak at 1211 cm
-1
 corresponds to  C-
O stretch of the propionic side chain; the 1664 cm
-1
 peak corresponds to C=O stretch.(8)  These 
characterization processes were used to ensure that the BH used in experiments studying the 
effects of the dimeric heme core were performed with a synthetic version of hemozoin that was 
structurally and spectroscopically indistinguishable from native hemozoin.  
 
 
 
 
 
 
 
 
 
 
 
Figure 13.  XRD of BH.  The XRD of BH synthesized by the Bohle method shows the distinct peaks at 
7, 21 and 24 2ζ that represent the characteristic peaks of the hemozoin biomineral.   
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Effect of BH on ROS and RNS production 
 Biologically, the production of ROS and RNS in phaocytic cells is predominantly 
mediated by the action of two enzymes: NADPH oxidase and iNOS.  The production of ROS 
during oxidative burst is a result of the activation of NADPH oxidase.  Activation of this 
constitutively expressed enzyme results in the reduction of molecular oxygen to the superoxide 
anion which is rapidly converted to secondary species such as hypochlorous acid (HOCl), the 
hydroxyl radical (OH
.
) and hydrogen peroxide (H2O2).(66; 70-72)  RNS are initiated by the 
induction of nitric oxide synthase.  Once translated, iNOS produces nitric oxide, which in turn 
can react with molecular oxygen to form a variety of derivatives, including NO2, N2O3, NO2
-
, and 
NO3
-
. (69) Together, these species act to degrade foreign pathogens.  Considering the innate 
toxicity of these reactive microbicidal agents, their modulation is an important component in 
establishing a successful parasitic infection.   
 BH’s ability to modulate the activity of NADPH oxidase was exhamined.(6)  As seen in 
Figure 20, BH does not inhibit the production of ROS in PMA-stimulated RAW mouse 
macrophage cells.  Preincubation with up to 0.4 mg/mL BH showed no inhibitory effect on 
superoxide anion production as mueasured by luminolenchance luminescence. (6) Resports have 
Figure 14. IR of BH.   IR of (1) β-hematin from Ziegler et al. J. Am. Chem. Soc. 1999, 121, 2395, (2) β-
hematin prepared via the dehydrohalogenation rection, and (3) P. falciparum hemozoin. 
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similarly indicated no inhibition of ROS in mouse macrophage-like B10R, BV2 microglial and 
peritoneal macrophage cells lines.(63; 73)  In contrast, phagocytosis of native hemozoin by 
human monocyte-derived macrophages resulted in inhibition of PMA-stimulated NADPH 
oxidase in a dose-dependant fashion.(19; 53)   
 
 
 
 
 
 
 
 
 
Challenge of LPS-stimulated iNOS in RAW mouse macrophage cells with BH does not 
inhibit the production of RNS either (Figure 15).(6)  In control reactions with unstimulated cells, 
levels of detected NO increased as levels of BH were increased, owing to the particular activation 
(Figure 16), indicating healthy, functioning macrophage cells.(6)  Additionally, 24 hr 
preincubation of RAW macrophage cells with BH does not inhibit restimulation with LPS 
(Figure 17).(6)  
The results shown in Figure 16 are consistent with studies in mouse macrophage-like 
B10R and N11 microglial cells which show no BH-dependant inhibition of NO(62) but are  
Figure 15.  BH effect on RNS and ROS production. Effect of β-hematin on ROS and RNS production. 
ROS production was assessed by DCF-DA (first 3 columns) where the white column  correlates to the 
percent activity of unstimulated cells, grey is the activity of cells stimulated with PMA and black are cells 
treated with β-hematin and stimulated with PMA. The Griess assay was used to assess RNS production (last 
3 columns) where the vertical grey column corresponds to unstimulated cells, diagonal  grey is the activity 
of cells stimulated with LPS and horizontal grey is the activity of cells treated with β-hematin and 
stimulated with LPS.(6) 
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contradictory to a report with murine peritoneal macrophages that appears to indicate BH 
inhibition of NO.(60)  Further, hemozoin directly isolated and exhaustively purified to remove all 
absorbed proteins, lipids and carbohydrates consistently has been shown to not inhibit NO 
production in human peripheral blood mononuclear cells and mouse macrophage B10R 
microglial cells.(62; 74)  Consequently, the results presented herein and in the preponderance of 
published data suggest that NO production is not inhibited with BH treatment.  In contrast, native 
hemozoin has been shown to decrease NO production in murine peritoneal macrophages.(75)  
The stark contrast concerning the immunoreactivity of BH versus native hemozoin with regards 
to modulating ROS and RNS production implies that there exists a biochemical distinction 
between the two.   
 
 
Figure 16. BH impact on NO production. Effect of increasing levels of β-hematin on NO production in 
Raw 264.7 cells as measured by the Griess assay.(6) 
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Degradation of BH by ROS and RNS in vitro 
If BH does not effectively inhibit the intracellular production of ROS and RNS, then 
these molecules should be available to react with the phagocytosed heme aggregate; however, 
experiments suggest that hemozoin can persist for up to 72 hrs within the phagolysosome.(2)  The 
differential inhibition capability between β-hematin and native hemozoin suggests that the 
immunosuppressive activity of native hemozoin is a result of more than just the biomineral 
structure.  Consequently, the effects of these microbicidal agents on BH stability may provide 
some degree of insight into the apparent biochemical differences between BH and hemozoin.  In a 
series of in vitro experiments, the susceptibility of BH to degradation by hydrogen peroxide, 
sodium hypochlorite and nitric oxide was carried out.(6)  For these experiments, both the 
concentration dependency and the kinetics of degradation were investigated.   
Figure 17.  Effect of BH treatment on restimulation with LPS. Effect of preincubation of RAW cells 
with β-hematin on RNS production as assessed by the Griess assay. The black column corresponds to RNS 
production of cells stimulated with LPS, the dark grey column is cells treated simultaneously with β-
hematin and LPS, and the white column represents cells first treated for 24 hours with β-hematin followed 
by restimulation with LPS for another 24 hours.(6) 
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BH showed a mark sensitivity to HOCl at pH 4.8, the pH of the phagolysosome, with an 
EC50 value of 5.5 ± 0.1 mM (Figure 18A).(6)  At a hypochlorite concentration of 10 mM, the 
kinetic data revealed an IC50 of 19 h for the β-hematin degradation (Figure 18B). The 
degradation of BH in the presence of HOCl results in the loss of aggregate integrity and the 
formation of an insoluble orange product.  The HOCl-mediated oxidation of the protoprophyrin 
IX methylene bridge likely results in the opening of the ring and release of iron.  The 
consequence of such a reaction would be the dissolution of the aggregate and formation of a 
product similar to bilirubin, the tetrapyrole end product of biological heme degradation by heme 
oxygenase.(76)   
 
Figure 18.  BH degradation by HOCl.  A. β-hematin degradation by sodium hypochloite (EC50 = 5.5 
mM). B. β-hematin degradation by sodium hypochlorite kinetics (IC50 = 19 h).(6) 
A. 
B. 
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As can be seen in Figure 19A, β-hematin was readily degraded by hydrogen peroxide 
exhibiting an EC50 value of 38.8 mMThough this experiment was allowed to incubate at 37 °C for 
20 hours, studies into the kinetics showed that the IC50 of the degradation was 2.2 h with a H2O2 
concentration of 200 mM (Figure 19B). The kinetics experiment was repeated for concentrations 
ranging from 200 mM to 12.5 mM.  Comparing the values obtained at the 21-hour mark for each 
concentration with those obtained in the concentration-dependant study verified the accuracy of 
the concentration-dependant study data (Figure 19C).   This value is consistent with hydrogen 
peroxide degradation of BH reported by Chen et al., who examined pigment stability in the 
contect of hemoglobin catabolism within the digestive vacuole.(8)  In this process, Hb, which 
also contains a five coordinate heme-Fe group, is degraded by hydrogen peroxide to release free 
iron.  Reactions between Fe(III)PPIX and hydrogen peroxide have been reported to result in 
formation of four dipyrrolic propentdyopents, hematinic acid and methylvinylmalemide.(77)  
Heme-Fe(III) can react with hydrogen peroxide to generate a formal perferryl species [ 
+
heme-
Figure 19. BH Degradation by H2O2. A. β-hematin degradation by hydrogen peroxide (EC50 = 38.8 mM).  
B. β-hematin degradation by hydrogen peroxide kinetics (IC50 = 2.2 h). C. Comparison of β-hematin 
degradation at 21 hours for concentration dependant study and kinetics data. 
 
A. B. C. 
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Fe(IV)=O or heme-Fe(V)=O ]which can then react with the olefinic porphyrin bridge to form a 
glycol and regenerate the ferric heme (Scheme 2).(78)   
 
 
 
 
The ferric heme reacts with another molecule of hydrogen peroxide to cleave the glycol 
and form an amide and an α-formly pyrrolic species.  Repeating this reation in other methane 
bridges results in the breakdown of the prophyrin to dipyrroles and monoryrroles.(77; 78)  
Further enhancement of the degradation process is obtained when the reaction of heme-Fe(III) 
and hydrogen peroxide results in the formation of heme-Fe(II) and superoxide anion.  The 
superoxide anion is able to oxidize the tetrapyrole rings of heme, leading to the degradation of 
heme and the release of iron.(79)  With hemozoin being a dimer consisting of Fe(III)PPIX units, 
it is plausible that its degradation process in the prescence of hydrogen peroxide is similar to 
those described for other metal containing prophyrin systems.   
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These studies also focused on nitric oxide’s ability to degrade β-hematin.   DeaNO, a NO 
releasing agent, was used as a surrogate for nitric oxide.  Exposure to NO was successful in 
degrading β-hematin, with an EC50 value of 33 ± 6.7 mM (Figure 20A).  To monitor the release 
of NO from the DeaNO, the Griess assay was performed on both the supernatant of the 
degradation experiment and on control experiments containing no β-hematin. As shown in Figure 
20B, there was a consistent decrease in the amount of NO present in the supernatant of the 
degradation experiment as compared to control experiments.  Notably, the control showed 
complete recovery of NO released by DeaNO when quantitated by the Griess assay. This 
resurgence implies that the decrease of NO in the degradation experiment was a result of NO 
being utilized during the degradation process.  The kinetics of this degradation showed that for a 
NO concentration of 100 mM, the IC50 was 5.7 hours, well below the 20 hours allowed in the 
concentration dependent study (Figure 20C).  
Figure 20.  BH degradation by NO. A. β-hematin degradation by NO (IC50 = 39 mM). B. Quantitation of 
NO released by DeaNO.  Control containing no β-hematin shown in green. Supernatant from NO degradation 
shown in pink. There is a consistent decrease in the amount of NO found in the supernatant of the degradation 
as compared to the control at all concentrations. C.  Kinetics of β-hematin degradation by NO. 
A. B. C. 
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Interestingly, it was observed that the supernatant of this experiment was a brown color 
that deepened as the DeaNO concentration was increased.  In contrast, the H2O2 and NaOCl 
degradation had clear supernatants suggesting a different mechanism of degradation.  Also, when 
the remaining β-hematin was dissolved for quantitation, it required a much more concentrated 
amount of NaOH to be completely dissolved.  This suggested that something on the surface of the 
β-hematin had changed.  To further investigate the surface change of the β-hematin, the UV 
spectra was taken of the dissolved β-hematin remaining from the degradation studies. This 
spectrum was compared to the spectrum of hematin, shown in Figure 21.  There is a λmax shift 
from a predominant peak at 385 nm for hematin to 357 nm for the β-hematin that remained from 
the NO degradation experiment.  This suggested that the surface of the β-hematin was being 
altered during the degradation process.  The combination of this data suggests that NO readily 
Figure 21.  UV of NO-heme compounds formed during BH degradation by NO. The absorbance of 
hematin in sodium phosphate buffer is shown in blue. The absorbance of the remaining BH from 100 mM 
NO degradation is shown in black. The absorbance for BH in sodium phosphate is shown in red and 
hematin which has been reacted with NO is shown in green. There are two peaks for hematin with the 
predominant absorbance at 385 nm.  The predominant peak for the BH from the NO degradation has 
shifted to 357 nm. 
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binds to the iron of β-hematin during the degradation process.  NO binding to ferric heme and 
formation of a ferric nitrosyl complex likely results in the spontaneous autorediction of the iron to 
the ferrous state.(80)  In terms of stability, reduction of the iron will result in an increased radius, 
weakening the iron-nitrogen bonds of the porphyrin.  Further, NO acts as an extremely strong 
ligand and its binding to the iron of heme groups has been shown to exert a large repulsive force 
on the ligand trans to the NO, potentially disrupting the reciprocating propionate linkages within 
the crystal lattice of hemozoin.(81)  IR analysis isolated reaction products prior to complete 
degradation revealed a vibration at 1636 cm
-1
 consistent with NO coordination in an Fe(II) 
porphyrin complex (Figure 22).(80) 
Regardless of the potential mechanisms of degradation, the insoluble BH biomineral is 
sensitive to the ROS and RNS that are generated upon phagocytosis.  Further, it is recognized that 
the crystals of BH are large enough to allow awater into the lattice.(82)  Therefore, it is feasible 
that small molecules such as HOCl, H2O2, and NO work their way into the crystal lattice, 
disrupting the structural integrity of hemozoin from within as well as on the surface.  The lower 
EC50 value (5.5 mM) of HOCl compared with that of H2O2 (38.0 mM) is consistent with it being a 
much more reactive microbicidal agent.(74)  Additionally, the ability of H2O2 to degrade heme is 
known to decrease in acidic environments, whereas HOCl degradation is inversely affected by the 
acidity.(83)  NO is not a particularly strong microbicidal agent either, so it is not that surprising 
that its EC50 value is also higher that than of HOCl.(84)  Finally, it is important to note that the 
concentration regimes of HOCl, H2O2 and NO examined here are relativent to biologically 
reported concentrations produced within professional phagocytic cells.(20; 84)  To investigate the 
facts of BH inside RAW cells, BH was phagocytosed and its in vivo stability examined.  
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Degradation of BH by RAW 264.7 murine macrophage cells  
Confocal microscopy offers an advantage over traditional microscopic techniques 
because the user can view only one particular plane of interest within a thick sample without 
interference from other planes.  When applied to cell imaging, this feature gives the user the 
ability to determine where a fluorophore is located within the cell both within the x-y plane as 
well as the z-plane.  By utilizing the natural fluorescence of β-hematin, it is not necessary to add 
any fluorophores in order to monitor the extent of β-hematin degradation.  In order to accurately 
quantitate the amount of β-hematin remaining in the cells, the experiment must focus solely on 
the β-hematin located within the cells.  This required the exclusion of any residual fluorescence 
from β-hematin located above or below the actual cells. Confocal microscopy, therefore, was the 
most appropriate method for performing this experiment.   
 
Figure 22.   IR of product formed from BH degradation by NO.  IR of the BH-NO complex obtained by 
reacting β-hematin with 50 mM DeaNO and isolated prior to complete degradation. 
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 Before monitoring the degradation of β-hematin within macrophage cells, it was first 
necessary to show the successful phagocytosis  β-hematin.  The colocalization of BH inside the 
acidic vacuoles was shown using the inante fluorescence of BH and Lysotracker Red, a dye 
specific to acidic compartments such as the phagolysosome.  The use of this dye presented a 
number of problems that required optimization.  Early attempts to obtain a colocalization image 
resulted in a high background on certain focal planes which masked the actual fluorescence of 
both the lysotracker and the β-hematin.  It was determined that the media was the cause of this 
background.  A number of controls eventually determined that the use of PBS instead of media 
during cell imaging resolved this issue.  A second problem occurred in the attempts to find two 
channels that were mutually exclusive through which to view both the lysotracker and β-hematin.  
β-hematin has a very narrow emission spectra and the use of pre-made excitation/emission 
programs resulted in the inability to collect adequate β-hematin fluorescene.  Therefore, the use of 
a customized excitation/emission program was used which excited the β-hematin channel with a 
514 nm laser and detected emission with a 533.2-542.9 nm bandpass filter. The lysotracker 
channel was excited with a 543 nm laser detected emission with a 585 longpass filter.  This very 
specific combination gave good fluorescence in both channels without bleed-through.  Here, the 
Figure 23.  Localization of BH to the phagolysosome.  Colocalization of β-hematin inside the acidic 
vacuoles as examined by Confocal microscopy. A. The differential interference contrast (DIC) image of the 
cell. B. Excitation at 514 nm followed by emision using a band pass filter from 533.2-542.9 allowed for the 
imaging of β-hematin fluorescence. C. Excitation at 543 nm followed by the use of a long pass 585 nm 
filter for emission allows for visualization of the lysotracker fluorescence. D. Composite figure of a-c 
demonstrating the colocalization of β-hematin inside the acidic vacuoles. 
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images of BH fluorescence and the fluorescence of the lysotracker dye clearly show BH 
colocalizing to acidic vacuoles of the macrophage cells (Figure 23).   The orthogonal slices (XY 
and XZ) of the confocal image also revealed segregation of BH exclusively within the cells, 
confirming that it had indeed being phagocytosed.(2)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24.  Quantitated fluorescence of Degradation of BH in RAW macrophage cells.  There is a 78% 
decrease in fluorescence associated with BH 72 hours after phagocytosis by RAW macrophage cells. 
Figure 25.  Confocal Image of Degradation of BH in RAW cells.  Confocal images β-hematin 
degradation inside RAW cells at time zero (A) and after 72 hours (B). Fluorescence images were obtained 
by excitation at 514 nm followed by collection of the emission spectra using a band pass filter from 533.2-
542.9 nm. 
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The quantitative analysis of BH stability as a function of time was probed at 0, 48, 72 hrs.   
The macrophage cells were treated with β-hematin to elict phagocytosis. After a period of 90 
minutes, excess β-hematin was washed away and the samples were allowed to incubate for the 
appropriate amount of time.  The cells were imaged using the above mentioned 
excitation/emission configuration.  For each of cell sample, 300-400 cells were quantitated to 
obtain an average fluorescence for that sample, and each time point was done in triplicate to 
ensure reproducibility.  Normalizing the fluorescence at the time zero, it was determined that in 
both unactivated and PMA activated cells, BH had been degraded by 67.2 ± 6.5% after 48 hrs and 
that by 72 hrs it had been degraded by 76.8 ± 2.7% (Figure 24).  Visually, the results clearly 
show dismishing fluorescence, noted by a marked decrease in the amount of red fluorescence 
ofver the time course of the experiment (Figure 25).  Controls in the absence of cells shows that 
BH fluorescence itself did not decrease with time, indicating the degradation observed was not 
due to photobleaching of BH.  Because of the small sample size used to assess degradation of BH 
by confocal microscopy, this was confirmed by the use of flow cytometry.  Flow cytometry 
allows for the analysis of samples in the tens of thousands of cells as compared to hundreds 
assessed by confocal microscopy.  Preliminary experiments were performed to determine whether 
the presence of BH within RAW cells was detectable by flow cytometry (Figure 26A).  These 
experiments showed a significant shift in both front and side scatter of cells indicating that they 
have increased in both size and internal complexity.  Further, when excited with a 630 nm laser, 
the fluorescent signal emitted at 680 nm was significantly increased after treatment with BH.  
This emission corresponds to the fluorescence emitted as a result of exciting the heme complex.  
The large shift in fluorescence indicates that it is possible to distinguish a BH positive sample 
population from a control population (Figure 26B).  The use of flow cytometry to assess the  
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amount of BH present in a cell population directly after phagocytosis and 48 hours after 
phagocytosis indicated a marked decrease in the percent of the population which yielded a BH 
positive fluorescent signal (Figure 27).     
 
Figure 26.  Detection of BH in RAW by flow cytometry.   Flow cytometry was used to distinguish 
BH positive RAW cell populations  (A) from control populations (B).  Upon phagocytosis of BH, an 
increase of front and side scatter are seen, as well as an increase in fluorescence associated with the BH 
heme moiety. 
A. B. 
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This substantial degradation of β-hematin by macrophage cells is a marked contrast to the 
apparent stability of native hemozoin within human peripheral blood monocytes.(2; 54)  These 
results, together with the observation that the ROS and RNS production was not inhibited by BH, 
and that the model reactions highlight BH sensitivity to microbicidal agents, indicate that the fate 
of BH is vastly different from that of native hemozoin despite the structural identity of the heme 
dimer core.  This discrepancy suggests the biomineral alone is not responsible for the inhibitory 
effects of hemozoin phagocytosis on macrophage cells.  To determine the source of hemozoin 
immunosuppression, it was necessary to look at the difference between hemozoin and β-hematin: 
the biological environment.   
 
  
Figure 27.  BH degradation in RAW cells by flow cytometry. A. Control untreated RAW populations 
showed low scatter and fluorescence.  B.  After phagocytosis with BH, there is an increase in internal 
complexity and fluorescence (indicated in red). C.  After 72 hours, the same samples from B were analyzed and 
the signal as a result of the BH has decreased substantially indicated BH degradation over 72 hours.  
A. B. C. 
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Inhibition of oxidative burst by HNE and 15-HETE 
When parasite-infected RBC’s rupture, they release the parasite, hemozoin and cellular 
debris into the vasculature.(49)  Analysis of native hemozoin has shown that the biomineral is 
coated with a gradient of oxidized membrane lipids, including HETE’s and HODE’s, which lead 
to secondary oxidation products, such as HNE.(55)  Recently, it has been determined that 
hemozin is able to nonenzmatically generate significant quantities of hydrozyated fatty acids(41; 
55) and to mediate the oxidation of fatty acides such as arachidonic and linoleic acid to produce 
secondary oxidation products like HNE.(85) Levels of HNE and 15-HETE within hemozoin-
laden macrophages have been found up to 230 nmol per 10
10
 cells and 33-39 µM, 
respectively.(53; 54)  HNE is an α,β-unsaturated aldehyde produced from lipid peroxidation.(86)  
It reacts primarily with the sulfhydryl group of cysteine, the side chain amino group of lysine and 
the imidazole of histidine.(87)  This reactivity makes it a potent biological agent capable of 
forming protein adducts affecting a range of cellular functions.  At relatively low concentration, 
HNE disrupts cytoskeletal integrity, impairs mitochondrial respiration, inhibits DNA, RNA and 
protein synthesis, stimulates neutrophil chemotaxis, and modulates platelet aggregation and 
changes in response to second messenger pathways.(88)   Similarly, 15-HETE has been shown to 
generate pathophysiological effects such as altered permeability of endothelial cells, edema, 
increased adherence of RBCs and induced chemotaxis and chemokinesis.(41; 55)  Consequently, 
macrophage function may be impaired by the presence of these immunoreactive molecules.   
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RAW cells treated with HNE followed by stimulation with PMA demonstrated a 
concentration-dependent inhibition of oxidative burst (Figure 28A).  As the concentration of 
HNE increased up to 100 µM, stimulation of NADPH oxidase was inhibited, with an EC50 value 
of 45.9 µM.  Studies of HNE inhibition of superoxide in human neutrophils have shown a similar 
response, with an EC50 value of 27 µM, consistent with the results reported here for mouse 
macrophage cells.(89)  LPS-activated iNOS was similarly inhibited by HNE in a concentration-
dependent manner, with EC50 values of 9.2 µM (Figure 28B).  Generated from the most abundant 
class of polyunsaturated fatty acids, HNE contains three functional groups, is lipophilic and easily 
diffusible, and highly reactive with cellular components, all characteristics that make HNE an 
efficient means of disrupting the host immune system in malaria.(21)  Previous reports have 
demonstrated that at concentrations over 10 µM, HNE is capable of inhibiting the activity of 
protein kinase C (PKC), a key signaling protein in NADPH oxidase activation.(54)  HNE is 
highly reactive with proteins, disrupting function by protein adduct formation.(21)  In fact, there 
has been a suggestion of the possible formation of HNE adducts on PKC.(90)  This is just one 
Figure 28.  HNE inhibition of oxidative burst in RAW macrophage cells.  Concentration dependent 
effect of HNE treatment on oxidative burst. Inhibition of ROS production (A) with increasing 
concentrations of HNE in RAW 264.7 cells as assessed by DCF-DA. Inhibition of RNS production (B) 
with increasing concentrations of HNE as assessed by the Griess assay. 
A. B. 
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potential target that HNE may interact with once inside the macrophage that may lead to 
inhibition of oxidative burst.   
 
 
 
 
 
 
 
 
Similarly, incubation with 15-HETE resulted in a concentration-dependent inhibition of 
PMA-stimulated burst, with an EC50 value of 8.0 µM (Figure 29A).  Human monocytes threated 
with 15-HETE have displayed a similar trend, with 100% inhibition of ROS production at 15 µM 
15-HETE.(54; 55)  LPS-activated iNOS was also inhibited up to 28.5% in the presence of 15-
HETE (Figure 29B).  While treatment of phagocytic cells with 15-HETE clearly results in the 
loss of ROS and RNS production, the mechanism of inhibition is not immediately obvious other 
than subsequent degradation of 15-HETE to HNE.  The inhibition of oxidative burst with these 
highly reactive agents points towards the importance of hemozoin not as a toxic substance itself, 
but rather as a mediator of the oxidation of fatty  acids to form highly reactive and toxic 
molecules such as HNE and 15-HETE.  Additionally, the particulate nature of the detoxification 
biomineral ensures that it will be targeted by the innate immune system.   
Figure 29.  15-HETE inhibition of oxidative burst in RAW macrophage cells.  Concentration 
dependent effect of 15-HETE treatment on oxidative burst. Inhibition of ROS production (A) with 
increasing concentrations of 15-HETE in RAW 264.7 cells as assessed by DCF-DA. Inhibition of RNS 
production (B) with increasing concentrations of 15-HETE as assessed by the Griess assay. 
A. B. 
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Reaction of BH with erythrocyte ghosts 
 The aforementioned results suggest that the inhibitory effects of hemozoin are due to its 
ability to react with membrane lipids and form highly reactive, immunosuppressive molecules.  
To examine the effects of the constitutive components of the malaria pigment on macrophage 
response in an appropriate model system, BH was reacted with membrane lipids from erythrocyte 
ghosts.  During the purification, the elution of the ghosts was monitored by the absorbance of 
aromatic residues in proteins at 280 nm (Figure 30).   
 
 
After purification of ghosts and following the overnight reaction with BH, RAW 
macrophage cells were treated with the reaction supernatant.  NADPH oxidase in PMA-activated 
RAW cells was inhibited in a concentration-dependent manner (Figure 31A), as was the 
activation of iNOS in LPS-activated cells (Figure 31B).  There was no detectble inhibition of 
ROS or RNS production upon treatment of BH or ghost supernatants alone, indicating that it is 
the products from the reaction between the two that cause the inhibition (Figure 32).   
Figure 30.  Elution profile of purified RBC ghosts from Sepharose 2B column.  The RBC ghosts were 
purified from other cellular debris by monitoring the UV absorption at 260 nm.   
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These results strongly suggest that erythrocytic rupture releases detoxification product  
 
hemozoin into a milieu of cellular debris, providing a substrate for the nonenzymatic, heme-
catalyzed peroxidation that results in a toxic gradient of primary and secondary fatty acid 
oxidation products.  Although the precise mechanism and cellular targets remain unelucidated, it 
is these products, not the aggregate of dimeric heme units, which effectively inhibit RAW 
NADPH oxidase and iNOS activity within macrophage cells.   
 
 
 
 
 
 
Figure 31.  Inhibition of oxidative burst by RBC ghosts which have been incubated with BH.  
Inhibitory effect of the products of ghost and β-hematin interactions on oxidative burst. Inhibition of ROS 
production (A) was obtained using luminol-enhanced chemiluminescence and inhibition of RNS (B) was 
obtained using the Griess assay. 
 
Figure 32.  Inhibition of oxidative burst by RBC ghosts only.  Effect of ghosts and β-hematin alone 
on the production of (A) reactive oxygen species as measured by luminol-enhanced chemiluminescence 
and (B) reactive nitrogen species as monitored by the Griess assay. 
A. B. 
A. B. 
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BH Degradation by HNE  
After demonstrating that the oxidized lipid products were essential to disrupting 
ROS/RNS production, the individual roles of some these oxidation products were probed to 
understand the complex mechanism of macrophage dysfunction under conditions of oxidative 
stress on the cells.  Specifically, a series of experiments were designed to determine the effect of 
HNE on macrophage ability to degrade β-hematin.   
 
 
 
 
 
 
 
 
Both confocal microscopy and flow cytometry show that functional macrophage cells are 
capable of degrading β-hematin.  However, when the same confocal experiment was repeated 
after samples were treated with HNE for a period of 3-4 hours prior to incubation, the outcome 
was in stark contrast.  Because there was no significant degradation seen after 48 hours in the 
untreated degradation samples, this experiment was slightly altered to use only 0, 24 and 48 hour 
time points, each in triplicate.    Compared to the untreated experiment, the cells treated with 
HNE (both activated with PMA and non-activated) had no significant degradation over the 48  
Figure 33.  Quantitated fluorescence of degradation of BH in RAW macrophage cells treated 
with HNE.  When treated with HNE, no significant degradation of BH in RAW macrophage cell s is 
seen after 48 hours.  
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hour time period.  As shown in Figure 33, the projection images visually suggested no 
degradation, which was confirmed by the quantitation of the average fluorescence (Figure 34).  
Analysis of BH degradation in HNE treated RAW cells by flow cytometry yielded similar results.  
There was substantially less degradation seen in the HNE treated populations after 48 hours as 
seen in the populations not treated with HNE.  However, within the context of the larger sample 
population analyzed by flow cytometry, it becomes clear that all degradation is not halted by the 
treatment with HNE.  The degradation of BH is nonetheless largely impaired by the treatment of 
HNE (Figure 35).   
 
 
 
 
Figure 34. Confocal Image of Degradation of BH in RAW cells after HNE treatment.  Confocal 
images β-hematin degradation inside HNE treated RAW cells at time zero (A) and after 48 hours (B). 
Fluorescence images were obtained by excitation at 514 nm followed by collection of the emission 
spectra using a band pass filter from 533.2-542.9 nm. 
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Conclusion 
 
 The composition of native hemozoin released uon RBC rupture has been reported to be 
65.1% proteins, 15.5% Fe(III)PPIX, 5.9% carbohydrates and less than 1% lipids and nucleic 
acids.(20; 91)  Both hemozoin and Bh are able to interact with membrane lipids to generate high 
levels of reactive secondary metabolites such as HNE and 15-HETE.  Inside hemozoin-laden 
macrophages, levels of these agents reach between 20 and 40 µM.(55; 92)  These molecules act 
as immunosuppressive agents that are capable of disrupting oxidative burst (both NADPH 
oxidase and iNOS-activated) and represent the key to understanding reactivity differences 
between structurally identical native hemozoin and BH.  Clearly, native hemozoin inhibits the 
activation of oxidative burst and is stable inside macrophages for long periods of time.(2; 53)  In 
contrast, BH is sensitive to themicrobicidal agents of oxidative burst, and macrophages are 
Figure 35.  BH degradation in RAW cells treated with HNE by flow cytometry. A. Control untreated 
RAW populations showed low scatter and fluorescence.  B.  After phagocytosis with BH, there is an increase 
in internal complexity and fluorescence (indicated in red). C.  After 48 hours, the same samples from B were 
analyzed and the signal as a result of the BH has decreased a marginal amount but a significant percent of the 
population still yields higher fluorescence and side scatter indicating HNE inhibited BH degradation.  
 
A. B. C. 
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capable of degrading this material.  Significantly, native hemozoin which has been thoroughly 
washed to remove debris from RBC rupture (including lipids) reacts in a fashion identical to BH, 
where it does not inhibit oxidative burst.   
 Native hemozoin is complex material with a similarly complex reactivity.  By 
systematically examining each of the malaria pigment’s components, we have been able to dissect 
their impact on the immune reactivity of a macrophage cell line.  Further, via the reaction 
between synthetic BH and RBC ghosts, we were able to effectively reconstruct the observed 
immunomodulating reactivity of native hemozoin.  In this fashion, we propose that hemozoin 
functions to construct a toxic minefield which disrupts the immune response to the parasitic 
infection.  The presence of particulate hemozoin and RBC debris invites the professional 
phagocytic cells to the site, trapping the cells into a veritable sea of reactive and toxic species 
which freely diffuse across the cell membrane and/or are brought inside as hemozoin is 
phagocytosed.  Once there, the highly reactive molecules, generated from the hemozoin-mediated 
oxidation of membrane lipids, disrupt macrophage function. 
 The hemozoin-mediated immunomodulation presented here represents but one aspect of 
how this biomineral helps regulate the host/parasite interaction.  Recent results also suggest a role 
for immunomodulation activity originating from the dimer heme moiety in Toll-like receptor 9 
activation and cytokine production perturbation.(56; 93)  Hemozoin has also been shown to 
suppress the adaptive immune system by modulating dendritic cell function and maturation, thus 
allowing further evasion of the immune system.  T cells which are subsequently activated by 
these modulated dendritic cells are characterized by decreased proliferation and effector 
functions.  This modulation of adaptive immune system activation may contribute to infection 
seen in malaria-endemic areas.(94)  Thus, parasitic survival strategy involves native hemozoin 
modulation of the host immune system on multiple fronts, innate and adaptive, ensuring parasitic 
success throughout the centuries despite host adaptations.  Continued efforts to elucidate the exact 
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mechanism behind these immunomodulations are critical for the development of new approaches 
to fighting this disease.   
 
Future Work 
 
 Though the degradation of BH was inhibited by the pretreatment with HNE, this is not 
the only lipid peroxidation product found associated with native Hz.  It is not even the only lipid 
peroxidation product shown to inhibit oxidative burst.  As a result, it would interesting to 
continue the degradation assays by flow cytometry to assess the effect of a range of these lipid 
peroxidation products on the stability of BH inside macrophage cells.  Even more interesting 
would be the pre-treatment of the macrophage cells with the BH/ghost incubation supernatant that 
contains the entire range of lipid production products that BH is capable of producing.  By using 
this supernatant, which would most closely resemble the make up of lipid peroxidation products 
seen associated with native Hz, this would allow the fate of BH to be investigated in the most 
biologically relevant context.  
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CHAPTER III 
 
PROTEIN KINASE C ADDUCTION AND MODULATION BY 4-HYDROXY-2-NONENAL 
 
Statement of Effort 
 
 This project was the collaborative effort of Dr. Clare Kenny Carney and me.  The 
undertaking to study the HNE adducts formation on PKC and the resulting functional 
consequences had two distinct halves – the identification of HNE adducts and the exploration of 
PKC functions as a result.  My goal was to determine how the formation of HNE adducts on PKC 
including the immediate and downstream effects of PMA activation such as translocation of PKC 
from the cytosol to the plasma membrane and a flux in intracellular calcium levels.  I also aimed 
to study the location of the HNE adducts in relation to the proteins tertiary structure by building 
and analyzing a PKC homology model.  The complimentary effort of identifying the location of 
the HNE adducts by mass spec was performed by my colleague Dr. Clare Kenny Carney.  
 
Introduction 
 
 The protein kinase C (PKC) family is a group of 12 distinct isoforms of ser/thr kinases 
found throughout a wide range of cell types.  Each isoform is categorized into three classes based 
on structural homology and cofactor dependence; however, there is growing evidence that 
individual isoforms display specificity in regulating distinct cellular events.(95)  Although the 
three PKC classes have structural differences, they all contain and a regulatory N-terminal 
domain, where structural differences are found, and a conserved catalytic C-terminal domain.
 (22) 
The regulatory domain of classical PKCs (PKCα, βI, βII, and γ) contain a C1 and C2 subdomain 
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which bind phorbol ester/diacylglycerol (DAG) and Ca
2+
 respectively.
(22)
  The regulatory domain 
of the novel PKCs (PKCδ, ε, ε, and ζ) is similar but is Ca2+ independent as it does not contain a 
Ca
2+
 binding site.  In contrast, the regulatory domain of atypical PKCs (PKCδ,η, and μ) have a 
structurally different C1 subdomain and lack a C2 subdomain altogether rendering them 
independent of phorbol ester, diacylgylercol and Ca
2+
.(22)  Despite the structural diversity of 
each class, most PKCs utlize two zinc-fingers within the C1 domain (except δ which only 
contains one.)
11
  Each of these zinc-fingers lies within one of the conserved Cys domains, which 
together makes up a 50 amino acid highly homologous stretch of the regulatory domain.(96)  
Within this domain, there are 6 conserved cysteine residues and 2 conserved histidine residues 
which tetrahedrally coordinate two Zn
2+
 ions.(96)  The unique structural characteristics of PKC 
are integral in its activation and translocation.  
Activation of classic PKCs is a multistep process that begins when PKC is activated by 
Ca
2+
 and phospholipid resulting in the translocation of the enzyme to the inner cell 
membrane.(97)  The membrane-bound protein is then further activated by the secondary 
messenger, diacylglycerol or tumor promoting phorbol esters.(98)  Previous studies have focused 
on the importance of the zinc-finger motifs in the activation of PKC by diacylglycerol or phorbol 
esters.(96) In particular, Korichneva et al. have shown that during the activation of PKC, there is 
a conformational change that results in the release of the chelated Zn
2+
 ions from the zinc 
fingers.(96)
 
The conformational change that occurs upon ligation of DAG or phorbol ester 
promotes insertion of a portion of PKC to be inserted into the lipid bilayer ultimately removeing 
the pseudosubstrate domain from the active site of the enzyme.(97; 98)  The removal of the 
pseudosubstrate exposes the active site and allows subsequent phorsphorylation of substrate Ser 
or Thr residues.(97)  
PKCs have been shown to regulate various cellular processes that range from 
mitogenesis, cell adhesion, apoptosis, angiogenesis, invasion, to metastatis.
 (95) 
  The variable 
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regulation of each isoform has been associated with cardiomyopathy, heart failture, diabetic 
cardiovascular complications, cancer as well as a variety of immune dysfunctions.(99)
.
 
Specifically, PKCβII contributes to superoxide formation through the activation of NADPH 
oxidase, resulting in respiratory burst in macrophage cells.(22; 99)
.
 Similarly, PKCε has been 
associated with macrophage signaling events as a result of LPS or GM-CSF, phagocytosis, and 
NO production.(22; 96; 100; 101) The wide range of functions specific to different PKC isoforms 
has been associated largely with the subcellular localization of enzyme, rather than substrate 
specificity.
 
 The diversity of PKC function has made it a central component in a wide range of 
pathologies, making it an intriguing target for drug development.  Though there are a variety of 
inhibitors such as strausporin that inhibit through ATP binding site competition, these are not 
very specific for PKCs with respect to other kinases.   In the development of PKC specific 
inhibitors, a large number of compounds which showed this desired specificity worked through a 
mechanism that involved the formation of PKC adducts.  These type of inhibitors usually 
function through a modification of protein cysteine residues and fall into two categories: those 
that target the catalytic domain, and those that target the regulatory domain.  Inhibitors that target 
the catalytic domain have been shown to inhibit kinase activity through a variety of mechanisms 
including S-cysteinylation, S-thiolation, S-cysteaminylation, and alkylation of cysteine residues 
in either the active site or at a critical Cys452 switch.(100; 102-104)  The distinctive structure of 
PKC, with its regulatory domain that is unique among other kinases, has shifted the focus of 
inhibitor development from the catalytic domain to this uncommon regulatory domain. These 
inhibitors typically result in the loss of phorbol ester binding.  One class of compounds inhibits in 
the regulatory domain by a ―cage type‖ mechanism.  These compounds, which includes 
calphostin C and hypericin, bind to a Ca
2+
-induced hydrophobic site, then a light reaction results 
in the production of reactive oxygen species which selectively modify oxidation susceptible 
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amino acides in the vicinity.(97; 105)  Interestingly, selenocompounds have been shown to inhibit 
PKC through both the catalytic domain (at low concentrations), as well as through further 
modification in the regulatory domain (at higher concentrations).(96; 101; 106) The mechanism 
of inhibition in the regulatory domain is believed to involve the collapse of the critical zinc 
fingers found in the cys-domains as a result of modification of the zinc-coordinating cysteine 
residues.(96; 101; 106)  Though inhibiting PKC through adduct formation has been a focus for to 
combat the pathology associated with inappropriate PKC activitivation, in proper PKC adduct 
formation in vivo has been implicated in many of the pathologies associated with oxidative stress.  
4-hydroxynonenal, a major product of lipid peroxidation, has also been connected to a 
number of oxidative-stress linked cellular activities, including growth inhibition and 
apoptosis.(107)  HNE has also been implicated in the pathology of  conditions such as cancer, 
arthritis, arthrosclerosis, cardiac disease, malaria, and neurological diseases such as Alzheimer’s 
disease.(90; 108-110)   HNE, a highly reactive aldehyde, forms shift base adducts to protein thiol 
and amino groups, often modulating their activity (Figure 36).(111) High levels of HNE in 
macrophage cells have been associated with the inhibition of oxidative burst, the mechanism of 
reactive oxygen species (ROS) production crucial to the destruction of phagocytosed material.  
Schwarzer et al. have shown exposure of monocytes to HNE at concentration of 10-100 μM 
resulted in the formation of a PKC-HNE complex and a corresponding loss of PKC activity.
 (109)
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While there are potentially several proteins whose function may be affected by HNE 
adduction, the connection between increased levels of HNE and decreased PKC activity provides 
an intriguing initial target. Given that there is little information available about the structure of 
PKC, elucidating the specific amino acids targeted by HNE using mass spectrometry in 
conjunction with biochemical experiments exploring the functional consequences of these 
adducts will yield important clues about the structure and function of this enzyme and its 
mechanism of inactivation. 
 
 
 
Figure 36.  HNE reactivity with Amino Acid Sidechains. HNE is a reactive electrophile that can 
readily form adducts on cysteines, lysines and histadines.   
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Materials and Methods 
 
Materials 
 Protein kinase C II, human recombinant (PKC II), 4-hydroxy-2-nonenal (HNE), 
phorbol-12-myristate-13-acetate (PMA), and polyclonal anti-PKC antibodies were purchased 
from Calbiochem. Novex 10% Tris-glycine gels were purchased from Invitrogen. Luminol (3-
aminophthalhydrazide) and dithiolthreitol (DTT) were obtained from Sigma-Aldrich. Monoclonal 
anti-HNE antibodies were purchased from Oxis Research. Sequencing grade modified bovine 
trypsin was obtained from Promega. Iodoacetamide (IAA) was obtained from Acros Chemicals. 
Fetal bovine serum was purchased from Atlanta Biologicals. Penicillin/streptomycin was 
purchased from Cellgro mediatech. Oregeon Green Calcium-indicating dye was obtained from 
Invitrogen.  The mouse macrophage cell line, RAW 264.7, originally obtained from the American 
Type Culture Collection (ATCC TIB-71) was a kind gift from the Virginia Shepherd lab 
(Vanderbilt University). All Uv-vis spectroscopy was caried out on a Bio-tek Synergy HT 
Multidetection Microplate Reader. Luminescent measurements were performed on a Moonlight 
3010 Luminometer. An Invitrogen Xcell Surelock™ complete mini-vertical electrophoresis 
system was used for all gel electrophoresis and western blotting studies. Confocal studies were 
performed on a Zeiss LSM 510 Meta inverted confocal microscope. Liquid chromatography mass 
spectrometry (LC-MS-MS) was performed on a Thermofinigan LTQ LC-MS-MS system 
equipped with Xcalibur 1.3 and Bioworks 3.1 software.  
 
Cell Culture 
 The adherent mouse macrophage cell line, RAW 264.7, was maintained in continuous 
culture with RPMI 1640 medium (GIBCO/BRL), supplemented with 10 % (v/v) heat-inactivated 
fetal bovine serum, and 100 µg/mL penicillin/streptomycin (complete medium) in an atmosphere 
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of 95% humidity and 5% CO2 at 37
o
C. Cell viability was determined by Trypan Blue exclusion 
using a haemocytometer.     
 
Measurement of Reactive oxygen species.  
RAW 264.7 cells were plated overnight in complete RPMI 1640 medium at 4E6 
cells/well in a 6 well plate. The following day, the media was removed and the cells were washed 
one time with PBS followed by treatment with HNE (0-50 µM) prepared in cold medium. After 3 
hours in 95% humidity and 5% CO2 at 37
o
 C, the supernatant was aspirated and oxidative burst 
was stimulated by the addition of 100 nM PMA prepared in PBS. After four minutes of 
stimulation, 950 µL of the supernatant was pipeted to a luminometer tube followed by the 
addition of 50 µL of 1.0 mM luminol (50 µM final).  Luminescence was measured for ten 
seconds using a Moonlight 3010 Luminometer.  
 
Cell treatment with HNE for western blot analysis.  
RAW 264.7 mouse macrophage cells were plated overnight at a density of 4E6 cells per 
100 mm dish. The following day, the cells were treated with 10 mL of 35 µM HNE prepared in 
media and incubated at 37 oC, 95% humidity and 5% CO2. Once the allotted time (0, 0.5, 1.0, 
1.5, 2.0, 2.5, and 3.0 hours) had passed, the samples were removed from the incubator, washed 
with 3 times with cold PBS, and treated with 400 µL of cold lysis buffer (25 mM Tris-HCl, pH 
7.4, 0.25 mM sucrose, 2.5 mM EDTA, 2.5 mM DTT). After five minutes of rapid agitation, the 
samples were scrapped, pipetted to microcentrofuge tubes, and gently sonicated with a probe 
sonicator. Next, the samples were centrifuged for 45 minutes at 13,200 RPM. The supernatant 
was collected and protein content was analyzed using the Biorad DC assay kit. 
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Western blot analysis.  
All samples examined by gel electrophoresis/western blotting, were prepared at a 2 
µg/µL concentration and run on Novex 10 % Tris-glycine gels (Invitrogen) followed by transfer 
to polyvinylidene difluoride (PVDF) membranes (Invitrogen). After complete transfer, the 
membranes were blocked for 1 hour or overnight with 5 % nonfat dry milk dissolved in Tris-
Tween buffer (TBST) composed of 25 mM Tris-HCl, pH 7.4, with 137 mM NaCl, 2.7 mM KCl, 
and 0.01 % Tween 20, TBST. PKC obtained from the cells was detected by incubation with 
rabbit polyclonal anti-protein kinase C(α/β) (371-388) antibodies (diluted 1: 230 in 5% nonfat dry 
milk) for 2 hours at room temperature. Standard PKC βII was detected by incubation with rabbit 
polyclonal anti-PKC βII primary antibody (diluted 1:100 in 5 % nonfat dry milk) for 2 hours at 
room temperature. For both, incubation with the primary was followed by TBST washing and 
incubation with a horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (diluted 
1:2000 in 5 % nonfat dry milk) for 1 hour at room temperature. HNE adducted proteins were 
detected by incubation with mouse monoclonal anti-HNE primary antibody (diluted 1:500 in 5 % 
nonfat dry milk) for 2 hours at room temperature, followed by incubation with a horseradish 
peroxidase-conjugated goat anti-mouse secondary antibody (diluted 1:2000 in 5 % nonfat dry 
milk) for 1 hour at room temperature. An ECL Western blotting analysis detection system 
(Amersham Biosciencees) was used to visualize the bands in all cases. 
 
Cell treatment with HNE for confocal microscopy.  
For all samples, RAW 264.7 mouse macrophage cells were plated overnight at a density 
of 5E4 cells per Mat-tek dish. The following day, the cells were treated with either 100 μL of 35 
µM HNE prepared in media or left untreated and incubated at 37°C, 95% humidity and 5% CO2. 
After 3 hours,  the cells were washed 3 times with PBS and activated by the addition of 100 μL of 
100 nM PMA.  After 30 seconds, the samples were quickly washed 3 times with PBS. Next, the 
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cells were fixed in 3.7% paraformaldehyde at 37°C, 95% humidity and 5% CO2. After 10 
minutes, the samples were rinsed twice with PBS and permiabilized by treatment with 0.2% 
Triton X-100 for ten minutes at room temperature.  After 3 washes with PBS, the samples were 
blocked  with 2% BSA 1 hour at 4°C.    Next, The cells were labeled with anti-PKC primary 
antibodies (1:500 dilution), followed by 10 nM 525 nm quantum dot conjugated goat anti-mouse 
secondary antibodies.  After labeling, samples were washed twice with PBS, covered with 2 mL 
of fresh PBS and immediately imaged on the Zeiss LSM 510 Meta inverted confocal microscope.  
Fluorescence imaging of PKC was accomplished by excitation at 488 nm, followed by collection 
using a long-pass filter 505 nm. 
 
Reaction of PKC with HNE.   
For these experiments the βII isozyme was chosen as it is most closely linked with 
oxidative burst. PKC βII ( 20 µg, 0.37 mg/mL shipped in 20 mM HEPES, pH 7.5, 2 mM EDTA, 
2 mM EGTA, 5 mM DTT, 100 mM NaCl, 0.05 % TRITON®  X-100, 50 % glycerol) was diluted 
to 400 µL with 20 mM Tris- HCl buffer, pH 7.4 and transferred to a Millipore Ultra free spin 
filter (MWCO 10 kDa). The samples were centrifuged at 3500 g for 12 minutes followed by 
removal of the eluent and addition of 200 µL of Tris-HCl buffer and recentrifugation. This cycle 
was repeated 4 times to remove glycerol and exchange buffer systems. The sample was then 
concentrated to a volume of 30 µL and treated with either 1 µL ethanol or 1 µL of 7.4 mM HNE 
prepared in ethanol (30:1 HNE:protein). After 3 hours at 37 oC, the samples were washed with 
10% ethanol to remove unreacted HNE. Subsequently, samples for gel analysis were washed 3 
times with 200 µL of Tris buffer. Samples to be digested were reduced by the addition of 100 
mM sodium borohydride for 10 minutes followed by 3 washes with 200 µL of AMBIC buffer (50 
mM ammonium bicarbonate, pH 8.0) to obtain the correct pH for tryptic digestion. Formation of 
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the HNE adduct on recombinant PKC βII was confirmed using western blotting techniques 
(Figure 37).  
 
Reaction of PKC with PMA followed by HNE.  
The buffer exchanged PKC βII was diluted up to 400 µL in Tris-HCl, pH 7.4, containing 
10 µM CaCl2, and 50 nM PMA and incubated for 5 minutes at 37 oC. The sample was then 
concentrated to 30 µL and a 30 fold excess of HNE was added. The reaction was incubated at 37 
oC for 3 hours and prepared for tryptic digestion as described above. Formation of the HNE 
adduct on recombinant PKC βII was confirmed using western blotting techniques (Figure 37).  
 
Protein Digestion.  
PKC βII, PKC βII reacted with HNE, and PKC βII reacted with PMA followed by HNE 
were concentrated to a volume of 30 uL containing approximately 10 µg of protein. To these 
samples, 45 mM dithiothreitol (1/10 v/v) was added followed by a 20 minute incubation at 60 oC. 
Next, 100 mM iodoacetamide (IAA) was added (1/10 v/v) and the samples were incubated in the 
dark for 10 minutes followed by the addition of sequencing grade modified bovine trypsin at a 
ratio of 1:50 protease:protein (w/w). The reactions were incubated overnight at 37 oC and 
stopped by the addition of 1 µL formic acid.  
 
Mass Spectrometry.  
Liquid chromotrography-mass-spectrometry (LC-MS) and LC tandem MS (LC-MS-MS) 
were used to analyze digested PKC βII, PKC βII reacted with HNE and PKC βII reacted with 
PMA followed by HNE. LC-MS with data dependent scanning and LC-MS-MS analyses were 
performed on a Thermofinnigan LTQ ion trap mass spectrometer equipped with the NanoSpray 
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source and using positive ESI and flow injection in acetonitrile/water (50:50 v/v) with 0.1% 
formic acid at a flow rate of 700 nL/min. The column is a packed tip, 100 µm X 11 cm, packed 
with Monitor C18 (Column Engineering), 5µm, 100 angstrom.  The PKC βII, PKC βII reacted 
with HNE, and PKC βII reacted with PMA followed by HNE adducts were subsequently detected 
and confirmed using the protein database search software SEQUEST (112) and the P-Mod (113) 
algorithm for ion series-based identification of MS-MS spectra corresponding to modified PKC 
βII sequences.      
 
PKC Homology Model 
 Homology model of murine PKCβI catalytic domain (residues 402 to 665) was generated 
using the PHYRE server using the sequence of PKCβI as a starting model (accession number 
MP_032881.1).  Electrostatic values were assigned using PQR server with the AMBER 
calculations.   
 
Imaging of Ca
2+
 Flux by Confocal Microscopy 
For all samples, RAW 264.7 mouse macrophage cells were plated overnight at a density 
of 5E4 cells per Mat-tek dish. The following day, the cells were treated with either 100 μL of 35 
µM HNE prepared in media or left untreated and incubated at 37°C, 95% humidity and 5% CO2. 
After 3 hours,  the cells were washed 3 times with PBS and treated with 1 nM Oregon Green Ca
2+
 
sensitive dye diluted in complete RPMI media and incubated at 37°C, 95% humidity and 5% CO2 
for 1 hr.  The samples were then quickly washed 3 times with PBS.  The samples were then 
imaged pre-activated on the Zeiss LSM 510 Meta inverted confocal microscope, exciting with a 
488 argon laser and collecting emissions using a 505 long pass filter.  The samples were then 
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activated by the addition of 100 nM PMA.  Fifteen minutes after activation, the samples were 
imaged again using the same settings, keeping the detector gain consistent between samples.  . 
 
Results 
 
Effect of HNE on reactive oxygen species production and formation of HNE adducts 
The ability of HNE to modulate the activity of NADPH oxidase was examined. RAW 
cells incubated with HNE for 3 hours followed by stimulation with PMA demonstrated a 
concentration dependent inhibition of oxidative burst (Figure 38A) with an EC50 value of 18.4 + 
1.2 µM. Further, RAW mouse macrophage cells were treated with 35 µM HNE and analyzed 
from 0-3 hours (Figure 38B). Studies of HNE inhibition of superoxide in human neutrophils have  
 
 
 
 
 
 
 
Figure 37.  Western blot analysis of HNE modified PKC from cell lysates. Western blot analysis 
was used to visualize PKC bands with monoclonal anti-protein kinase c antibodies (A). Additionally, 
HNE adduct formation on PKC was visualized with monoclonal anti-HNE antibodies (B).  
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shown a similar response with an EC50 value of 27 µM (114). These results suggest that HNE is 
able to inhibit stimulation of oxidative burst in a concentration dependent manner but do not 
highlight the loci of the molecular mechanism behind such inhibition. Previous reports have 
demonstrated that at concentrations over 10 µM, HNE is capable of inhibiting the activity of PKC 
(80kDa (115).   
 
 
 
To examine the possibility of HNE forming adducts on PKC, cell lysates from samples 
treated with 35 µM HNE were examined by western blot analysis. The amount of cytosolic PKC 
obtained from the cell lysates remains fairly consistent from 0 to 3 hours (Figure 39). However, 
the HNE bands, absent at 0 hour, slowly begin to increase in concentration with time, suggesting 
increased adduct formation with time. This time dependent formation has been seen before with 
HNE adduction on myoglobin (116).  While western blot analysis detected the adduction of HNE 
to PKC, it is unable to elucidate the affect of this adduct on PKC function.  
 
Figure 38.  Effect of HNE treatment on oxidative burst in RAW cells. A. Inhibition of ROS 
production with increasing concentrations of HNE as assessed by luminol enhanced chemiluminescence.  
B.  Inhibition of ROS production with 35 µM HNE over time as assessed by luminol enhanced 
chemiluminescence. 
A. B. 
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Mapping the loci of HNE adduction  
The classic PKC isoforms (α, -βI/βII and γ ) are the most closely correlated with 
macrophage oxidative burst.  Protein kinase CII , in particular, is  closely linked to oxidative 
burst.  For this reason, it was selected as the isoform. To avoid the potential contamination of the 
protein with other cellular component, standard recombinant PKCβII protein was used. Mass 
spectrometry was utilized to determine the specific amino acid site(s) of HNE adduction.  PKC 
βII (control), PKC βII reacted with HNE, and PKC βII reacted with PMA and  
 
 
 
 
 
Figure 39.  Effect of HNE treatment on PKC translocation.  PKC bands visualized with 
monoclonal anti-protein kinase c antibodies (A). HNE adduct formation on PKC visualized with 
monoclonal anti-HNE antibodies (B). The translocation of PKC from the cytosol to the membrane was 
monitored simultaneously with the appearance of HNE adducts on the protein.  It was found that the 
amount of cytosolic PKC remainded consistent (A) as the HNE adducts formed.(B). 
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Peptide Modification Percursor Precursor  Amino Acid 
    Observed Calculated Modified 
LDNVMLDSEGHIK unmodified 735.9 735.9 His 479 
469-481 HNE 814.9 814.9   
  
   
  
EHAFFR unmodified 403.6 403.7 His 597 
596-601 HNE 482.8 482.8   
  
   
  
EAVAICK unmodified 733.5* 733.4* Cys 572 or 
567-573 HNE 891.5* 891.5* Lys 573 
  
   
  
RLGCGPEGER unmodified NO 537.3 Cys 586 
583-592 HNE 616.3 616.3   
  
   
  
NVHEVK unmodified 725.4* 725.4* His 30 
30-35 HNE 883.5* 883.5*   
  
   
  
* indicates [M+1H] instead of [M +2H], NO: Not Observed     
 
 
 
then HNE were tryptically digested for LC-MS-MS. These peptides were analyzed using LC-MS 
data dependent scanning and LC-MS-MS on a Thermofinnigan LTQ system. Adducts were 
subsequently detected and confirmed using the database search software Sequest (112) and the P-
Mod algorithm (113) for ion series-based identification of MS-MS spectra corresponding to 
modified PKC sequences . While analysis of the mass spectral data with Sequest confirmed 
protein digested fragments and some HNE adduction sites, P-Mod allowed for a more in depth 
analysis of protein modifications and revealed 5 potential sites of adduction for the HNE treated 
unstimulated PKC (Table 1). Adducts to His32, His479, His597, Cys572, and Cys586 were all 
found to have mass additions consistent with HNE adduction via Michael addition. Activation of 
Table 1.  Unmodified and HNE-modified PKC peptides observed by LC/MS/MS after  tryptic 
digestion. 
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the enzyme with PMA (in the presence of Ca2+) before HNE treatment resulted in the formation 
of the same adduct pattern with the exception of His 479 where no adduction was found.  Sodium 
borohydride reduction of the protein prior to trypsin treatment was performed in an attempt to 
stabilize potential lysine/HNE Schiff base adducts for subsequent detection, but no lysine 
modifications were observed in these samples (Table 1).  
Tandem mass spectrometry of the HNE modified peptides gave conclusive data 
concerning the specific amino acids to which HNE had adducted (Figures 46-50). Mass addition 
of 158 m/z has been shown to represent the presence of a Michael addition of reduced HNE to a 
peptide. In the tandem MS/MS spectra, a series of b and y ions that correspond to cleavages along 
the peptide backbone are observed. The b series results from N-terminal backbone cleavages and 
the y series ions reflect the C-terminal peptide backbone cleavages. After identification of 
peptides that may be targeted by HNE adduction, a targeted ion scan of the adducted precursor 
peptide was generated. Trapping these ions followed by tandem MS/MS fragmentation allowed 
for multiple scans of the same peptide and therefore averaged b and y ion spectra. Figures 46-50 
illustrate the b and y ion traces of the HNE modified peptides, while figures 51-54 illustrate the b 
and y traces of the native peptides. Finally, figures 55-58 illustrate the b and y traces of sample 
stimulated with PMA prior to HNE treatment.  Figures 46-58 can be found at the end of this 
chapter. The formation of modified secondary ions (a ions), b ions with loss of H2O or NH3 
further supports the evidence of peptide modification. Tables 2-6 which contain all observed 
secondary ion can be found in at the end of this chapter.   
Figure 46 shows the LC-MS/MS spectra for the tryptic peptide NVHEVK (residues 30-
35) the HNE modified protein (spectra for unmodified Figure 51). A conclusive b and y ion 
fragmentation pattern exists for a Michael adduct on His 32 of this peptide. Compared to the 
control peptide, most notable is the 158 increase in both the b 3 and the y 4 ion in the HNE 
modified peptide. Daughter b and y ions upstream from the addition site show consistent 158 
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increases in mass (including b4 and b5). Based upon the characteristic 158 increase in relevant 
fragmentation ions, it was concluded the HNE reacted with the imidazole group of His32 to form 
a Michael adduct. Similar examination of the LC-MS/MS spectra of the HNE modified 
RLGCGPEGER peptide (residues 583-592) revealed the presence of an HNE Michael addition at 
Cys 586 (Figure 47, PMA activated Figure 55). Here, increases of m/z 158 beginning at y7 (b 
ion at the site not seen) are clear in the aldehyde-modified peptide. Ions upstream of the 
adduction site show 158 mass unit increases as well, including b5-b9, y8 and y9 indicating 
Michael addition of HNE to the thiol group of Cys586 forming a Michael adduct. For the 
modified peptide EHAFFR (residues 596-601), LC-MS/MS reveals a fragmentation pattern 
consistent with a  Michael adduct on His597 (Figure 48, spectra for unmodified Figure 52, PMA 
activated Figure 56). Compared with the control peptide, both b2 and y5 ions in the HNE 
modified peptide show mass increases of 158 with daughter b ions (b3-b5) upstream from the 
addition site also showing 158 increases in mass. Together these results indicate HNE reacting 
with the imidazole group of the H597 to form a Michael adduct. The LC-MS/MS spectra (Figure 
49, spectra for unmodified Figure 53, PMA activated Figure 57) of the HNE modified 
LDNVMLDSEGHIK peptide (residues 469-481) contains a mass addition of m/z 158 beginning 
at the b11 and y3 ions and continuing with upstream ions b12 and y4-y11 indicative of a Michael 
addition at His479. The LC-MS/MS spectra (Figure 50, spectra for unmodified Figure 54, PMA 
activated Figure 58) of the modified peptide EAVAICK (residues 567-573) reveals a 
fragmentation pattern consistent with either a Michael addition on C572 or K573. Increase of m/z 
158 beginning at b6 and y2 are seen in the HNE modified peptide as compared to the control. 
However, the mass of the b6 ion also corresponds to modified y6 with loss of NH3, making it 
difficult to determine whether or not the adduct is on the cysteine or the lysine specifically. Ions 
upstream of the adduction site show 158 mass unit increases as well, including y2-6. Again, 
without the presence of y1 (modified or unmodified), a conclusive identification of adduction site 
can not be determined. However, the presence of modified b6 with loss of water (727.41) does 
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indicate that the adduct is most likely resides on the cysteine residue, although no conclusion can 
be at this time.   
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Figure 40.  Homology model of HNE adduction sites on PKCβI with hydrostatic surface. Ribbon 
views of PKCβI homology models with the HNE adduction sites (red) show that they are largely 
congregated on the lower side of the catalytic domain with the exception of H479 (A and B).  Further 
analysis of the hydrostatic surface reveals that the adducts are in a region of low charge density.  
A. B. 
C. D. 
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PKC Homology Mapping of HNE adducts 
 Though the crystal structure of PKCβII has not been determined, the crystal structures of 
several members of the protein kinase C family have been constructed.  The high levels of 
homology, 90%  between the classical type of PKC members makes the crystal structure of PKCβI  
a valid structure for comparison to study the location of the HNE adducts on tertiary structure of 
PKCβII.(117) Not surprisingly, the homology structures showed that the majority of the adducted 
residues were located near the surface of protein (Figure 40).  It also showed that the four sites of 
adductions were located along the same region of the protein.  This region of the protein is largely 
solvent assessable and has an overall low charge density.  His597 and C572 are found to be 
located in two helix structures.   
 
 
 
Figure 41.  Homology model of HNE adduction sites and adduction sites of other PKC inhibitors 
on PKCβI. The addition of C502 and C488 (blue) to the homology model shows that these residues, 
which are the adduction sites of active-site targeting inhibitors, is located in a different domain than the 
HNE adduction sites (red).   
A. B. 
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The addition of the HNE adduct could feasibly lead to the disruption of hydrogen bonding within 
these helices.  By contrast, two residues, C502 and C488, not adducted by HNE but often seen 
adducted by other inhibitors, specifically active site targeting inhibitors, are located on at a 
different point on the surface of the catalytic domain (Figure 41).  This region of the domain 
surface has a higher negative charge density than the location of our HNE adducts.  Further , 
when the active site residues of the catalytic domain were also ploted on the homology model, 
C502 and C488 are found to be near the catalytic active site (Figure 42).  By contrast, the HNE 
adduction sites are located on the other side of the catalytic domain from the active site.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42.  Homology model of HNE adduction, Active site targeting inhibitor adduction, and active 
site residues on PKCβI. When the active site residues are highlight (orange), it is evident that residues 
C502 and C488 (blue) are near the active site, as expected for the adduction sites of active-site targeting 
inhibitors.  The HNE adduction sites (red), however, are not located near the active site suggesting their 
mode of inhibition is not related to inhibition of the active site.  
A. B. 
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Effect of HNE adduction on PKC function  
 To investigate the effect of HNE adduction on PKC function, two aspects of the 
activation of PKC were investigated: protein translocation and Ca
2+
 influx.  A critical step in 
proper PKC activation is the translocation of the cytosolic form of the protein to the 
membrane.(117)  The effect of HNE on PKC translocation was examined by confocal 
microscopy. Anti-PKC antibodies were used to image the subcellular location of the protein prior 
to and following PMA activation.  Before PMA activation, PKC is seen principally in the cytosol 
for all samples (Figure 43).  
 
 
 
 
Figure 43.  Confocal analysis of PKC translocation. A)  Untreated RAW cell samples were fixed with 
paraformadlehyde and labeled with Anti-PKC primary antibodies, followed by 525 quantum dot conjugate 
secondary antibodies. The samples should display a large distribution of PKC throughout the cytosol of the 
cell. B.) Cells which were activated with PMA were fixed and labeled similar to the untreated samples.  
However, in these samples, it is evident that the PKC has now translocated and is concentrated at the plasma 
membrane of the cells.  C.) However, cells that were treated with 35 μM prior to PMA activation did not 
demonstrate the same translocation seen in PMA activation alone.  Instead, the PKC remained distributed 
throughout the cytosol as seen in the untreated samples.  This indicated HNE treatment resulted in a 
dysfunction of PKC which inhibited its translocation upon phorbol activation.  
 
A. C. B. 
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Following PMA activation, cells that were not treated with HNE demonstrated rapid translocation 
of PKC from the cytosol to the plasma membrane in a manner consistent with previous reports.  
In contrast, cells treated with HNE prior to PMA activation did not show translocation, but rather 
remain diffused throughout the cytosol (Figure 43).  These images provide evidence that the 
adduction of HNE to PKC has serious deleterious consequences on the protein function. In order 
to begin to elucidate potential mechanisms through which HNE exerts these effects, the region(s) 
of the protein being modified must first be determined. Though the above experiments were able 
to successfully demonstrate both the presence of HNE adducts and potential ramifications, , the 
data does not yield the specific location nor the number of adducts present on PKC. 
 Further downstream affects of HNE adduction were also investigated to assess the extent 
of PKC activation, specifically an increase in intracellular calcium levels within in the cell.  
When PKC is properly activated by PMA, the PMA receptors are stimulated leading to the 
activation of PKC coupled with phospolipase C.(117)  This activation leads to the formation of 
1,2-diacylglycerol (DAG) and increased intracellular Ca
2+
 levels due to its release from inositol 
1,4,5-triphosphate-sensitive Ca
2+
 stores.  Confocal microscopy was used to study the effect of 
treatment with HNE on the extent of intracellular Ca
2+
 flux after activation with PMA.  To do 
this, samples were treated with a calcium specific dye, Oregon Green, and the extent of 
fluorescence was correlated to the amount of calcium present in a particular cell (Figure 44).  In 
control cells which had been activated with PMA, there is a distinct increase in fluorescent signal 
from the Oregan Green Calcium sensitive dye, corresponding to an increase in intracellular 
calcium.  However, when previously treated with 35 µM HNE for three hours, treatment with 
PMA does not elicit similar increases in fluorescence.  This indicates that the treatment with HNE 
in disrupting the ability of PMA to activate the RAW cells in a way which results in the inhibition 
of Ca
2+
 influx.  This inhibition is likely the result of HNE adduction to PKC resulting in the 
inability  
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of the protein to be activated by PMA, which therefore fails to trigger the release of  Ca
2+
.   
 
Discussion 
 
Due to the variety of key roles PKC plays in cellular signaling, inhibition of this enzyme 
results in disturbed cellular functioning. HNE is a known mediator of oxidative stress, and its 
presence is capable of reducing enzymatic activity. Confocal studies showed that the presence of 
Figure 44.  Confocal images of Ca2+ flux in RAW cells.  Untreated control (A) and HNE treated  (D) 
RAW cells gave no fluorescent signal as a result of auto fluorescence.  When the control (B) and HNE 
treated samples (E) are treated with the calcium sensitive dye, Oregon Green, low levels of fluorescence 
are seen.  When the control, Oregon green treated samples are activated with PMA, an increase in 
fluorescence is seen corresponding to an increase in intracellular calcium (C).  When HNE, Oregon green 
treated cells are stimulated with similar levels of PMA, no increase in fluorescence is seen (F). 
A. B. C. 
F. E. D. 
 89 
 
HNE results in the reduction of PMA-induced PKC translocation, a key step in proper PKC 
activation. Mass spectrometry revealed that the majority of HNE adducts were found in the 
catalytic domain (H479, H597, C572, C586) and one was found in the regulatory domain (H32). 
The important relationship between PKC function and structure underlies the detrimental impact 
of HNE adduction. The impact of these specific adduct sites can not be determined from mass 
spec along, however, clues to their interations can be found by examining the available 
information on PKC activity and its inhibition.  
There have been many studies looking at inhibition of the catalytic domain. For example, 
studies using a peptide substrate analogue (N-biotinyl-Arg-Arg-Arg-Cys-Leu-Arg-Arg-Leu ) have 
shown that adduction at critical catalytic domain cysteines can have devastating functional 
consequences.(118)  This potent peptide inhibitor is thought to work by the formation of a 
disulfide linkage between Cys502 (all residue numbers are based on the numbering for the βII 
isoform) of PKC and the cysteine residue of the analogue, an adduction which results in 
enzymatic inactivation.  Another example of PKC inhibitors which work by forming disulfide 
linkages with catalytic cysteine residues are the Selenocompounds.(119; 120) Selenite and 
selenocystine inactivate PKC through redox reactions with catalytic site cysteine residues; it is 
thought specifically C386, C488, C502 and C572. Of note, C572 is also the location of one the 
adduction sites seen as a result of HNE treatment.  While the exact role of C572 in PKC 
activation has not been elucidated, it is clearly a site sensitive to adduction and worthy of further 
investigation. 
The idea of a small molecule inactivating PKC is not novel. There are several other small 
molecules which have been shown to shown to inactivate PKC through the formation of covalent 
adducts to catalytic domain cysteines.  For instance, 4-hydroxytamoxifen (OH-Tam), an 
oxymetabolite of the chemopreventive agent tamoxifen, has been shown to irreversibly inactivate 
PKC in vitro.(121)  OH-TAM works by generating a phenoxyl radical from the phenolic 
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compound which can react with vicinal thiols, resulting in PKC inactivation.   N-ethylmaleimide 
has been shown to inactive PKC-ε through S-cysteaminylation of Cys 386.(122)  Similarly, 
chelerythrine, a specific PKC inhibitor, alkylates cysteine residues within the catalytic domain 
resulting in enzyme inactivation. This benzophenanthridine alkaloid reacts with cysteines through 
an electrophilic iminium carbon with the requirement of a basic residue in close proximity to 
fulfill the need for a lower  pKa.Cys572, one of the sites of HNE adduction, is one of only two 
cysteines in the catatlytic domain flanked by a basic residue. Perhaps this site is sensitive also to 
chelerythrine. Either way, Cys572 is a residue of interest for future studies aimed at examining 
which sites of HNE adduction are most important for PKC inactivation. While many inhibitors 
have focused on the catalytic domain, the regulatory domain is also sensitive to adduction and 
infactivation of PKC. 
 The N-terminal regulatory domain of PKC is responsible for a number of roles critical in 
the proper activation and regulation of the enzyme including autoinhibition by the 
pseudosubstrate, and translocation and activation of the enzyme by phorbol ester binding.  H32, a 
site sensitive to HNE modification, directly flanks the pseudosubstrate region and it has been 
determined that any change to the pseudosubstrate sequence can render it less sensitve to phorbol 
activation.(122) This suggests the addition of the H32 HNE adduct could affect the binding 
affinity of the substrate for the catalytic active site, reducing the enzyme response to phorbol ester 
activation.Conversely, the additional bulk caused by the H32 adduct could limit the ability of the 
pseudosubstrate to be removed from the catalytic active site during conformational change 
resulting from activation.   
Another mechanism through which modification of H32 could be detrimental to 
activation is interruption of PMA binding. Though H32 has not been shown to directly bind 
PMA, it lies near the PMA-binding site and is involved in hydrogen bond stabilization of PMA 
binding.  However, even without inhibiting PMA binding, the H32 HNE adduct could hinder 
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proper PMA activation through the regulatory domain. The binding of PMA has been associated 
with formation of a hydrophobic patch of the protein which then drives translocation of the 
enzyme from the cytosol to the membrane.  However, studies using PMA derivatives have shown 
that by modulating the hydrophobicity translocation to the membrane upon PMA binding can be 
interrupted.  It is reasonable then to postulate that the addition of an HNE adduct, which contains 
a carbonyl and hydroxyl group, within close proximity to the cys-rich regions responsible for 
PMA binding could alter the hydrophobicity of the surface.   The result then would be an 
impaired ability to evoke protein translocation.  Intriguingly this would allow a mechanism by 
which HNE could cripple PKC function without direct interaction with the catalytic site.   
The construction of a PKC homology model of the PKCβI catalytic domain to explore the 
location of the several of the HNE adducts with respect to the tertiary structure of the domain. 
Despite the lack of a cystral structure for PKCβII,, the high level of homology between the classic 
PKC isoforms makes it possible to explore the local environment of the residues which are 
adducted by HNE within the context of the protein structure.   In the catalytic domain, there were 
four residues which were found to have HNE adducts, H479, H597, C572, and C586.  Of these 
residues, two of them in particular, C572 and H579, are found to be located within a series of 
helices (Figure 45).  The close proximity of these four helices would imply that an extensive 
amount of hydrogen bonding, both inter and intra-helix.  It could be easily hypothesized that the 
bulky HNE adducts could disrupt the hydrogen bonding, destabilizing the network of helices.  
Because the catalytic domain is made up of little more than a small number of helices and loops, 
the destablilization of two of these helices could lead to a decrease in the overall stability of the 
entire domain.  To explore this hypothesis, a simple circular dichorism experiment could be 
performed PKC to determine is there is a decrease in helical structures after treatment with HNE.   
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Two of the most common sites of adduction by other types of PKC inhibitors, C502 and 
C488 are not found to be sites of HNE adducts.  When these two residues are mapped on the 
homology model, they are found to be located in an entirely different region of the catalytic 
domain.  This region has a much higher negative charge density than the location of the HNE 
adducted residues.  Further, these residues are located in much closer proximity to the catalytic 
active site of the domain.  Because the type of inhibitors that form adducts at C502 and C488 are 
typically active site selective, it is reasonable to hypothesize that the active site targeting of these 
inhibitors allow them to access residues that are largely hidden in the inactive state of the domain.  
By targeting the active site, these inhibitors allow the protein to undergo the necessary changes to 
Figure 45.  Homology model of HNE adduction sites demonstrate interaction of residues with 
helical structures.  Two of the sites of HNE adduction, C572 and H597, are located in helical secondary 
structure of the catalytic domain.  The adduction of these residues could lead to hydrogen bonding 
disruption and consequently, the destabilization of the domain. 
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become active.  During the activation of the protein, a number of events, including the binding of 
a number of activators, phosphoralyation and the removal of the psuedosubstrate, all induce 
changes which lead to an active state protein.  This active state is then inhibited by the active site 
targeting inhibitors.  Because of all the changes undergone by the protein during activation, it is 
reasonable to deduce that residues which were previously inaccessible, including C502 and C488, 
could become accessible to these inhibitors.  However, because treatment with HNE does not 
induce the active state of the protein, these residues would remain inaccessible to HNE and 
therefore resistant to adduction.  
It is imperative to determine which sites of adduction are the most sensitive to HNE using 
a time study of the formation of HNE adducts. Along the same lines, future work examining 
which of the adducts plays the most important role in the inhibition of PKC activation will help 
illucidate more information about the structure/function relationship of PKC. Cys572 is of 
interest as it a site that has been shown to be sensitive to adduction previously and has been 
thought to be involved in the inactivation of PKC with various inhibitors such as 
selenocompounds and chelerythrine. While it is not expected that every adduct site found in this 
study is crucial for PKC inactivation, there is literature precedence suggesting Cys572 is a 
potentially a key target of HNE modification. 
 
Conclusion 
 
 As the major aldhydic byproduct of membrane peroxidation, HNE has been the focus of 
much concentrated study from cellular apoptosis to stimulation of fibrogenesis and inflammation 
to protein adduction (116; 123-126). HNE is believed to play a role in a several diseases from 
malaria (115) to Alzheimer’s, indicating the global importance of this molecule (123). Due to its 
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highly reactive nature, the increased levels of HNE found monocytes that have phagocytized the 
malaria pigment hemozoin (127) indicate the immunomodulatory role this molecule may play in 
malarial disease. HNE is a well-known cytotoxic agent due to its ability to modify the amino acid 
side chains. The inhibition of oxidative burst mediated by HNE may be due to the highly reactive 
HNE forming Michael and Schiff base adducts on residues of key proteins within the 
macrophage. Once formed, these adducts may inhibit the activity of the protein through multiple 
pathways. For example, adducts may form on or adjacent to active site residues, blocking 
substrate binding, or perhaps adduction results in a conformation change in the protein that 
prevents the active conformation of the protein. Clearly, the inhibitory nature of HNE on PKC is 
due to the formation of covalent adducts on key amino acid residues. These results suggest that 
the highly reactive nature of HNE may lead to the loss of key cellular functions by disrupting 
protein function.  It has been shown here that the presence of the HNE adducts not only inhibits 
PKC translocation upon activation with PMA, it also inhibits the increase in intracellular Ca
2+
 
typically seen with PMA activation of PKC.  The location of these HNE adduction sites points to 
residues on the protein that may be of interest for continuing the work to understand how protein 
kinase c functions.   
 
Future Work 
 
 While we have begun to investigate the functional consequences of HNE adduct 
formation on PKC activation, sweeping questions still remain.  The present data clearly 
demonstrates that the formation of all five HNE adducts limits the translocation of PKC, it does 
not give information as to the exact adduct (or adducts) which have the debilitating effects on the 
enzyme.  Combined with kinetics experiments to evaluate the order of HNE adduct formations, it 
would be interesting to see which had the greatest effect on PKC function.  It would be also be 
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useful to take a closer look at the inhibition of intracellular calcium flux.  The preliminary studies 
suggest that the intracellular calcium flux typically seen with PMA activation is inhibited by pre-
treatment with HNE.  By taking a more quantitative approach, it would be possible to determine 
the extent to which the calcium flux is being inhibited and determine if there is partial activation 
of PKC even with HNE treatment or if it is completely inhibited.  Beyond the expansion on these 
functional studies, other studies might give insight into the mechanism of PKC inhibition.  PKC 
contains two critical zinc fingers which are essential to proper PKC function.  The formation of 
HNE adducts might destablilize these zinc fingers ultimately destabilizing the entire enzyme.  By 
investigating the dissociation constant of the zinc ions, you would investigate any possible effects 
on zinc finger stability associated with HNE adduct formation. 
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 b and y ion traces for HNE Modified PKC peptides 
 
Figure 46. MS/MS of HNE modified NVHEVK peptide.  Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide NVHEVK of HNE-modified PKC. [M+2H]
+2
 442.3 is 
shown. 
Figure 47. MS/MS of HNE modified FLGCGPEGER peptide.  Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide RLGCGPEGER of HNE-modified PKC. [M+2H]
+2
 616.3 is 
shown. 
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Figure 48. MS/MS of HNE modified EHAFFR peptide.  Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide EHAFFR of HNE-modified PKC. [M+H]
+
 964.5 is shown. 
Figure 49. MS/MS of HNE modified LDNVMLDSEGKIK peptide. Deconvoluted MS/MS spectra 
obtained from the LC/MS/MS analysis of the tryptic peptide LDNVMLDSEGKIK of HNE-modified PKC. 
[M+2H]
+2
 814.9 is shown. 
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B and y ions for unmodified PKC peptides 
  
Figure 50. MS/MS of HNE modified EAVAICK peptide.  Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide EAVAICK of HNE-modified PKC. [M+H]
+
 891.5 is 
shown..Purple indicates ions that are evidence of modification of the cysteine residue. 
Figure 51. MS/MS of unmodified NVHEVK peptide. Deconvoluted MS/MS spectra obtained from the 
LC/MS/MS analysis of the tryptic peptide NVHEVK of native PKC. [M+H]
+
 725.5 is shown. 
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Figure 52. MS/MS of unmodified EHAFFR peptide.  Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide EHAFFR of native PKC. [M+H]
+
 806.5 is shown. 
 
Figure 53. MS/MS of unmodified LDNVMLDSEGKIK peptide. Deconvoluted MS/MS spectra 
obtained from the LC/MS/MS analysis of the tryptic peptide LDNVMLDSEGKIK of native PKC. 
[M+2H]
+2
 735.9 is shown. 
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B and y ion traces for PMA activated HNE modified PKC peptides 
 
Figure 54. MS/MS of unmodified EAVAICK peptide. Deconvoluted MS/MS spectra obtained from 
the LC/MS/MS analysis of the tryptic peptide EAVAICK of native PKC. [M+H]
+
 733.6 is shown 
Figure 55. MS/MS of PMA activated HNE modified NVHEVK peptide. Deconvoluted MS/MS spectra 
obtained from the LC/MS/MS analysis of the tryptic peptide NVHEVK of HNE-modified PMA-treated PKC. 
[M+2H]
+2
 442.3 is shown. 
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Figure 56. MS/MS of PMA activated HNE modified RLGCGPEGER peptide.  Deconvoluted MS/MS 
spectra obtained from the LC/MS/MS analysis of the tryptic peptide RLGCGPEGER of HNE-modified 
PMA-treated PKC. [M+2H]
+2
 616.3 is shown. 
 
Figure 57. MS/MS of PMA activated HNE modified EHAFFR peptide.  Deconvoluted MS/MS 
spectra obtained from the LC/MS/MS analysis of the tryptic peptide EHAFFR of HNE-modified PMA-
treated PKC. [M+2H]
+2
 482.8 is shown. 
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Figure 58. MS/MS of PMA activated HNE modified EAVAICK peptide. Deconvoluted MS/MS spectra 
obtained from the LC/MS/MS analysis of the tryptic peptide EAVAICK of HNE-modified PMA-treated PKC. 
[M+H]
+
 891.5 is shown. Purple indicates ions that are evidence of modification of the cysteine residue. 
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Table of Secondary Ions 
 
Fragment Treatment Obs. Calc. Fragment Treatment Obs. Calc. 
K Control 129.1 129.1 HEV or VEH Control 366.2 366.2 
  HNE 129.0 129.1   HNE 524.4 524.3 
  PMA HNE 
 
    PMA HNE 524.4 524.3 
y1-NH3 Control 
 
  a4 Control 452.4 452.2 
  HNE 130.2 130.1   HNE 610.4 610.4 
  PMA HNE 130.1 130.1   PMA HNE 
 
  
a2 Control 
 
  b4-NH3 Control 463.3 463.3 
  HNE 186.2 186.1   HNE 621.5 621.5 
  PMA HNE 186.2 186.1   PMA HNE 621.4 621.4 
HE-H2O Control 249.0 249.1 y4-H2O Control 494.3 494.3 
  HNE 
 
    HNE 
 
  
  PMA HNE 
 
    PMA HNE 
 
  
HE Control 267.1 267.1 a5 Control 551.3 551.3 
  HNE 425 425.2   HNE 709.5 709.4 
  PMA HNE 425.3 425.2   PMA HNE 709.7 709.4 
[NVHEVK-H2O]
2+
 Control 
 
  b5-NH3 Control 562.3 562.3 
  HNE 433.9 433.8   HNE 720.4 720.4 
  PMA HNE 433.9 433.8   PMA HNE 720.5 720.5 
b5-H2O Control 597.4 597.3 b5+H2O Control 
 
  
  HNE 
 
    HNE 755.5 755.4 
  PMA HNE 
 
    PMA HNE 755.5 755.4 
HEV or VEH-H2O Control 348.2 348.2   
  
  
  HNE 
 
    
  
  
  PMA HNE          
 
 
 
 
 
 
 
Table 2. Secondary ions from fragmentation of NVHEVK 
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Fragment Treatment Obs. Calc. Fragment Treatment Obs. Calc. 
a2-NH3 Control 225.2 225.2 b7-H2O Control 853.5 853.5 
  HNE 225.2 225.2   HNE 853.6 853.5 
  PMA HNE 
 
    PMA HNE 
 
  
b2-NH3 Control 
 
  b7-NH3 Control 
 
  
  HNE 253.3 253.3   HNE 854.5 854.4 
  PMA HNE 253.2 253.2   PMA HNE 854.6 854.4 
y3-NH3 Control 
 
  b8-H2O Control 
 
  
  HNE 344.3 344.2   HNE 910.6 910.6 
  PMA HNE 344.2 344.2   PMA HNE 910.6 910.6 
y4-H2O or Control 
 
  y8-H2O Control 
 
  
[Y8-H2O]
2+
 HNE 472.4 472.2, 474.7   HNE 944.5 944.5 
  PMA HNE 
 
    PMA HNE 944.6 944.5 
[b9-H2O]
2+
 or Control 
 
  a9-NH3 Control 
 
  
[b9-NH3]
2+
  HNE 520.5 520.3,520.8   HNE 1012.5 1013 
  PMA HNE 520.5 520.3,520.8   PMA HNE 1012.7 1013 
[RLGCGPE Control 
 
  a9  Control 
 
  
GER-H2O]
2+
 HNE 607.8 607.8   HNE 1029.7 1030 
  PMA HNE 607.8 607.8   PMA HNE 1029.7 1030 
y6-NH3 Control 
 
  b9-NH3 Control 
 
  
  HNE 627.5 627.5   HNE 1040.6 1041 
  PMA HNE 627.5 627.5   PMA HNE 1040.6 1041 
a7 Control 
 
    
  
  
  HNE 843.6 843.5   
  
  
  PMA HNE 843.6 843.5         
 
 
 
 
 
 
 
 
 
 
Table 3. Secondary ions from fragmentation of RLGCGPEGER 
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Fragment Treatment Obs. Calc. Fragment Treatment Obs. Calc. 
FF Control 295.2 295.1 a4 Control 615.5 615.5 
  HNE 
 
    HNE 
 
  
  PMA HNE 
 
    PMA HNE 
 
  
HAF Control 356.3 356.2 b4-H2O Control 
 
  
  HNE 
 
    HNE 625.5 625.3 
  PMA HNE 
 
    PMA HNE 625.4 625.3 
b2-H2O Control 
 
  y5-NH3 Control 660.5 660.3 
  HNE 407.3 407.3   HNE 818.7 818.5 
  PMA HNE 407.3 407.3   PMA HNE 
 
  
[y5]
2+
 Control 
 
  HAFF Control 
 
  
  HNE 418.4 418.4   HNE 661.5 661.4 
  PMA HNE 
 
    PMA HNE 
 
  
[EHAFFR-H2O]
2+
 Control 
 
  a5 Control 
 
  
  HNE 474.1 474.3   HNE 762.5 762.4 
  PMA HNE 
 
    PMA HNE 
 
  
y3-NH3 Control 452.4 452.2 b5-H2O Control 
 
  
  HNE 
 
    HNE 772.5 772.4 
  PMA HNE 
 
    PMA HNE 772.6 772.4 
b3-H2O Control 
 
  [EHAFFR-H2O]
+1
 Control 660.5 660.3 
  HNE 478.4 478.3   HNE 946.6 946.5 
  PMA HNE       PMA HNE     
 
Secondary ions from fragmentation of LDNVMLDSEGHIK 
 
 
 
 
 
 
 
 
 
 
Table 4. Secondary ions from fragmentation of EHAFFR 
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Fragment Treatment Obs. Calc. Fragment Treatment Obs. Calc. 
DNV or a6+2 Control 392.2 392.2, 392.7 DNVMLDS-NH3 Control 758.7 758.3 
  HNE 392.2 392.2, 392.7   HNE 
 
  
  PMA HNE 
 
    PMA HNE 
 
  
GH Control 
 
  y7-H2O Control 767.5 767.4 
  HNE 353.3 353.2   HNE 925.6 925.5 
  PMA HNE 
 
    PMA HNE 
 
  
MLD Control 
 
  DNVMLDS  Control 
 
  
  HNE 360.3 360.2   HNE 775.7 775.3 
  PMA HNE 
 
    PMA HNE 
 
  
a4-NH3 Control 
 
  b7-NH3 Control 
 
  
  HNE 397.2 397.2   HNE 784.1 784.4 
  PMA HNE 
 
    PMA HNE 
 
  
a4  Control 
 
  DSEGHI or Control 
 
  
  HNE 414.3 414.2 LESEGH HNE 797.4 797.4 
  PMA HNE 
 
    PMA HNE 
 
  
[EGH-H2O] Control 
 
  b8-NH3 Control 
 
  
  HNE 464.3 464.3   HNE 871.5 871.4 
  PMA HNE 
 
    PMA HNE 
 
  
a5-NH3 or Control 
 
  MLDSEGH or Control 
 
  
VMLDS-H2O HNE 528.4 528.3 LDSEGH-H2O HNE 910.6 910.4, 910.5 
  PMA HNE 
 
    PMA HNE 
 
  
y3-HN3 Control 
 
  y8-H2O Control 
 
  
  HNE 538.3 538.4   HNE 1039 1039 
  PMA HNE 
 
    PMA HNE 
 
  
b5-NH3 or  Control 556.4 556.2 y9-H2O Control 1012 1012 
NVMLD-NH3 or HNE 556.3 556.2   HNE 1170 1170 
DNVML-NH3 PMA HNE 
 
    PMA HNE 
 
  
  
  
  NVMLDSEGH Control 
 
  
y11+2 Control 621.8 622.2   HNE 1142 1142 
  HNE 701.0 701.0   PMA HNE 
 
  
  PMA HNE 
 
  b12-NH3 Control 
 
  
b6-NH3 Control 
 
    HNE 1466 1466 
  HNE 669.4 669.3   PMA HNE 
 
  
  PMA HNE 
 
  b12+NH3 Control 
 
  
VMLDSE Control 
 
    HNE 1501 1501 
  HNE 675.6 675.3   PMA HNE 
 
  
  PMA HNE             
 
 
Table 5. Secondary ions from fragmentation of LDNVMLDSEGHIK 
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Fragment Treatment Obs. Calc. Fragment Treatment Obs. Calc. 
IC Control 217.1 217.1 y3-H2O Control 503.4 503.3 
  HNE 
 
    HNE 503.5 503.3 
  PMA HNE 
 
    PMA HNE 
 
  
AVA Control 242.3 242.2 y3-NH3 Control 
 
  
  HNE 
 
    HNE 504.4 504.3 
  PMA HNE 
 
    PMA HNE 504.4 504.3 
a3 Control 272.2 272.2 a6 Control 559.5 559.4 
  HNE 
 
    HNE 
 
  
  PMA HNE 
 
    PMA HNE 
 
  
b3-H2O Control 282.2 282.2 b6-H2O Control 569.6 569.3 
  HNE 282.2 282.2   HNE 745.5 745.4 
  PMA HNE 282.2 282.2   PMA HNE 
 
  
AIC Control 288.3 288.1 y4-H2O Control 
 
  
  HNE 
 
    HNE 574.4 574.4 
  PMA HNE 
 
    PMA HNE 574.5 574.4 
AVAI-
CO Control 327.4 327.2 y4-NH3 Control 
 
  
  HNE 327.4 327.2   HNE 575.5 575.4 
  PMA HNE 
 
    PMA HNE 575.5 575.4 
b4-H2O Control 353.4 353.2 y5-H2O Control 
 
  
  HNE 353.2 353.2   HNE 673.6 673.4 
  PMA HNE 353.2 353.2   PMA HNE 673.6 673.4 
a4 Control 
 
  y5-NH3 Control 
 
  
  HNE 343.3 343.2   HNE 674.6 674.4 
  PMA HNE 
 
    PMA HNE 674.6 674.4 
y2-H2O Control 
 
  b6-H2O Control 
 
  
  HNE 390.3 390.3   HNE 727.5 727.4 
  PMA HNE 390.3 390.3   PMA HNE 725.6 725.4 
y2-NH3 Control 
 
  y6-H2O Control 
 
  
  HNE 391.4 391.4   HNE 744.6 744.6 
  PMA HNE 391.3 391.3   PMA HNE 744.6 744.6 
a5-H2O Control 
 
  y6-NH3 Control 
 
  
  HNE 438.5 438.5 or b6 HNE 745.5 745.5, 745.4 
  PMA HNE 438.3 438.3   PMA HNE 745.6 745.5, 745.4 
a5 Control 456.3 456.3 [EAVAICK-H2O]
+2
 Control 
 
  
  HNE 456.5 456.3   HNE 873.6 873.5 
  PMA HNE 456.4 456.3   PMA HNE 873.6 873.5 
b5-H2O Control 466.3 466.3   
  
  
  HNE 466.4 466.3   
  
  
  PMA HNE 466.4 466.3         
 Table 6. Secondary ions from fragmentation of EAVAICK 
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CHAPTER IV 
 
NANOBLOSSOMS: A LIVE CELL PROBE FOR THE DETECTION OF RESPIRATORY 
SYNCYTIAL VIRUS 
 
Statement of Effort 
 
 .  In the design, development and application of the nanoblossom probes, I was assisted 
by Dr. Ash Jayagopal and Jonas Perez.  In the design and synthesis of the nanoblossoms, I 
performed all synthesis and characterization assays including both the in vitro characterization of 
the probes themselves as well as characterizing their in vivo properties.  The in vivo assays 
included exploring the cytotoxcity, stability, specificity in the cellular environment and the rate of 
transfection.  Because my largest interest I this project was aimed at developing a tool for 
effective live cell RNA imaging, I also performed  a wide range of in vivo labeling and imaging 
using confocal microscopy including initial RNA labeling experiments as well as multiplexed 
spatial resolution experiments.   While this project was  my pet project from its inception, it 
would not  have been possible without the experimental contribution of Dr. Ash Jayagopal and 
academic insight provide by Jonas Perez. Dr. Ash Jayagopal was kind enough to lend us his 
expertice by performing the gold colloidal experiments as well as the mechanism of 
internalization experiments including the endocytosis inhibitors.   Jonas Perez was provided 
indispensible guidance in the early stages of this project without which this project would have 
been far more difficult to get off the ground. 
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Introduction 
 
Proper RNA processing and trafficking is essential to nearly all cellular functions.  It 
plays an underlying role in cellular replication, homeostasis, and response to external 
stimuli.(128; 129) Currently, there are a number of methods available to study RNA, and to some 
extent, its trafficking.  Reverse Transcriptase PCR (RT-PCR) is a highly specific and sensitive 
tool for detection of specific RNA sequences.(26-28)  RT-PCR has been used successfully in the 
detection of low levels of RNA making it a useful method when sample is limited. Unfortunately, 
this method is labor intensive and contamination is a constant concern.  More importantly, RT-
PCR cannot be used to study live cells because the RNA must be extracted rendering it useless in 
studying the molecular mechanisms of RNA trafficking.  Fluorescently-labeled oligonucleotide 
probes have also been widely employed to explore and quantify intracellular RNA.  Some of 
these methods include Förster resonance energy transfer (FRET) pairs, molecular beacons, and in 
situ hybridization(29-33).  These probes are designed to hybridize with a specific RNA sequence, 
providing in vivo spatial information about that particular strand of RNA.  However, probe 
internalization is a significant challenge with these techniques.  Various transfection methods 
have been developed to shuttle fluorescently labeled oligonucleotides into cells including cationic 
lipids and polymers, modified viruses, dendrimers, and liposomes.  Each of these methods has 
limitations and ultimately the necessity of chemical transfection reagents limits the utility of these 
probes. Further, these probes are also susceptible to rapid degradation by cellular nucleases 
leading to high backgrounds, false positives and poor target detection.  Although these obstacles 
can be circumvented by cell fixation, doing so renders them inapplicable for live cell imaging.  
Recently, the unique advantages of nanoparticles have been exploited to develop probes that 
overcome a number of limitations found with the aforementioned methods.(34; 35)   
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The field of nanotechnology capitalizes on the unique properties of nanoscale materials, 
ranging in size from 1- 100 nm.(130)  The underlying basis for the nanoscale properties is closely 
related to the length associated with it.  The fundamental physics and chemistry of a material will 
change when the dimensions of a solid become comparable to one or more of these characteristic 
lengths, many of which exist at the nanometer length scale.  At this scale, objects such as 
nanoparticles take on properties and functions that differ from those seen on the bulk scale.(130)  
A common approach to take advantage of the characteristics of nanoscale materials is to tune 
their chemical and spectral properties by changing their size and/or shape.  This ability to tune the 
properties of nanoscale material has long been ultilized in electronic and chemical applications 
such as electrocatalysis, electrochemical sensor devices and redox recognition.(130; 131)  
Recently the focus has expanded to encompass a new range of biological applications.  
Nanoparticles, of various compositions, can be effective vehicles for drug delivery.  
Nanoparticles have also been used to probe the internal cellular structure and dynamics of various 
biological systems including the vescular secretion of neurotransmitters and distinguishing 
healthy colon cells from adenocarcinoma cells.(132)   The use of magnetic nanoparticles as MRI 
contrast agents have also led to their use in identifying atherosclerotic lesions in cardiovascular 
tissue.(133)  The development of nanoparticles to study these and other biological systems has 
demonstrated their versatility and functionality. 
Metal nanoparticles have become a critical componet in the development of 
nanotechnology-based detection methods for respiratory viruses.  Gold and silver nanoparticles 
have garnered much of the attention in this field because of their unique physical and chemical 
properties.  The surface of gold nanoparticles (AuNPs) acts as a soft metal ion that easily binds to 
soft ligands such as thiols.  This reactivity provides an efficient strategy to readily functionalize 
particles with relevant biological molecules.(134)  The deep-red color seen in solutions of AuNPs 
is the result of the surface plasmon band (SPB), a broard absorption band in the visible region 
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between 510 and 580 nm.(135)  The SPB experiences wavelength shifts based on AuNP size, 
shape, temperature and the nature of functionalized ligands, which has made it the subject of 
extensive study of the optical spectroscopic properties of AuNPs.  The ligand shell of AuNPs 
alters the refractive index causing either a red or blue shift, allowing SPB shifts to be used to 
assess the extent of ligand functionalization.(135)  AuNPs possess the advantageous ability to act 
as fluorescence quencher molecules as a result of nonradiative energy transfer from the dye to the 
metal surface.(136; 137)   In the case of chromophore-AuNP composites, the quenching 
efficiency of AuNPs outperforms that of most organic acceptors.  The dominating design factor 
affecting the efficiency of quenching by the AuNP is the distance between surface of the AuNP 
and the chromophore.(137)  In cases where the chromophore is separated from the AuNP by a 
bulky spacer, such as antibiodies or carbon-based linker molecules, there is a decrease in 
quenching seen that corresponds to the increasing distance between the AuNP surface and the 
chromophore.(137)  Each of these properties makes AuNPs interesting platforms for the 
development of respiratory infection diagnostics. 
AuNPs functionalized with oligonucleotides have been shown to efficiently enter live 
cells without the aid of harsh transfection/permeabilization agents and have limited cytotoxic 
effects.  The recent development of ―nano-flares‖ (NF) takes advantage of these qualities to yield 
a real-time probe capable of detecting specific RNA sequences with minimized background 
interference.(34)  A NF consists of an AuNP conjugated to a long probe sequence of DNA, which 
is compliment to the RNA of interest.  There is also a short hybridzed ―reporter‖ strand of 
fluorescently- tagged DNA.  In this state, the organic fluorophore is quenched as a result of its 
proximity to the AuNP. Upon hybridization of the probe strand with the target RNA compliment, 
the reporter strand is released, spatially separating it from the AuNP and  resulting in a 
fluorescent signal that can be correlated to the presence of the RNA sequence of interest.(34)   
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While NFs overcome many of the challenges faced by previous approaches, their design 
yields a signal that diffuses away from the hybridized RNA/NF construct.  Consequently, 
important spatial information is lost in live cell microscopy applications.  Here, we have 
developed a new probe for studying RNA trafficking that exploits the advantages of 
oligonucleotide functionalized AuNPs and overcomes the spatial limitations of previous designs.    
Nanoblossom (NB) probes consist of an AuNP conjugated to a strand of hairpin DNA, which 
contains a fluorophore at the 3΄ end (Figure 59).   
 
 
 
 
 
A specific sequence of RNA, the compliment to the ―loop‖ region of the DNA hairpin, 
can be detected through hybridization with the NB.  Without compliment DNA or RNA, the 
hairpin sequence of the NB oligonucleotide remains folded, with the fluorophore quenched due to 
the proximity of the gold nanoparticle surface.  Upon binding the specific RNA target, the hairpin 
 
 
Au 
 
Au 
Figure 59. Nanoblossom Construct.  Nanoblossoms were synthesized by conjugating a 26 base hairpin DNA 
with a T-10 linker to a Au nanoparticle through a 5’ thiol. In the closed state, the fluorophore is quenched due 
to its proximity to the gold nanoparticle.  However, upon binding with the appropriate compliment, the hairpin 
opens and the fluorophore is then a sufficient distance from the nanoparticle to overcome the quenching.  This 
allows for the detection of compliment by monitoring fluorescence intensity.  Importantly because the 
fluorophore does not dissociate, the fluorescence intensity can be used to learn about the spatial orientation of 
the RNA.  
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opens and the fluorophore extends a sufficient distance from the nanoparticle to overcome 
quenching.  More importantly, the fluorophore does not dissociate from the NB.  This allows not 
only the detection of the RNA of interest, but also the identification of its spatial location in real 
time.   
RNA viruses, whose replication is dependant on proper RNA translation and trafficking, 
are an ideal test system to develop NB probes.  In particular, we have focused on probes to 
examine respiratory syncytial virus (RSV) genomic RNA during infection.  RSV is the leading 
cause of lower respiratory tract infections in children under the age of five in the United States, 
resulting in an estimated 90,000 hospitalizations per year.(138)  RSV is an enveloped negative-
sense, single stranded RNA paramyxovirus.  The attachment (G) and fusion (F) proteins are 
necessary for proper virion attachment, membrane fusion, and nucleocapsid release into the host 
cell.  The nucleocapsid is composed of genomic viral RNA, nucleoproteins (N), phosphoproteins 
(P) and polymerase proteins (L) which aid the virus in commandeering host cellular machinery to 
propagate infection.  During viral infection, the full length genomic viral RNA is replicated and 
packaged with newly synthesized viral proteins which then bud from the cell as a virion, free to 
infect other cells.(138)  Little is known about viral RNA trafficking within host cells during the 
course of the infection.  This is due, in part, to the lack of adequate tools to probe live cells and 
monitor the progression of infection in real time. When applied to the study of RSV, sequence 
specific NBs would provide a powerful tool for the detection of viral infection and real-time 
study of RSV pathogenesis.   
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Material and Methods 
 
Materials 
 All chemicals were used as received unless otherwise noted.  Fetal bovine serum was 
purchased from Atlanta Biologicals (Atlanta, GA, USA).  Penicillin/streptomycin, trypan blue 
and Mg
2+
/Ca
2+
 free PBS were obtained from Cellgros Mediatech (Herdon, VA, USA). The human 
cell line, HEp-2, was obtained from the American Type Culture Collection (ATCC).    
Oligonucleotide sequences were purchased from Biosearch Technologies.  Gold nanoparticle 
solutions were purchased from Ted Pella, Inc.  RSV type A2 virus and RSV anti F-protein 
antibodies were a kind gift from the Jim Crowe laboratory (Vanderbilt University).  Quantum 
dots, propidium iodide, calcein-AM, and Alexa Fluor 647 conjugates of transferrin, 70 kDa 
anionic dextran, cholera toxin B and biotinylated goat anti-mouse antibodies were purchased 
from Invitrogen Corp.  Lab-Tek II chambered coverglass was from Nunc.  The Goldenhance 
autometallographic gold colloid enhancement kit was from Nanoprobes, Inc.  Cytochalasin D and 
Dynasore were purchased from Tocris Bioscience.  Brefeldin A was from Epicentre 
Biotechnologies.  Genistein was from Ascent Scientific.  All buffers used for endocytosis assays, 
trypan blue, Nuclear Fast Red, and Chloroquine, Chlorpromazine, nocodazole, nystatin, 
progesterone, porcine heparin, 2-deoxy-D-glucose, sodium azide, and amiloride were from Sigma 
Chemical at the highest available purity.  All solutions were sterile-filtered through a 0.2 µm Pall 
Supor membrane syringe filter prior to use in cell cultures.  All cell culture materials were 
obtained from Gibco unless otherwise noted.  All other chemicals were purchased from Fisher 
Scientific (Hampton, VA, USA) unless otherwise specified. 
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Cell Culture and RSV infection 
HEp-2 cells were grown in Opti-MEM growth media supplemented with 2% (v/v) fetal 
bovine serum (complete Opti-MEM), 2% amphoericin B, 2% glutamine and 0.1 % gentamycin 
and incubated in an environment of 37 °C with 5% carbon dioxide and 5% humidity.  For 
reproducible sample infection with RSV type A2 at different multiplicity of infections (MOI), the 
following protocol was used.  HEp-2 cells were plated and allowed to grow to 80% confluency in 
an environment of 37 °C with 5% carbon dioxide and 5% humidity.  Once the samples reach 80 
% confluency, the cells were counted using Trypan Blue exclusion and a hemocytometer, and the 
cell count averaged.  The determined cell count was multiplied by the desired MOI to determine 
the correct number of plaque forming units (pfu) needed to treat the samples. This was divided by 
the virus titer to determine the volume of virus stock to be used in sample infection.  Samples 
were treated with RSV diluted in complete Opti-MEM growth media to the appropriate 
concentration then incubated for 1 hour.  After incubation, complete Opti-MEM growth media 
containing 0.75% w/v autoclaved methylcellulose was added to each sample and incubated for 
the appropriate period of infection. 
 
Synthesis and Characterization of Nanoblossoms 
To synthesize the nanoblossoms, the genomic RSV compliment DNA strand was used for 
RSV-NB.  The sequence of the strand is CGA CGA AAA ATG GGG CAA ATA CGT CG  
from 5’ to 3’.  At the 5’ end, there is a thiol attached to a ten T linker.  A Quasar 670 or CAL 
fluor Red590 fluorophore is conjugated at the 3’ end (RSV-NB-Cy5 or RSV-NB-Red590, 
respectively).  For the GAPDH-NB, the exon 6 compliment strand was used with the sequence 
CGA CGG AGT CCT TCC ACG ATA CCA CGT CG.  A CAL fluor Red590 fluorphore is 
conjugated at the 3’ end.  Before attachment to the gold nanoparticle, the hairpin DNA strand was 
activated to reduce any disulfide bonds formed between strands.  To do this, the lyophilized DNA 
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was resuspended in 1:1 solution of 100 mM DTT and 0.2 mM phosphate buffer, pH 8.3, and 
incubated at room temperature, protected from light.  After one hour, the samples were filtered 
and washed with RNase free water using a Millipore Microcon YM-3 spin filter.  After the final 
wash, the filtered DNA was resuspended and aliquots were stored at -80 °C.  The final 
concentration of this DNA solution was determined by measuring the UV absorption at 254 nm.  
Once the DNA was activated, it was conjugated to 15 nm gold nanoparticles to form the complete 
nanoblossom.  For this, 450 nM DNA was added to the 2.325 nM Au nanoparticle solution and 
incubated at RT for 4 hours, protected from light.  After 4 hours, phosphate buffer (final 
concentration = 10mM), Tween 20 (0.1% final concentration) and sodium chloride (0.1mM) were 
added to the solution, mixing thoroughly between each addition.  The solution was incubated at 
RT for an additional four hours, protected from light.  After 4 hours, sodium chloride was added 
to the solution to give a total sodium chloride concentration of 0.2 mM and incubated for 4 hrs at 
RT protected from light. This step was repeated.  After the final incubation, the solution was 
centrifuged at 13, 200 rpms for 30 min and the supernatant was removed and kept for later 
analysis.  The Au pellet was resuspended in Mg
2+
/Ca
2+
 free phosphate buffered saline solution 
(PBS), using sonication to disrupt the pellet if necessary and washed 3 times in PBS.  After the 
final wash, the Au pellet was resuspended in 1 mL of PBS and the nanoblossom concentration 
was determined by measuring absorbance at 260 nm and 520.  The concentration was calculated 
using the extinction coefficient for Au nanoparticles (ε520 = 3.64E8 M
-1
cm
-1
). The absorbance of 
the supernatant was also measured at 260 nm to determine the concentration of unconjugated 
DNA.  The ratio of unconjugated DNA to nanoblossom concentration was used to calculate the 
average number of DNA strands per gold nanoparticle.  To do this, the absorbance at 260 of a 
solution that contained no AuNPs was compared to the supernatant from the NB conjugation 
experiment to determine the extent bound to the AuNP during conjugation. The emission 
spectrum of the nanoblossoms was obtained for a 1 µM RSV-NB-Cy5 or GAPDH-NB solution.  
This solution was incubated with 2 µM RSV compliment or GAPDH compliment, respectively, at 
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70 ºC for 1 hr and then cooled to RT for 12 hours, protected from light.  The emission was 
collected from 580 to 800 nm on a Cary Eclipse Fluorescence Spectrophotometer, at 1 nm 
increments.  Dynamic light scattering (DLS) data was collected for a 0.25 nM solution of AuNPs 
only, RSV-NBs only and GAPDH-NBs only.  The RSV-NBs and GAPDH-NBs were centrifuged 
and resuspended in RNase free water prior to DLS measurements.  DLS measurements were 
taken with seven measurements per run, with five runs per samples using a Malvern Zetasizer 
nanoZS.  The runs were then averaged to obtain the size distrubution for particles present in each 
solution.  Resistence to degradation by DNase I was assayed by diluting RSV-NB-Cy5 or 
GAPDH-NB to 1.6 nM in Mg
2+
/Ca
2+
 free PBS containing 50 mg/mL of BSA and 0.25 nM 
MgCl2·6H2O.  0.38 mg/L DNase I was added to the diluted RSV-NB  or GAPDH-NB in a black 
96 well plate and fluorescence monitored in 1 min increments for 120 min. 
 
Efficiency of NB transfection 
Flow cytometry was used to determine the extent of nanoblossom internalization and 
efficiency of transfection.  For this, HEp-2 cells were plated in 6 well plates, and infected as 
described above, with a MOI of 1. To optimize RSV-NB incubation times, samples were treated 
with 0.5 nM RSV-NB-Cy5s diluted in culture media and incbuated for either 6, 4, 2, 1, or 0.5 hrs.  
The samples were washed 3 times with Mg
2+
/Ca
2+
 free PBS and fresh culture media was then 
added and samples were allowed to hybridize under these conditions for an additional 12 hours.  
After 12 hours, the samples were lifted from the plate using a 10 % EDTA solution, centrifuged 
and resupended in a solution of 1 nM propidium iodide diluted in PBS.  The samples were 
analyzed on a Custom Becton Dickinson five-laser LSRII analytical cytometer using APC 
excitation and filter settings to measure PI fluorescence signal.  The fluorescence signal from the 
nanoblossoms was simultaneously monitored using a Cy5 excitation/filter set.  Gating allowed 
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the PI signal from cells that are positive for nanoblossom fluorescence to be specifically 
monitored. 
 
In vitro nanoblossom specificity assays 
In vitro experiments were performed to demonstrate the specificity of the synthesized 
nanoblossoms.  For each concentration, the NB solution was added to a solution of either the 
compliment sequence (RSVcomp or GAPDHcomp) or a random sequence, femA.  The sequence 
for RSVcomp from 3’ to 5’ is TTT TTT TAC CCC GTT TAT TTT TT.  The sequence for 
GAPDHcomp from 3’ to 5’ is TTT TTT GGT ATC GTG GAA GGA CTC TTT TT.  The 
sequence for the femA control sequence is A GTA TTG GAA GTC GTT CGA AAT TGA TCA 
CTC GCA from 3’ to 5’.  The control femA sequence contained approximately the same C and G 
composition as the RSV compliment.  RSV-NB-Red590 specificity was investigated for RSV-
NB-Red590 concentrations from 2.885 nM to 1.4 nM, diluted with PBS.  For both RSVcomp and 
femA, concentrations ranging from 1.005 μM to 7.85 nM were investigated.  Appropriate 
concentrations of RSV-NB-Red590 and either RSVcomp or femA were combined in a 96 well 
plate.  The sample was covered, heated to 70 °C for one hour and allowed to cool to room 
temperature for 12 hours, protected from light.  After 12 hours, the fluorescence was measured 
using a Bio-Tek Synergy HY multidetection microplate reader. The samples were excited using a 
530/25 and the emissions will be collected using a 590/30 filter.  GAPDH-NB specificity was 
verified with the same method.   
 
RSV genomic RNA labeling in HEp-2 cells 
Confocal microscopy was used to demonstrate the ability of the nanoblossoms to label 
RSV specific RNA in the human epithelial cell line, HEp-2.  HEp-2 cells were plated and infected 
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as described above with an MOI of either 3 or 0.1.  Seventeen hours after infection, the samples 
were treated with 0.5 nM RSV-NB-Cy5 and incubated for 6 hrs. The samples were then gently 
washed with Mg
2+
/Ca
2+
 free PBS 3 times, fresh complete Opti-MEM growth media was added to 
each sample and allowed to incubate for an additional 12 hrs.  Immediately prior to imaging, 
samples were gently washed with Mg
2+
/Ca
2+
 free PBS 3times and  PBS was added to each sample 
for imaging.  Uninfected controls were treated with RSV-NB-Cy5 similarly.  Untreated RSV 
infected controls were treated in a similar manner using complete Opti-MEM media only.  
Finally, uninfected, untreated controls were also treated in a similar manner using complete Opti-
MEM media only.  All samples were imaged on a Zeiss LSM 510 Meta inverted confocal 
microscope equipped with LSM Image Browser software with 40x magnification.  The samples 
were exciting using a 630 laser and emissions were detected using a 650 long pass filter, keeping 
the detector gain consistent during imaging of all samples.   
 
Microscopic detection of Nanoblossoms in HEp-2 cells 
HEp-2 cells were plated on Lab-Tek II chambered coverglass at a density of 50 X 10
4
 
cells per chamber (1.7 cm
2
) in DMEM with 10% FBS, and was maintained at 5% CO2, 37°C 
overnight.  The following day, HEp-2 cells were infected with RSV at an MOI of 0.25 (12,500 
PFU/mL) or left uninfected and cultured for an additional 48 hrs.  Following this incubation 
period HEp-2 cells were rinsed three times in Hank’s Balanced Salt Solution (HBSS), and the 
media was replaced with DMEM containing either 0.5 mM GADPH-NB or 0.2 mM RSV-NB for 
4 hours at 37°C.  In a parallel experiment, cells exposed to the same NB doses for the same 
duration were incubated with trypan blue to ensure that cell viability was > 95% to identify 
spurious uptake results.  Following this period, cells were rinsed three times in HBSS, fixed in 
4% paraformaldehyde in PBS for 15 min. at room temperature, then rinsed three times in PBS 
containing 50 mM glycine.  HEp-2 cells were then stained for detection of gold colloids using 
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Goldenhance according to the manufacturer’s instructions.  Fast Red was used as a nuclear 
counterstain.  The samples were mounted using Cytoseal 60 (Richard Allan Scientific).  Cells 
were then viewed on a Nikon TE2000U microscope at 40X-100X magnification and 
photographed using a Hamammatsu C7780 cooled CCD color digital camera controlled by Image 
Pro Plus 5.1 (Media Cybernetics).             
 
Analysis of mechanism of Nanoblossom internalization  
HEp-2 cells were plated in 96-well microplates at a density of 5 X 10
4
 cells per well and 
incubated at 37°C and 5% CO2 in DMEM with 10% FBS overnight.  A subset of these wells were 
selected for RSV infection at MOI = 0.25 the following day, and cells were incubated for an 
additional 48 hrs.  The following day, cells were rinsed three times in serum-free DMEM, and 
were either untreated or pretreated with 100 µL volumes of DMEM containing 
nystatin/progesterone, sodium azide/2-deoxy-D-glucose, chlorpromazine, chloroquine, brefeldin 
A, dynasore, serum, nocodazole, heparin, amiloride, genistein, cytochalasin D, or no additives at 
specified concentrations for 1 hour.  The range of working concentrations of reagents was 
determined using values reported in the literature, or, when possible, empirically using known 
tracers of endocytosis: transferrin (clathrin-dependent), cholera toxin B (lipid-raft-dependent), or 
dextran (caveolar-depedent).  An acceptable working concentration for nanoblossom 
internalization assays was determined when the reagent inhibited internalization of the tracer by > 
15% in HEp-2 cells as measured by microplate spectrophotometry.  This concentration was used 
as the middle concentration in a range of 3 concentrations, to evaluate dose-dependent effects.  
Media was then aspirated and replaced with DMEM containing the same additives as well as 
RSV-NBs or GADPH-NBs, and incubated for 4 hrs.  Following this period, cells were rinsed 
three times in HBSS, fixed for 15 min. at room temperature with 4% paraformaldehyde in PBS, 
and analyzed for nanoblossom fluorescence using a Molecular Devices Spectramax M5 
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microplate reader (Cy5, 647 nm excitation, 665 emission, FAM, 570 nm excitation, 591 nm 
emission, with auto-cutoff monochromator setting).  As several solutions used to dissolve 
endocytosis study reagents were made in DMSO, cells were incubated with NBs suspended in 
DMEM with the highest concentration of DMSO used (0.5%) to monitor any solvent-induced 
effects.  Cells were incubated in parallel with endocytosis study reagents, DMEM, and 1 µM 
calcein-AM as a viability indicator to ensure reagents did not induce significant (> 5%) cell death 
in any case as determined by fluorescence microscopy and automated image analysis using Image 
Pro Plus 5.1.  Experiments were performed in triplicate.      
 
Cytotoxicity of Nanoblossoms 
HEp-2 cells were plated in 6 well plates, and infected as described above, with a MOI 
that ranges from 0.1 to 3.  After 7 hours of incubation at 37 °C, the samples were treated with 0.5 
nM RSV-NB and incubated for 6 hrs.  After 6 hrs, the samples washed gently with PBS three 
times, fresh complete Opti-MEM growth media was added and the samples were incubated for an 
additional 12 hrs.  Untreated control samples were treated in a similar manner using complete 
Opti-MEM media only.  After 12 hours, the samples were lifted from the plate using a 10 % 
EDTA solution, centrifuged and resupended in a solution of 1 nM PI.  The samples were analyzed 
on a Custom Becton Dickinson five-laser LSRII analytical cytometer using APC excitation and 
filter settings to measure PI fluorescence signal.  Gating enabled the PI signal from cells that are 
positive for RSV-NB fluorescence (monitored using a Cy5 excitation/filter set) to be specifically 
monitored.  The PI signal from untreated infected control samples was compared to that of RSV 
infected samples treated with RSV-NBs to determine the cytotoxicity.  
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Multicolor Labeling of HEp-2 cells 
HEp-2 cells were plated and infected as described above with an MOI of either 0.1 or 3.  
Seventeen hours after infection, the samples were treated simultaneously with 0.5 nM RSV-NB-
Cy5 and incubated for 6 hrs. The samples were then gently washed with Mg
2+
/Ca
2+
 free PBS 3 
times, fresh complete Opti-MEM growth media was added to each sample and allowed to 
incubate for an additional 12 hrs.  After 12 hours, either the F-protein or cellular markers were 
labeled.  For the F-protein labeled samples, the samples were incubated with anti F-protein 
primary antibodies for 30 minutes, then goat anti-mouse biotinylated secondary antibodies for 
one hour.  Finally, the samples were incubated with 10 nm 525 strepavidin conjugated quantum 
dots for 30 minutes.  The samples were washed with Mg
2+
/Ca
2+
 PBS three times between each 
step. For the samples labeled with cellular markers, samples were treated with 50 nM SYTO-13 
nuclear dye and 25 nM Mitotracker dye, diluted in complete OPTI-MEM media and incubated for 
30 minutes at 37 ºC.  All samples were then prepared for imaging.  Immediately prior to imaging, 
samples were gently washed with Mg
2+
/Ca
2+
 free PBS 3 times  and  PBS was added to each 
sample for imaging.  Uninfected controls were treated with RSV-NB-Cy5 similarily.  Untreated 
RSV infected controls were treated in a similar manner using complete Opti-MEM media only.  
Finally, uninfected, untreated controls were also treated in a similar manner using complete Opti-
MEM media only.  All samples were imaged on a Zeiss LSM 510 Meta inverted confocal 
microscope equipped with LSM Image Browser software with 40x magnification.  For F-protein 
labeled samples, the samples were exciting using a 488 laser (525 qdots) and 630 laser (RSV-NB-
Cy5) with emissions detected using a 550-620 band pass filter (525 qdots) and 650 long pass 
filter (RSV-NB-Cy5), keeping the detector gain consistent during imaging of all samples.  For 
samples labeled with ceullar markers, samples were exciting using a 488 laser (SYTO-13), 543 
laser (Mitotracker) and 630 laser (RSV-NB-Cy5) with emissions detected using a 500-530 band 
pass filter (SYTO-13), 550-620 band pass filter (Mitotracker) and 650 long pass filter (RSV-NB-
Cy5), keeping the detector gain consistent during imaging of all samples.   
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Correlation of RSV-NB signal with initial RSV infection 
HEp-2 cells were plated, infected and prepared for flow cytometry as described in the 
cytotoxicity section.  The samples were analyzed on a Custom Becton Dickinson five-laser LSRII 
analytical cytometer using APC excitation and filter settings to measure PI fluorescence signal.  
The fluorescence signal from RSV-NB-Cy5s was simultaneously be monitored using a Cy5 
excitation/filter set.  The monitoring of RSV-NB-Cy5 signal highlighted the relationship between 
the extent of sample infection and nanoblossom fluorescence.  The signal was plotted against the 
MOI for each sample to show the linear range of detection as well as signal saturation. Gating out 
PI positive cells allowed only viable cells to be monitored.   
 
Virus Titer  
 To assess the effect of NB treatment on the ability of RSV infection to progress, plaque 
assays were used to titer viral infectivity for cells which had been treated previously with RSV-
NBs.  HEp-2 cells were plated in 24 well plates and allowed to grow for 24 hours or to 80% 
confluency.   The samples were then treated with 1 nM RSV-NBs and allowed to incubate for 6 
hrs in an atmosphere of 5 % humidity, 5% CO2 at 37 °C.  The RSV-NBs were then removed and 
replaced with fresh complete Opti-MEM media.  Samples were then allowed to incubate for an 
additional 12 hours in an atmosphere of 5 % humidity, 5% CO2 at 37 °C.  Following incubation, 
samples were infected with RSV A2.  Serial dilutions were used so that individual plaques could 
be counted after 4 days of infection.   To do this, 4 wells were left uninfected, 4 wells were 
infected with stock, 4 with 10x dilution, 4 with 100x dilution, 4 with 1000x dilution and 4 with 
10,000x dilution.  The samples were then covered in methylcellulose containing Opti-MEM and 
allowed to incubate for 4 days in an atmosphere of 5 % humidity, 5% CO2 at 37 °C.  After 4 days, 
the samples were fixed using cold methanol and the RSV F-protein was labeled.  To label the F-
protein, the samples were incubated with anti F-protein primary antibodies (1:1000 dilution) for 1 
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hr at RT, followed by incubation with an HRP conjugated goat anti-mouse  secondary 
antibodies(1:1000 dilution) for one hour.  Finally, the samples were treated with HRP substrate 
for 20 minutes and the plaques were visually counted.   
 
Results 
 
Synthesis and Characterization  
To synthesize sequence specific NBs, DNA hairpins were conjugated to an AuNP 
through a 5΄ thiol.  Using modifications of molecular beacons developed by Santangelo et al, the 
NB DNA hairpin consists of a 5΄ 10 polythymine linker, followed by a 5 base ―stem‖ region 
found on each side of a ―loop‖ region, which is complimentary to the target sequence.(31)  In the 
closed state, the 5 base stem forms hydrogen bonds with its compliment located on the 3΄ side of 
the ―loop‖ region resulting in a folded conformation.   Located on the 3΄ terminus is a fluorescent 
dye (Figure 59).  This construct is very similar to that of the molecular beacon which typically 
consists of a strand of hairpin DNA flanked by a fluorophore and a quencher molecule.  However, 
with the NB construct, a single AuNP acts as the quencher for multiple strands of DNA.  Typical 
nanoblossom synthesis results in approximately 40 hairpins per AuNP, as determined by UV-Vis 
spectroscopy.   
 
 
 125 
 
 
 
 
 
In the design of sequence specific NBs, two different NB were developed – a RSV 
specific NB and a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) specific NB to serve as 
a control probe.  For the RSV specific NB (RSV-NB), the loop region of the probe targeted a 
gene end-intergenic start sequence which has three exact repeats and six almost-exact repeats 
with various numbers of nucleotide mismatches throughout the genome.(139; 140)  Similar 
intergenic repeats are common in other RNA viruses(141), suggesting that the approach may be 
generalized to the study of other viruses. Successfully used in antisense and small interfering 
RNA experiments(140-142), this site was considered the most accessible and therefore a prime 
site for oligonucleotide binding and probe targeting. A NB was also designed that was 
complimentary to the housekeeping gene GAPDH.  This NB probe was used to control for the 
compromised cell state as a result of infection with RSV.  GAPDH is a human glycoprotein 
involved in a diverse range of activities in mammalian cells.  This protein has been implicated in 
nuclear RNA export, membrane transport and fusion, protein phosphotransferase reactions, and a 
number of other important cellular functions.  The sequence used to design the GAPDH specific 
NB (GAPDH-NB) is complimentary to a sequence found in the Exon 6 region of the GAPDH 
Table 7.  Characterization of RSV- and GAPDH-NBs in the presence of their respective compliments.  
RSV- and GAPDH-NBs were characterized after synthesis in the presence of the appropriate compliment 
sequence.   The two types of NBs were found to have similar characteristics making GAPDH-NBs a good 
control sequence for RSV-NBs. The use of differing fluorescent dyes allowed the two NBs to be used 
simultaneously. 
22 nm 28 nm 
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gene.  Previous studies have shown that this region is not involved in RNA-binding protein 
interactions or the formation of double stranded RNA, making it a good target. 
RSV-NB and GAPDH-NBs characterization is summarized in Table 7.  Dynamic light 
scattering showed that the conjugation of closed RSV hairpins on AuNP resulted in an expected 
increase in overall diameter of 11nm. Similarly a 14 nm increase was seen with the conjugation 
of GAPDH specific hairpins to AuNP.  In order to achieve NB specificity, optimization of the 
length of the thyamine linker was required.  Early efforts to develop a sequence specific RSV-NB 
utilized a T3 linker.  However, this short linker resulted in non-specific fluorescent signal.  As a 
result, the linker was lengthened to T10.  In the presence of a DNA strand matching the target  
 
 
 
 
sequence (RSVcomp or GAPDHcomp), the hairpin opens, resulting in an emissions peak at 672 
nm for the RSV-NB, which contains a Quasar 670 fluorphore, a cyanine 5 (Cy5) equivalent.  A 
Figure 60. Absorbance and Emission Specta for RSV- and GAPDH-NBs.  The RSV-NB have an 
absorbance spectrum with the characteristic peaks at 254 nm and 520 nm.  The open RSV-NB 
emission spectrum has a λmax at 670 nm (A). The GAPDH-NBs have an similar absorbance spectra 
and the open GAPDH-NB emission spectrum has a λmax at 611 nm (B). 
 
A. B. 
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similar emission peak was seen at 611 nm for the GAPDH-NB which has a CAL fluor Red590 
fluorophore at the 3’ end (Figure 60).   This peak is not observed in the closed state for either NB 
species.   To verify signal specificity, RSV-NBs were incubated with either RSVcomp or a 
nonspecific sequence, femA.  RSVcomp hybridized with the NB opening the hairpin, resulting in 
a 2-fold increase in fluorescent signal compared to femA (Figure 61).   A titration of RSV-NB 
with excess compliment shows the expected saturation behavior.  Above RSVcomp 
concentrations of 50 nM, all of the accessible ―petals‖ of the RSV-NB have opened. Similar 
experiments were performed with GAPDH-NB, which showed a 1.5-fold increase in fluorescence 
in comparison to femA (Figure 61).  To determine the susepctibility of the probes to degradation 
by cellular DNases, RSV-NBs and GAPDH-NBs were exposed to DNase I.  In the presence of 
DNase I, RSV-NBs and GAPDH-NBs were degraded at a rate of 0.072 nmol min
-1 
and 0.094 
nmol min
-1
, respectively (Figure 62).     
 
 
 
 
Figure 62.  In vitro Specificity of RSV- and GAPDH-NBs.  In solution, the RSV-NB specifically hybridizes 
with the compliment RSV DNA. Hybridization opens the hairpin, allowing the fluorophore to emit a 
fluorescent signal (A, pink).  Similarly, GAPDH-NB specifically hybridized with the compliment GAPDH 
DNA, emitting a fluorescent signal (B, pink).  However, in each case, no fluorescence signal was detected 
using a noncomplimentary sequence, femA (A and B, blue).   
A. B. 
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Transfection 
RSV-NB in vivo specificity was explored in HEp-2 cells. The HEp-2 cell line is 
commonly used as a model to study RSV infection and is ideal for investigating the intracellular 
properties of the RSV-NBs.   The multiplicity of infection (MOI) of a sample corresponds to the  
 
 
 
 
 
 
 
 
 
percent of the cell population likely infected during initial infection period.  Infected with RSV at 
a MOI of 3, nearly all cells are infected at the time of imaging.  
  Flow cytometry was used to determine if uninfected populations can easily be 
distinguished from RSV-infected HEp-2 cell populations (MOI = 1, approximately 90% of the 
cells infected) which have been treated with equal concentrations of RSV-NBs (Figure 63A).  
For these assays, the viability dye PI was used to eliminate signal as a result of dead cells, 
thereby, insuring all intensity increases were a result of virus detection within viable cells.  
Figure 62.  Degradation of RSV-NBs by DNase I.  When reacted with Dnase I, the RSV-NBs had a rate 
of Degradation by Dnase I of 0.072 nmol/min as determined from the linear region of the fluorescence 
emission spectrum. 
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Analysis of the RSV-NB signal demonstrates a three fold difference between the fluorescence of 
uninfected- and RSV-infected cell populations.   To further explore the concentration-signal 
relationship, HEp-2 cells were infected with initial RSV MOIs ranging from 0 to 1 ensuring 
different levels of infection for each sample at time of analysis (Figure 63B).  When treated with 
equal concentrations of RSV-NB, a viral concentration dependant increase in the mean intensity 
of RSV-NB fluorescence was observed from 0 MOI to 0.5 MOI.  For this range of MOIs, this 
infected percentage would range  
 
 
 
 
 
 
from 0 (0 MOI) to 50 % (0.5 MOI) of the cell population.  Above 0.5 MOI blossom saturation 
occurs.  Further analysis of the flow cytometry data showed an efficiency of transfection of >95% 
(Figure 64).   
Figure 63. Flow cytometric analysis of RSV-NB signal in RSV-infected cells.  A. RSV-infected cell 
populations can easily be distinguished from uninfected populations when treated with 0.5 nM RSV-
NB by monitoring the fluorescence using flow cytometry. The histograms demonstrate that there is a 
three fold difference between the fluorescence of uninfected cells and RSV-infected cells.  B.  Flow 
cytometry was also used to demonstrate the relationship between fluorescent signal and initial RSV 
infection concentration. When treated with equal concentrations of RSV-NB, the mean intensity of 
fluorescence increases as a function of initial RSV infection. For this assay, all samples were infected 
for 35 hours before the signal was detected.  This corresponds to the first spike in RNA concentration 
after infection. 
A. B. 
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Further experiments were conducted to verify NB internalization.  Gold colloid staining revealed 
diffuse and perinuclear distribution of NB in the cytoplasm of HEp-2 cells.  RSV-NB were visible 
in RSV-infected cells to the same extent as uninfected cells (Figure 65).  Using this method, 
observations indicated that both RSV-NB as well as GAPDH-NB are efficiently internalized in 
HEp-2 cells, and that internalization is independent of the specific target sequence.    
 
 
 
 
Figure 64.  Efficiency of transfection of NBs.  In RSV-infected cells  which had been treated  with 
RSV-NB , 95.3 %  of the population had a positive fluorescent signal, indicating a >95.3 % efficieny of 
transfection.  B. In contrast, RSV-infected cells which had not been treated with RSV-NB did not show a 
positive fluorescent signal. 
Figure 65.  Light micrograph of RSV-NB within HEp-2 cells.  Light micrographs of nanoblossoms (black 
dots) in HEp-2 cells incubated with NBs. Nanoblossoms appear as black punctate spots against the white 
background due to treatment with the Goldenhance gold colloid amplification kit (Nanoprobes, Inc.).  
Distribution of the NB is diffuse and perinuclear, qualitatively suggesting a non-endosomal mode of 
translocation.  Cells did not take up trypan blue, the exclusion of which indicates cell viability of labeled 
cells. (A) HEp-2 incubated with 0.5 nM GADPH-NB. (B) RSV-induced cell syncytium showing 
intracellular RSV-NB.  (C) Uninfected HEp-2 still internalize NB directed against RSV RNA. 
A. B. 
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To elucidate the mechanism of NB uptake in HEp-2 cells, biochemical and 
pharmacologic-based endocytosis inhibition assays were performed.  These assays evaluated the 
effects of impairing single modes of classical endocytosis on NB translocation across the cell 
membrane (Table 8).  Preliminary studies support the hypothesis that NBs are capable of 
efficient transport into mammalian cells due to an intimate interaction with lipid domains on cell 
membranes, rather than energy-dependent endocytosis.  Fluorescence-based pharmacologic 
screening assays revealed that the compounds or conditions that influence cell membrane fluidity  
 
Inhibitor Mechanism of Action 
Effect on NB 
fluorescence  
Chlorpromazine inhibits clathrin pit formation none 
Chloroquine inhibits endosomal acidification <-10 % 
Serum numerous, uncharacterized -30% 
Heparin competitively inhibits heparin sulfate proteoglycan-mediated endocytosis none 
4C pretreatment reduces membrane fluidity, inhibits energy-dependent endocytosis -20% 
Azide/2-
deoxyglucose depletes cellular energy <-10% 
Nystatin/Progesterone 
depletes membrane cholesterol, inhibits lipid raft/caveolin-mediated 
endocytosis 30% 
Cytochalasin D inhibits actin-based intracellular transport <-10% 
Nocodazole  inhibits microtubule-based intracellular transport <-10% 
Brefeldin A inhibits late endosomal trafficking (Golgi-ER sorting) <-10% 
Dynasore inhibits dynamin-mediated endocytosis (including clathrin, caveolin) <-10% 
Amiloride inhibits fluid-phase macropinocytosis none 
Genistein inhibits tyrosine kinases none 
 
 
 
Table 8.  Effect of Classic Endocytosis Inhibitor on cellular entry by NB. The observed decrease or 
increase in relative fluorescence signal in microplate spectrophotometry assays is compared to control.  
Results are shown for GADPH-NB signal in uninfected HEp-2 cells, although results are representative of 
those observed for RSV-NB in infected cells. 
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had profound influences on NB fluorescence (Figure 66).  Nystatin and progesterone, which 
induces cholesterol sequestration and disturbs membrane fluidity and continuity, enhanced NB 
fluorescence by up to 70%.  Alternately, preincubation at 4°C, which decreases membrane 
fluidity, reduced NB fluorescence by over 15%.  The presence of fetal bovine serum in the media 
reduced NB signal by over 20%.   
In contrast, inhibitors of classical clathrin-mediated endocytosis (chlorpromazine),(143) 
dynamin-dependent endocytosis (Dynasore),(144) and macropinocytosis (amiloride),(145) did 
not exhibit dose-dependent effects on NB signal, nor did downstream trafficking inhibitors such 
as brefeldin A (Golgi-ER trafficking)(146) and nocodazole (microtubule-assisted 
trafficking).(147)  Even global endocytosis inhibitors such as cellular energy depletion (sodium 
azide, 2-deoxy-D-glucose)(148) did not reduce NB signal below a 15% margin, suggesting that 
energy-dependent translocation mechanisms play a minimal role in cytosolic delivery of NBs 
(Figure 66).  
 
 
 
 
 
 
 
 
 
Figure 66.  Effect of Global Endocytosis Inhibitors on cell entry by NBs.  Summary of major 
inhibitors and enhancers of NB transport.  Results are expressed as mean ± SD, n = 3, for HEp-2 cells 
incubated with GADPH-NB, although trends were similar for RSV-NB. 
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The cytotoxic effects of RSV-NB probes were examined by flow cytometry over a wide 
range of initial infection concentrations.   After 35 hours of infection, the samples were treated 
with PI and analyzed by flow cytometry.  At each MOI, samples treated with RSV-NB showed no 
decrease in cell viability when compared to untreated controls (Figure 67).  The cell death that 
was observed resulted from natural virally induced lysis.  This result demonstrates that RSV-NB 
treatment does not have a significant cytotoxic effect at concentrations relevant to signal 
detection.   To determine the effect of NB treatment on the progression of infection, a plaque 
assay was used.  These assays showed that while RSV infection was somewhat hindered by RSV-
NB treatment, four days post infection, cells were still heavily infected.  Treatment with RSV-NB 
did not completely halt the progression of the viral infection. 
 
 
 
 
 
 
 
 
 
 
 
Figure 67.  Cytotoxicity of RSV-NBs.  Flow cytometry was used to show RSV-NB treated samples 
(blue) did not show greater cell death than untreated samples (pink).  Samples were infected with a 
specified MOI and the extent of cell death determined after 35 hours infection.  The similar percent of 
viable cells for RSV-NB treated sample and untreated samples indicates that RSV-NBs are not cytotoxic 
at relavent concentrations. 
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 Labeling 
Confocal microscope images showed that RSV-infected samples treated with RSV-NBs 
displayed a distinct fluorescent signal.  The uninfected control samples remained dark at 
analogous detector gains and were indistinguishable from the untreated control samples (Figure 
68).  Thus, while uptake of NB is nonspecific, fluorescence of NB is RNA-specific.  Signal 
analysis of the orthogonal slices xy and xz reveal that the RSV-NB signal was clearly in the 
cytosolic region of the cell. Further, the RSV-NBs were likely not localized to an endosome.  If 
they had been sequestered in endosomes, a fluorescent signal would not have been observed as 
the virus’ RNA is found exclusively in the cytosol.   
 
 
 
 
 
Figure 68.  In vivo specificity of RSV-NBs.  RSV-infected HEp-2 cells which have been treated with 0.5 
nM RSV-NBs show a distinct fluorescence signal as seen by confocal microscopy (A).  By comparison, 
uninfected HEp-2 cells treated with equal concentrations of RSV-NBs showed no signal at comparable 
detector gains (B).  RSV-infected (C) and uninfected control samples which have not been treated with 
RSV-NBs  also displayed no fluorescent signal.  
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To confirm the ability of NBs to enter and label viable non-infected cells, GAPDH-NBs 
were used to label HEp-2 cells (Figure 69).  These samples clearly demonstrated fluorescent 
signal when treated with GAPDH-NB that was not present in untreated samples.  RSV-infected 
cells simultaneously labeled with both RSV-NB and GAPDH-NBs showed differential labeling 
of the GAPDH sequence and viral RSV RNA.  These experiments demonstrated the ability to use  
 
 
 
 
different sequences on NBs to simultaneously label more than one target RNA sequence.  Some 
colocalization of RSV-NBs and GAPDH-NBs was seen (Figure 70).  Importantly, while 
fluorescent signal confirmed the presence of multiple NB species RSV-infected cells, only the 
GAPDH-NB fluorescence was observed in healthy uninfected cells.   
 Two experiments were performed to explore the multicolor labeling potential of NB and 
traditional labeling techniques. Multiplexed spatial imaging was used to simultaneously label 
Figure 69.  In vivo labeling of housekeeping gene using GAPDH-NB. HEp-2 cells which have been treated 
with 0.5 nM GAPDH-NBs show a distinct fluorescence signal as seen by confocal microscopy demonstrating 
the ability of of NBs to enter healthy HEp-2 cells. 
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RSV viral RNA as well as two cellular organelles, the nucleus and mitochondria (Figure 71).  
Though the nucleus and mitochondria are clearly visible in all samples, fluorescent RSV-NB 
signal was only visible the in RSV-infected cells.  These experiments also clearly show that the 
RSV-NB signal is not located in the nucleus and rather appears to be in the cytosolic region of the 
cell, as previously discussed.   
 
 
 
 
 
 
 
 
 
 
 
The RSV F-protein and viral genomic RNA were colabeled in HEp-2 cells. The F-protein 
was labeled using anti-F protein primary antibodies and 525 nm quantum dots as previously 
described in Bentzen, et al, then treated with RSV-NBs(149).  RSV-infected cells showed the F-
protein quantum dots and RSV-NBs found in the same cells with the F-protein signal localized to 
Figure 70.  Dual labeling of RSV-infected HEp-2 cells with RSV- and GAPDH-NBs.  RSV-infected 
HEp-2 cells have been treated with both 0.5 nM RSV-NB and 0.5 nM GAPDH-NB show. GAPDH-NB 
signal (red) can be distinguished from the RSV-NB signal (blue).  In these dual labeled samples, areas of 
colocalization of the GAPDH-NB and RSV-NB signal can be identified.  However, the majority of the 
RSV-NB signal is located in a different cellular region than the GAPDH-NB signal. 
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the surface of the cells and the genomic RNA localized to the cytoplasmic region.   In contrast, 
uninfected samples did not show signal from either the F-protein or RSV-NBs (Figure 72).   
 
Discussion 
 
Synthesis and Characterization 
An ideal probe to detect and study RNA in live cells would be easily synthesized, suitable 
for entering live cells, resisting cellular degradation and be able to specifically identify a RNA 
strand of interest.  The characterization of NBs has shown this tool to possess many of these ideal 
properties.  Dynamic light scattering showed a diameter increase expected as a result of the 
addition of the hairpin DNA to the AuNP; however, it did not show any peaks corresponding to 
larger diameters which would indicate aggregation of AuNPs.  NBs serve as a source of localized 
high concentration of the probe (40 probe strands per AuNP), and is therefore able to detect low 
concentrations of compliment.  In vitro specificity assays showed that NBs could distinguish 
between its target sequence and a random sequence containing a similar GATC make up.  The 
increased fluorescent signal is on the same order of magnitude as previously seen with other 
oligonucleotide functionalized AuNP.  Moreover, because the use of different dyes gave distinct 
emissions spectra, NBs for different strands of target RNA can be used simultaneously.  In case 
of both the RSV-NB and the GAPDH-NB, the conjugation of the fluorescently labeled 
oligonucleotide to the AuNP did not cause a significant shift in the emissions peak.   
Previous fluorescently labeled oligionucleotide based tools were susceptible to probe 
degradation, often resulting in high background.  DNase I cleavage would emancipate the 
oligonucleotide from the surface of the AuNP, relieving the gold-induced quenching.  Analogous 
molecular beacon probes, which are not conjugated to AuNPs, are degraded at a rate of 1.25 nmol 
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min
-1
, 17x quicker than RSV-NBs and 13x quicker than GAPDH-NB.   Previous reports have 
shown that NFs are degraded at a rate of 0.275 nmol min
-1
,(34) which is almost 4 times faster 
than the hairpin configuration of RSV-NBs and GAPDH-NBs.  This decreased susceptibility to 
degradation by DNase I suggests the NB construct may be more stable in cellular environments.  
This stability allows for a lower background signal from NBs, making them a more reliable probe 
for both detection and spatial resolution of RNA trafficking. 
 
Transfection 
The ability to distinguish RSV-infected HEp2 cell populations from uninfected makes 
them an interesting candidate for the detection of RSV infections.  Similar fluorescent 
oligonucleotide-based approaches have been applied to the identification of RSV infected cells.  
Molecular beacons which target end-intergenic regions of bovine RSV have been utilized for the 
identification of infected cell populations.  However, effective delivery requires a reversible 
permeabilization method such as sterptolysin O (SLO).  While this method is considered less 
damaging than conventional transfection methods, its delivery efficiency is cell-type dependant.  
In contrast, the NB have been shown to efficiently enter live cells without the aid of any 
transfection agent.  NBs instead show transfection efficiencies of <95% which is consistent with 
previous literature showing that oligonucleotide functionalized AuNPs can readily pass through 
the cell membrane into cells.  NF’s were shown by flow cytometry to have an transfection 
efficiency of <99%.   In addition, cells treated with NF have showed a 2.5 increase in fluorescent 
intensity as compared to a non-complimentry control.  This is similar to the 3 fold signal 
difference seen by flow cytometry between RSV-infected and uninfected cell populations.  This 
indicates that the NBs are just as efficient of a probe in cell as NFs.    However, the use of NB can 
be expanded beyond simple detection to monitoring viral trafficking because of the unique 
characteristic that offers spatial resolution.   Because the fluorescent signal was specific to RSV-
 139 
 
infected cells, additional gold colloid staining examine the presence of NBs in both RSV-infected 
and uninfected cells. These studies verified the conclusion that the increase in fluorescent 
intensity seen in RSV-infected cells was the result of NB opening, not more efficient transfection 
into infected cells.   
Though the ability of NBs to readily cross the plasma membrane into cells had been 
confirmed, these experiments offered little to explain the mechanism of NB uptake.  Therefore, 
the biochemical and pharmacologic-based endocytosis inhibition assays were used to provide 
insight into potential mechanisms.  The increased NB uptake found with nystatin and progestorne 
may be a result of the depletion of cholesterol by nystatin and progesterone via enhanced fluidity 
of lipid domains. However, these results could be a side effect of the pore forming capabilities of 
nystatin compounds, although membrane permeabilization has been mainly observed in fungi, not 
mammalian cells.(150)  The observation that 4°C preincubation, impaired NB signal by more 
than 15%, which is not seen with any specific endocytosis inhibitors, supports the hypothesis that 
NB uptake is primarily due to lipid membrane-NB interactions.  Additionally, the decrease in NB 
uptake seen in the presence of fetal bovine serum could be either due to serum protein adsorption 
on NB surfaces, thereby conferring steric hindrance or bulkiness upon the construct, or due to 
competitive inhibition of the attachment protein(s) or lipid domains on the cell membrane by 
serum components.(151) The general mechanism accepted for many AuNPs in the size range of 
14-100 nm and other functionalized nanoparticles such as DNA wrapped single-walled carbon 
nanotubes arises from the adhesion of media proteins to the surfaces of nanoparticles during a 
typical cell culture incubation experiment.  This results in receptor-mediated endocytosis.  
Interestingly however, in the case of NBs, endocytosis inhibitors were found to have minimal 
effect on the transfection of NBs and energy dependant translocation mechanisms appear to have 
a minimal influence.    With low cellular toxicity, NBs proved to be a promising tool to expand 
upon to probe their labeling capabilities in live cells experiments. 
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 Labeling 
The labeling of viral RNA in RSV-infected HEp-2 cells made it possible to not only 
identifies infected cell samples, but also where it is localized within the cell.  The use of other 
onligonucledutide functionalized AuNP, such as NFs, could only provide information about 
presence of RNA, void of spatial information.  Previously, RSV has been labeled using molecular 
beacon probes in live cells.  The use of NBs gave image information of equal caliber to the 
molecular beacons, without many of the drawbacks associated with the use of these probes.  At 
analogous infection times, the NBs are able to detect RSV infection as efficiently as the 
molecular beacon probes.  However, the NBs are more resistant than molecular beacons alone to 
DNase degradation and therefore are a more reliable tool.  The NB signal is also clearly localized 
inside the cytosolic region of the cell, where viral RNA is expected to be located.  In contrast, 
other nanotechnology based probes such as quantum dots are often sequestered in vesicles or 
become non-homogenously distributed in the cytoplasm, limiting their use to fixed cells. The 
nanoblossom approach alleviates these problems and allows for specific RNA monitoring in 
living systems. 
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Because RSV-infected cells already represent a compromised host system, it was 
important to establish that NBs could effectively enter and label healthy cells.  For this, a control 
sequence compliment to the housekeeping gene GAPDH was used to label healthy cells.  HEp-2 
cells labeled with GAPDH-NB showed fluorescent signal diffused in the cytosolic region of the 
cell similar to previously published GAPDH-GFP confocal experiments which show localization 
of GAPDH to the cytosol.  The ability of label more than one specific strand of RNA through the 
use of multiple NBs was explored by labeling HEp2 cells with both RSV- and GAPDH-NBs.  
Both strands of RNA could be found in the cytosolic region of the cell though they were clearly 
distinguishable from each other.   
 
Figure 71.  Colabeling of RSV RNA and cellular markers.  RSV-infected (A) and uninfected (B) Hep-2 
cells were treated with RSV-NB (blue), mitotracker dye (red) and SYTO-13 nucleic acid stain (green).  The 
RSV-infected samples showed a RSV-NB signal located in the cytosolic region of the cells that was not 
present in the uninfected control samples.    
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Bs are a specific, stable and nontoxic tool for RNA detection in live cells.  The greatest 
potential of NBs is their ability to obtain spatial information, in particular, the relationship 
between RNA localization and other aspects of cellular geography in live cells.  NBs could be 
combined with other labeling techniques to acquire enriched spatial information, enabling one to 
explore the relationship between viral RNA and other cellular components such as organelles or 
the encoded viral protein.  The co-labeling of viral RNA using RSV-NBs and the nucleus and 
mitochondira using organelle specific dyes demonstrates this ability (Figure 72).   The cellular 
markers add a frame of reference for gaining further insight into the cellular location of the viral 
RNA. 
 
Figure 72.  Colabeling of RSV RNA and RSV F-protein.  Confocal microscopy was used to 
demonstrate the multiplexing potential of RSV-NBs as well as illustrate the spatial information avilable 
by the use of RSV-NBs.  For these assays, the viral surface protein, F-protein, was labeled using 525 
Qdots and the viral RNA labeled using RSV-NBs.  In the RSV-infected samples, the F-protein (green) is 
visible on the surface of the cell while the viral RNA (blue) is localized to the interior cytosolic region of 
the cells (A).  By comparison, the uninfected control samples did not show a fluroescent signal for either 
the F-protein or viral RNA (B).   
Table 1. Summary of inhibitors/enhancers of NB signal in HEp-2 cells. 
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Final labeling experiments served to highlight the potential of NBs for live cell labeling 
and imaging of RNA within the context of a paromyxovirus infection (Figure 73).  In Figure 78, 
RSV-NBs were combined with anti-body labeling techniques used in conjuction with quantum 
dots to simultaneously label both the viral RNA and a viral surface protein, the F-protein.   
Similar labeling of the F-protein with quantum dots has previously shown that at 35 hours, a 
small amount of F-protein is already visible on the membrane of an infected cell.  However, little 
was known about the location of the genomic RNA.  Our findings were consistent with the 
Figure 73.  Orthogonial View of Colabeling of RSV RNA and RSV F-protein. The orthogonial view 
of the RSV-NB/QD dual labeled RSV-infected cells. In these dual labeled samples, as expected, the F-
protein is found largely at the surface of the cell whereas the RSV-NBs are localized to the interior of the 
cell. 
 
20 nm 
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expected localization of the F-protein but were able to provide new insight into the location of the 
genomic viral RNA.  It is clear that the viral RNA is still largely localized in the inner region of 
the cell at this point.  However, by tuning the NB probe sequence to regions of RNA specific to 
certain genes, one would be able to determine exactly how that RNA is trafficked in relation to 
the protein it encodes for.    
 
Conclusion 
 
There is a need for new probes to label and image RNA in live cells that are able to 
overcome the limitations of those currently available.  To design a better probe, it would require a 
specific list of optimal characteristics including the ability to be easily synthesized and 
characterized, specific signal with low non specific signal, favorable in vivo  properties (low 
cytotoxicity, stable, and easily internalized) as well as possess the ability to be combined with 
other traditional labeling techniques to achieve multiplexing and ultimately use this to gain spatial 
resolution.  Nanoblossoms are a novel probe which aim to fulfill these requirements to improve 
our ability to label and monitor RNA in live cells.   
To demonstrate their utility, NBs have been developed within the context of Respiratory 
Syncytial Virus.  As such, NBs are able to provide a new tool to aid in the examination of viral 
lifecycle.  In addition to the detection of RSV, RSV-NBs were used in live cells to relay spatial 
information about cellular trafficking of RNA.  This was demonstrated by the multicolor labeling 
of cytosolic viral RNA, with RSV-NB, and the viral surface F-protein, with Qdots.    By 
expanding these techniques through the alteration of the hairpin loop sequence and the choice of 
3’ terminal dye, NBs can be readily tuned to study multiple specific sequences of RNA 
simultaneously.  
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Future Work 
 
  The experiments described here demonstrate the most preliminary steps in the 
development of a probe with great potential.  However, the next stages of development would 
focus on both better characterizing the properties of the nanoblossoms themselves as well as 
investigating their range of applicability.  Specific characterization experiments would include 
investigating what effect altering the loading of hairpins onto AuNPs would have on amount of 
fluorescent signal seen in the presence of compliment.  It would be interesting to see if the 
number of hairpins per AuNP would result in an increase of fluorescence associated with more 
hairpin opening or if the increased number of hairpins would cause a decrease in fluorescent 
signal as a result of steric interactions inhibiting hairpin opening.  Other examples of optimizing 
and characterizing the NBs would include optimizing the hairpin including the length of the 
compliment stem and the length of loop sequences.  The GATC make up of both the stem 
sequence and the loop sequence could have potential effects on the specificity of the NB.  In the 
case of the stem, altering the GATC make up could increasing or decreasing the strength of the 
stem binding.  In contrast, the GATC make up of the loop region would effect how strongly the 
compliment binds to the NB and could effect any potential of the compliment ―coming off‖ of the 
NB once it had initially bound.   
 Though characterization and optimization of NBs is important for the development of the 
probe, it is also important to investigate the range of applicability.  To do this, NBs would be 
applied to the detection and labeling of a variety of RNA sequences and even more interestingly, 
to a wide range of cell types.  In order for NBs to become a widely utilized probe, it is essential to 
demonstrate that they can be effective tools in systems beyond the narrow one in which we have 
developed it.  Finally, it would be interesting to do more studies into the mechanism of NB 
internalization.  By developing a better understanding of how NBs are able to enter cells, it would 
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give more insight into the potential limitations of the probe because the probe would be limited 
by its mechanism of internalization to cells which would allow for internalization.   
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APPENDIX A 
 
LABELING OF CELLULAR ORGANELLES IN MDCK CELLS 
 
 Subcellular localization is an important aspect of many biological processes.  In the 
development of tools to study cellular trafficking, the ability to label cellular markers such as 
organelles is a valuable skill.  Here, several organelles have been labeled in the polarized MDCK 
cells and nonpolar HEp-2 cells including mitochondria, endoplasmic reticulum, nucleus, tight 
junctions (MDCK only) and actin.   
 
Materials and Methods 
 
Materials 
 DMEM culture media, OptiMEM culture media, gentimyacin, and phosphate buffered 
saline were obtained from Gibco. L-glutamine, amphoterician B, non-essential amino acids, and 
anti-calnexin antibodies were obtained from Sigma.  Formaldhyde and bovine serum albumin 
were obtained from Fisher Scientific.  Triton-X was obtained from MP Biomedicals. The human 
cell line, HEp-2, was obtained from the American Type Culture Collection (ATCC).     All other 
chemicals were obtained from Invitrogen.  All chemicals were used as they were received unless 
otherwise noted.  
 
Cell Culture 
The adherent canine kidney epithelial cell line, MDCK, was maintained in continous 
culture with DMEM  (GIBCO/BRL), supplemented with 10% fetal bovine serum, 1% non-
essential amino acids, 1% L-glutamine, 1% amphoterician B, and 0.1% gentimyacin in an 
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atmosphere of 5 % CO2, 5% humidity at 37 °C.  The human epithelial cell line, HEp-2, was 
maintained in OptiMEM culture media, supplemented with 2% fetal bovine serum, 1% L-
glutamine, 1% amphoterician B, and 0.1% gentimyacin in an atmosphere of 5 % CO2, 5% 
humidity at 37 °C. Cell viability was determined by Trypan Blue exclusion using a 
hemocytometer. 
 
Cell Labeling and Confocal Microscopy   
MDCK cells were plated at 5 x 10
4
 cells per dish onto Mat-Tek dishes and allowed to 
grow to 80% confluency in an atmosphere of 5 % CO2, 5 % humidity at 37 °C.  After 24 hours, 
the media was aspirated from the samples, which were then gently washed with phosphate 
buffered saline solution (PBS) 3X to remove any remaining media.  The samples were then fixed 
by incubating with 3.7 % formaldehyde for 10 minutes at 37 °C.  Following fixation, the samples 
were washed 3x with PBS and were subsequently permeablized by incubating 0.2 % Triton X-
100 for 7 minutes at 4 °C. After two additional PBS washes, the samples were incubated with 2 
% BSA blocking buffer for 1 h at 4 °C, then prepared with the appropriate fluorophore.  For tight 
junction labeling, the samples were incubated for 1 h at 4 °C with an anti-ZO-1 antibody 
conjugated to a 525 nm quantum dot diluted in PBS (2 % BSA) to a final antibody concentration 
of 5 mg/mL.  The nucleus was labeled by incubating the samples with  2.5 μM  TO-PRO-3 iodide 
nuclear stain  (Invitrogen) diluted in PBS with 2 % BSA for 30 min at 4 °C. To label F-actin, 
samples were treated with 10 μM rhodamine phalloidin (Invitrogen), diluted in PBS (w/ 2 % 
BSA) and incubated for 30 min at 4 °C.  To label the ER, anti-calnexin antibodies were used as 
primary antibodies and labeled with 525 quantum dots.  Samples doubled labeled for actin and 
the nucleus were first labeled with rhodamine phalloidin (as described above) then washed three 
times with PBS.  This was followed by treating the samples with TO-PRO-3 (as described 
above).  All double labeled samples were treated similarly.  For actin/tight junction labeling, the 
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tight junctions were labeled first, followed by F-actin.  Nucleus/tight junction double labeling was 
achieved by first labeling the tight junctions then the nucleus.  Finally, the triple labeled samples 
were labelled initially for tight junctions, washed three times with PBS, labeled with the F-actin 
dye, washed again 3X with PBS and finally labeled with the nuclear dye.  After labeling, all 
samples were washed three times with PBS, covered with 2 mL of fresh PBS and immediately 
imaged on the Zeiss LSM 510 Meta inverted confocal microscope.  Fluorescence imaging of tight 
junctions was accomplished by excitation by 488 nm Argon laser, followed by collection using a 
long pass 515 nm filter. Fluorescence imaging of the nucleus was accomplished by excitation at 
633 nm with a He-Ne laser, followed by collection using a long pass 650 nm filter. Finally, 
fluorescence imaging of F-actin was accomplished by excitation at 543 nm He-Ne laser, followed 
by collection using a long pass 560 nm filter. The λmax for excitation and emission for each 
fluorescent label is summarized in Table 9.  The labeling of HEp-2 cells was done similarly for 
nucleus and F-actin dyes.  
 
 
 
Results 
 
Samples were either single labeled, double labeled or triple labeled, combing 
complimentary dyes to label up to three organelles simultaneously.  The resulting combinations 
listed are shown below for MDCK (Figure 74-80) and HEp-2 cells (Figure 81-83). 
 
Table 9.  Excitation and Emission wavelengths of Organelle markers.   
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MDCK cells 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 74.  Nucleus labeled MDCK cells.   
Figure 75.  Tight junctions labeled MDCK cells. 
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Figure 76.  F-actin labeled MDCK cells.   
Figure 77.  ER labeled MDCK cells. 
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Figure 78.  Nucleus and Tight Junction labeled MDCK cells. 
Figure 79.  Nucleus and ER labeled MDCK cells. 
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Figure 80.  Triple labeled MDCK cells.  Nucleus (blue), tight junction (green), and F-actin (red) 
labeled MDCK cells.  Colocalization is shown on bottom right.  
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HEp-2 cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 81.  Nucleus labeled in HEp-2 cells. 
Figure 82.  F-actin labeled in HEp-2 cells. 
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Figure 83.  Nucleus and F-actin labeled HEp-2 cells. 
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APPENDIX B 
 
RSV F-PROTEIN LABELING WITH QUANTUM DOTS IN HEp-2 CELLS AND FISH 
OPTIMIZATION 
 
 The F-protein is a RSV surface protein necessary for proper virion fusion to a host cell as 
well as the fusion seen in cell to cell infection.  Because it is located at the surface of infected 
cells early in infection, it is a convenient marker for RSV infection.   Here a F-protein specific 
antibody and quantum dots were used to label the F-protein of RSV infected cells in a time 
dependent manner.  The development of fluorescence in situ hybridization (FISH) assays has 
become an interesting diagnostic tool in the development of virus detection systems.  FISH is 
typically performed on cells which have been fixed in a number of ways, depending on the 
particular cell line of interest.  The most critical factors in chosing a proper fixation and 
permiblization method are the propensity to produce autofluorescence and the interaction of the 
method with the target sequence.  I this appendix, fixation and permiblization protocols for HEp-
2 cells have been analyzed for their autofluorescent properties as well as their effect on target 
nucleic acid sequences to be used in the further development of a RSV-specific FISH protocol. 
 
Materials and Methods 
 
Materials 
 
 DMEM culture media, OptiMEM culture media, gentimyacin, and phosphate buffered 
saline were obtained from Gibco. L-glutamine, amphoterician B, non-essential amino acids, and 
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anti-calnexin antibodies were obtained from Sigma.  Formaldhyde and bovine serum albumin 
were obtained from Fisher Scientific.  Triton-X was obtained from MP Biomedicals.  All other 
chemicals were obtained from Invitrogen.  All chemicals were used as they were received unless 
otherwise noted. RSV type A2 virus and RSV anti F-protein antibodies were a kind gift from the 
Jim Crowe laboratory (Vanderbilt University).  The human cell line, HEp-2, was obtained from 
the American Type Culture Collection (ATCC).     
 
Cell Culture and RSV infection 
 
HEp-2 cells were grown in Opti-MEM growth media supplemented with 2% (v/v) fetal 
bovine serum (complete Opti-MEM), 2% amphoericin B, 2% glutamine and 0.1 % gentamycin 
and incubated in an environment of 37 °C with 5% carbon dioxide and 5% humidity.  For 
reproducible sample infection with RSV type A2 at different multiplicity of infections (MOI), the 
following protocol was used.  HEp-2 cells were plated and allowed to grow to 80% confluency in 
an environment of 37 °C with 5% carbon dioxide and 5% humidity.  Once the samples reach 80 
% confluency, the cells were counted using Trypan Blue exclusion and a hemocytometer, and the 
cell count averaged.  The determined cell count was multiplied by the desired MOI to determine 
the correct number of plaque forming units (pfu) needed to treat the samples. This was divided by 
the virus titer to determine the volume of virus stock to be used in sample infection.  Samples 
were treated with RSV diluted in complete Opti-MEM growth media to the appropriate 
concentration then incubated for 1 hour.  After incubation, complete Opti-MEM growth media 
containing 0.75% w/v autoclaved methylcellulose was added to each sample and incubated for 
the appropriate period of infection. 
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Labeling and Imaging F-protein in HEp-2 cells 
 
 HEp-2 cells were plated at 5 x 10
4
 cells per dish onto Mat-Tek dishes and allowed to 
grow to 80% confluency in an atmosphere of 5 % CO2, 5 % humidity at 37 °C.  After 24 hours, 
the media was aspirated from the samples, which were then gently washed with phosphate 
buffered saline solution (PBS) 3X to remove any remaining media media and samples were 
infected as described above. After the appropriate time post infection, the samples were then 
fixed by incubating with 3.7 % formaldehyde for 10 minutes at 37 °C.  Following fixation, the 
samples were washed 3x with PBS and were subsequently permeablized by incubating 0.2 % 
Triton X-100 for 7 minutes at 4 °C. After two additional PBS washes, the samples were incubated 
with 2 % BSA blocking buffer for 1 h at RT.  The samples were then incubated with anti F-
protein primary antibodies for 30 minutes, then goat anti-mouse biotinylated secondary antibodies 
for one hour.  Finally, the samples were incubated with 10 nm 525 strepavidin conjugated 
quantum dots for 30 minutes.  All samples were imaged on a Zeiss LSM 510 Meta inverted 
confocal microscope equipped with LSM Image Browser software with 40x magnification.  
Samples were exciting using a 543 laser with emissions detected using a 560 band pass filter, 
keeping the detector gain consistent during imaging of all samples.   
 
FISH Fixation and Permiablization Optimization 
 
 HEp-2 cells were plated at 5 x 10
4
 cells per dish onto Mat-Tek dishes and allowed to 
grow to 80% confluency in an atmosphere of 5 % CO2, 5 % humidity at 37 °C.  After 24 hours, 
the media was aspirated from the samples, which were then gently washed with phosphate 
buffered saline solution (PBS) 3X to remove any remaining media and samples were infected as 
described above. Seventy two hours post infection, the samples were then fixed with one of the 
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fixation/permiablization method combinations.  These combinations are summarized in Table 10.  
To evaluate the effect of each fixation and permiablization combination on the target sequence,  
the samples were treated with a molecular beacon probe specific for  a RSV gene end-intergenic 
start sequence.  This sequence has three exact repeats and six almost-exact repeats with various 
numbers of nucleotide mismatches throughout the genome.  Similar intergenic repeats are 
common in other RNA viruses, suggesting that the approach may be generalized to the study of 
other viruses. Successfully used in antisense and small interfering RNA experiments, this site was 
considered the most accessible and therefore a prime site for oligonucleotide binding and probe 
targeting.  The sequence of the molecular beacon was 5’-Cal Fluor Red-CGA CGA AAA ATG 
GGG CAA ATA CGT CG-BHQ-2-3’ where the bold bases form the molecular beacon stem. 
Control samples were not treated with the molecular beacon.  After treatment with the molecular 
beacon for 1 hr, samples were gently rinsed with PBS three times and prepared for imaging.  The 
samples were imaged on a Zeiss LS LSM 510 Meta inverted confocal microscope equipped with 
LSM Image Browser software with 40x magnification.  To determine the extent of 
autofluorescence in the region of the molecular beacon excitation and emission, samples were 
exciting using a 543 laser with emissions detected using a 560 band pass filter, keeping the 
detector gain consistent during imaging of all samples.   
 
Results 
 
Labeling and Imaging of RSV F-protein 
 
 The F-protein was successfully labeled in RSV-infected HEp-2 cells.  Fluorescent signal 
corresponding to the presence of the F-protein could be detected as early as one hour.  Each time 
point post infection saw an increase in fluorescent signal corresponding to an increase in the 
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quantity of F-protein present (Figure 84A-E).  By contrast, uninfected control samples showed 
no fluorescence at all time points (Figure 84F-J).   
 
 
 
FISH Fixation and Permiablization Optimization 
 
 The optimization of fixation and permiablization protocols (fix/perm) was completed by 
analyzing the effect of thirteen fix/perm combination on autofluorescence and target sequence 
interactions (Table 10).  Of these, seven fix/perm combinations included additives aimed at 
A1. E1. D1. C1. B1. 
E2. D2. C2. A2. B2. 
Figure 84.  F-protein labeled HEp-2 cells.  Infected samples showed an increase in fluorescent signal 
corresponding to an increase in F-protein present from 1 hr (E-1) to 96 hours (A-1).  Uninfected control 
samples showed no fluorescence at the corresponding time point (A-2 – E-2). 
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reducing autofluorescence.  Most fix/perm combinations showed little autofluorescence but also 
largely inhibited the binding of the molecular beacon to its target (Figure 85).  A few fix/perm 
combinations, GT and GTS in particular, did not interfere with the binding of the molecular 
beacon with its target sequence.  These fix/perm combinations did have higher autofluorescence 
than others but there was a substantial increase in fluorescence seen with the treatment of the 
molecular beacons suggesting these are the most promising conditions.  Because there is a 
substantial increase in signal associated with molecular beacon treatment, the autofluorescence 
can be accounted for by lowering the detector gain for all samples to remove background signal, 
allowing only fluorescence as a result of molecular beacon binding to be detected.   
 
 
 
 
 
 
Table 10. Fixation and Permiablization Methods.  The abbreviation representing each protocol is 
listed on the far left.  IN the case of some protocols, additives were used in attempts to decrease 
autofluorescence.  Those are listed in the middle column. 
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A-Untreated 
FAA-Untreated FPT-Untreated FHT-Untreated C-Untreated 
GTS-Untreated A2-Untreated GTG-Untreated GT-Untreated 
FT-Untreated EG-Untreated M-Untreated 
A-MB treated 
C-MB treated FAA-MB treated FPT-MB treated FHT-MB treated 
GTS-MB treated 
FT-MB treated EG-MB treated M-MB treated 
A2-MB treated GTG-MB treated GT-MB treated 
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Figure 85. Images of FISH fix/perm optimization protocols. For each set of fix/perm conditions, 
both the untreated and molecular beacon treated samples were infected with RSV as described above.  
Samples were imaged 3 days post infection. Fluorescent signal seen in the untreated samples is the 
result of autofluorescence whereas fluorescence seen in the molecular beacon treated samples is the 
result of both autofluorescence and fluorescence as the result of molecular beacon hybridization.  
Conditions which have increased fluorescence in the molecular beacon treated samples have not had 
the nucleic acid target compromised by the fix/perm process.  
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